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Abstract 
 
Current methods used in the diagnosis of coronary artery disease vary in sensitivity and 
specificity and have a number of limitations. The aim of this thesis investigation was to 
explore a new technique for inducing hypocapnia in resting subjects and investigate whether 
this technique has any clinical applications in the diagnosis of coronary artery disease.  
 
In 18 healthy subjects, the effects of hypocapnia, induced by mechanical hyperventilation (in 
21% or 15% inspired O2), on cardiac electrical activity and heart function were investigated 
using an electrocardiogram (ECG) and echocardiogram. In addition, a pilot study was 
conducted to examine the effect of hypocapnia on the ECG of four patients suffering from 
coronary artery disease with stable angina. 
 
Experiments using mechanical hyperventilation showed that the most severe hypocapnia 
tolerable (PetCO2 = 20 ± 0mmHg) in normal healthy subjects causes a significant increase in 
T wave amplitude (increase of up to 0.09 ± 0.02mV, P < 0.01) in the anteroseptal leads (V1-3) 
of 18 normal subjects but these changes do not exceed the clinical thresholds for hyperacute T 
wave amplitudes. Hypocapnia did not cause any other significant ECG or echocardiographic 
changes during mechanical hyperventilation.  
 
Reducing inspired O2 to 15% during hypocapnia in nine normal subjects did not accentuate 
any of the T wave changes seen during hypocapnia, nor did it cause any clinically significant 
changes to appear.  
 
In two patients suffering from coronary artery disease with stable angina, no clinically 
significant ECG changes were seen during hypocapnia. These patients were taking isosorbide 
mononitrate medication which could have interfered with the vasoconstrictive effects of 
hypocapnia. In two patients not taking this type of medication, small increases in T wave 
amplitude (of up to 0.05 ± 0.01mV) and decreases in ST segment height (of up to 0.05 ± 
0.01mV) were observed. 
 
These results show that hypocapnia, induced by mechanical hyperventilation, of the greatest 
severity tolerable in normal subjects, does not induce clinically significant ECG changes in 
normal healthy subjects as has been previously suggested. Preliminary results from four 
patients suffering from stable angina suggest that hypocapnia does cause small ECG changes 
but these are not consistent and are unlikely to be of clinical importance. However, 
conclusions about the clinical applications of this technique cannot be made until more 
patients are studied. 
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Chapter 1 
 
Introduction 
 
The aim of this thesis is to investigate the effects of hypocapnia induced by mechanical 
hyperventilation on cardiac electrical activity and heart function. This is of interest because of 
the potential clinical applications of this technique in the diagnosis of coronary artery disease. 
 
In patients who suffer from coronary artery disease, a narrowing of the coronary artery 
diameter (due to a build up of atherosclerotic plaques) reduces blood flow and O2 delivery to 
the myocardium (Braunwald et al., 2001). If this occlusion of the coronary artery is of 
sufficient severity, myocardial ischemia will develop because of an imbalance between the O2 
supply and the O2 demand. This causes abnormalities in contractility and electrical activity 
within the heart which can be detected using a variety of cardiac imaging techniques.  
 
For patients who experience chest pain (angina) during physical activity, the presence of 
coronary artery disease can be detected using invasive anatomical testing for obstructive 
coronary artery disease (coronary angiography) or non-invasive functional testing for 
myocardial ischemia (Cooper et al., 2010). The current clinical procedures for diagnosing 
coronary artery disease with stable angina are discussed below. All previous literature 
described in this thesis refers to experiments carried out in unanaesthetised man unless 
otherwise stated. 
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1.1. Diagnostic tests for coronary artery disease 
According to recent guidelines published by the National Institute for Clinical Excellence 
(NICE) (Cooper et al., 2010), patients who present with unknown chest pain should undergo a 
clinical risk assessment to establish the likelihood that their chest pain is of cardiac origin. 
During this risk assessment, clinical history and risk factors for cardiovascular disease are 
recorded and a physical examination takes place. The decision to recommend further 
diagnostic testing for coronary artery disease is based on the outcome of the clinical risk 
assessment. According to the guidelines, patients with a high risk of having coronary artery 
disease (60-90% risk) should be recommended for invasive anatomical testing with coronary 
angiography (see chapter 1.1.1). Those with a moderate risk of developing coronary artery 
disease (30-60% risk) should undergo functional testing for myocardial ischemia (see chapter 
1.1.2-1.1.5). The methods, limitations and clinical sensitivity and specificity for coronary 
artery disease of these functional tests are described below. The sensitivity of a diagnostic test 
refers to the percentage of cases in which the test positively identifies the existence of disease. 
The specificity of a diagnostic test refers to the percentage of cases in which the test is 
negative in a patient without disease. 
 
1.1.1. Coronary angiography  
Coronary angiography is an invasive, anatomical test for coronary artery disease and is 
considered the reference ‘gold’ standard test to which all other diagnostic tests for coronary 
artery disease are compared (Pepine, 1992; Braunwald et al., 2001). The technique uses a 
catheter inserted into the coronary artery, via the femoral/brachial/radial artery, into which a 
radiocontrast agent is injected and an x-ray image of the heart is recorded (Braunwald et al., 
2001). Flow of the radiocontrast agent through arteries that are partially occluded is restricted 
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and this can be identified on the radiograph. A coronary artery with an occlusion of >70% is 
considered severe and likely to cause angina (i.e. a positive result for coronary artery disease 
with stable angina) (Cooper et al., 2010). This technique allows the identification of the 
specific artery affected by the coronary artery disease.  
 
The main limitations of this technique are that it is highly invasive, expensive and involves 
exposing the patient to a significant dose of radiation (Cooper et al., 2010). In addition, it has 
a relatively high threshold for detection (atherosclerotic plaques must be large [>70% 
occlusion] before they are noticeable on an angiogram) and does not give information on the 
functional effects of reduced blood flow (i.e. identify the actual presence or absence of 
myocardial ischemia) (Pepine, 1992).  
 
1.1.2. Exercise ECG 
Electrocardiogram (ECG) exercise stress testing is a non-invasive, functional test for 
myocardial ischemia, commonly used in the diagnosis of coronary artery disease. The 
sensitivity, specificity and limitations of the test are summarised in table 1.1.  
 
In patients with suspected coronary artery disease, the physiological stress induced by 
exercise increases the workload of the heart, therefore augmenting O2 demand and creating an 
O2 deficit. This happens because the coronary blood supply cannot match the demand due to 
obstructions in the diseased arteries (Pepine, 1992). This causes changes in cardiac electrical 
activity which can be identified on an ECG waveform. 
 
The original exercise stress test was developed by Master et al., (1942) and involved a double 
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two-step test of varying intensity, adjusted for each patient according to their exercise 
tolerance. ECGs were recorded during the test and revealed ST elevation or depression of 
>0.5mm or flattening/inversion of the T wave in 39% of 54 patients with normal resting 
ECGs and 67% in 29 patients with abnormal resting ECGs indicating the existence of 
coronary artery disease.  
 
Table 1.1. Sensitivity and Specificity of current diagnostic tests for coronary artery 
disease. 
Table 1.1. References: 1Gianrossi, et al., (1989), 2Heijenbrok, et al., (2007), 3Nandalur, et 
al., (2007). 
 
Treadmill exercise testing commonly uses the Bruce protocol (Pepine, 1992). This multistage 
exercise test consists of four stages of exercise of increasing speed and gradient, each lasting 
3 minutes with the final stage being carried out until exhaustion (Bruce et al., 1963). Each 
Diagnostic Technique Sensitivity Specificity Limitations Recommended by NICE?
Coronary Angiography Gold standard Gold standard
Highly invasive, 
expesive, exposure to 
radiation
Yes - in patients with 60-90% 
risk of developing CAD
Exercise ECG1 68% 77%
Lower accuracy than 
other techniques, little 
use in patients with 
limited exercise capacity
No - no longer considered 
cost effective by the NHS
MPS with SPECT2 88% 73%
Side effects of stress 
agents, exposure to 
radiation, requires two 
visits to the hospital
Yes - in patients with 30-60% 
risk of developing CAD
Stress echocardiography2 79% 87%
Side effects of stress 
agents, accuracy 
depends on the 
observer 
Yes - in patients with 30-60% 
risk of developing CAD
Stress perfusion MRI3 91% 81%
Side effects of stress 
agents, access to MRI 
scanners, can cause 
claustrophobia
Yes - in patients with 30-60% 
risk of developing CAD
Stress wall motion MRI3 83% 86%
Side effects of stress 
agents, access to MRI 
scanners, can cause 
claustrophobia
Yes - in patients with 30-60% 
risk of developing CAD
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stage represents an increase in exercise intensity of three metabolic equivalents (3 times the 
resting metabolic rate) (Pepine, 1992). The test is stopped if patients experience chest pain or 
ischemic ECG changes occur.  
 
The sensitivity and specificity of the ECG exercise stress test was assessed in a meta-analysis 
of 147 studies by Gianrossi et al., 1989. All studies compared the standard ECG exercise test 
to coronary angiography (reference standard). The ECG exercise test was found to have a 
sensitivity of 68% and a specificity of 77% for coronary artery disease.  
 
The ECG exercise test is considered safe if done under supervision and only induces 
myocardial infarction/death in 1/2500 patients tested (Gibbons et al., 1997). Limitations of the 
technique include a low detection rate in patients with single vessel disease. It also has less 
use in patients who have a limited exercise capacity because a heart rate of >85% of maximal 
must be achieved for the test to be effective (Braunwald et al., 2001). In addition, ECGs can 
be difficult to measure during the test because movement of the arms and legs can create 
muscle artefacts which distort the ECG waveform (Mason & Likar, 1966). This often makes 
ECG recordings illegible, although this problem can be avoided by using the modified ECG 
electrode placement devised by Mason & Likar (1966). There is some dispute as to whether 
this modified electrode placement alters the ECG waveform significantly from the standard 
ECG (Kleiner et al., 1978; Takuma et al., 1995; Jowett et al., 2005; Rautaharju et al., 1980; 
Pahlm et al., 1992; Krucoff et al., 1994; Gamble et al., 1984; Papouchado et al., 1987; 
Edenbrandt et al., 1989; Sevilla et al., 1989).  
 
Due to its low sensitivity and specificity compared to other diagnostic techniques (Gianrossi 
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et al., 1989; table 1.1), the ECG exercise test is no longer considered cost effective for 
diagnosing coronary artery disease and therefore is not recommended for use by NICE 
guidelines (Cooper et al., 2010). 
 
1.1.3. MPS with SPECT 
Myocardial perfusion scintigraphy (MPS) using single proton emission computed tomography 
(SPECT) is a non-invasive functional test for myocardial ischemia. The sensitivity, specificity 
and main limitations of the test are summarised in table 1.1.  
 
This technique uses radiopharmaceutical tracers (thallium TI-201 or technetium Tc-99m) 
which are injected into the coronary arteries at rest and during myocardial stress (exercise or 
pharmacological) (Cooper et al., 2010). The distribution of the tracer within the myocardium 
reflects regional blood flow and is measured using SPECT imaging. In patients with coronary 
artery disease (with stable angina), this blood flow is reduced during myocardial stress 
indicating the presence of myocardial ischemia. Stress can be induced by exercise or 
pharmacologically using stress agents such as dobutamine (increases heart rate and 
myocardial contractility), dipyridamole or adenosine (increases vasodilatation in healthy 
coronary arteries causing blood to flow away from diseased arteries) (Heijenbrok-Kal et al., 
2007). 
 
When coronary angiography is use as the reference standard, the sensitivity and specificity of 
MPS with SPECT varies depending on the techniques or pharmacological agent used to 
induce myocardial stress. Used with exercise, the test has a sensitivity of 88% and specificity 
of 67% (Heijenbrok-Kal et al., 2007). When pharmacological stress agents are used to induce 
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myocardial stress, MPS with SPECT has a sensitivity of 91% (adenosine), 90% 
(dipyridamole) or 84% (dobutamine) and a specificity of 81% (adenosine), 75% 
(dipyridamole) or 73% (dobutamine). The overall sensitivity and specificity of MPS with 
SPECT for coronary artery disease is 88% and 73% respectively (Heijenbrok-Kal et al., 
2007). 
 
An advantage of MPS with SPECT is the openness of the scanning equipment which, unlike 
MRI, is unlikely to cause claustrophobia. In addition, it can be used in obese patients where 
alternative imaging techniques (such as ECG and echocardiography) are impractical (Cooper 
et al., 2010). The disadvantages of the technique are that it involves a significant dose of 
radiation and two separate visits to the hospital. On occasions where pharmacological stress 
agents are used, side effects such as shortness of breath, headaches, dizziness, nausea, 
flushing, arrhythmias, airway obstruction or acute bronchospasm can occur (Cooper et al., 
2010). 
 
1.1.4. Stress echocardiography 
Stress echocardiography is a functional test for myocardial ischemia in which ultrasound is 
used to image the left ventricle and detect changes in wall motion and thickening during 
myocardial stress. The technique avoids the exposure to radiation used in alternative tests and 
can be performed using equipment that is widely available in a healthcare setting. Additional 
advantages of this technique are that it is low cost (in comparison to MPS with SPECT, MRI 
or coronary angiography), short in duration and allows identification of co-existing cardiac 
diseases (Braunwald et al., 2001). It is therefore recommended for use in patients with a 30-
60% risk of having coronary artery disease with stable angina by NICE guidelines (Cooper et 
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al., 2010). 
 
Stress is induced either by exercise or pharmacologically using stress agents such as 
dobutamine, dipyridamole or adenosine (Heijenbrok-Kal et al., 2007). Echocardiography is 
used at rest and then during stress to find evidence of decreased wall motion/thickening in at 
least one left ventricular segment and/or compensatory hyperkinesis in a non-ischemic 
segment (Cooper et al., 2010).  
 
As with MPS with SPECT, the sensitivity and specificity of stress echocardiography for 
coronary artery disease varies depending on the technique or pharmacological stress agent 
used to induce myocardial stress. A meta-analysis by Heijenbrok-Kal et al., (2007) found that 
when compared to coronary angiography as the reference standard, the sensitivity of stress 
echocardiography is highest with exercise stress (83%) compared with adenosine (79%), 
dipyridamole (72%) or dobutamine (81%). Conversely, exercise stress echocardiography was 
found to have the lowest specificity (84%) when compared to the pharmacological stress 
agents, adenosine (92%), dipyridamole (95%) or dobutamine (84%). According to 
Heijenbrok-Kal et al., (2007) the overall sensitivity and specificity of stress echocardiography 
for coronary artery disease is 79% and 87% respectively (table 1.1). 
 
The disadvantages of stress echocardiography centre on the difficulty in gaining accurate 
images of the left ventricle in some patients and a high dependence on the echocardiography 
technician’s imaging skills and experience for accurate diagnosis (Braunwald et al., 2001; 
Geleijnse et al., 1995; Picano et al., 1991). For example, stress echocardiography is not 
appropriate for use in patients with obesity, chronic obstructive airways disease or chest 
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deformity where an appropriate acoustic window cannot be obtained (Cooper et al., 2010). In 
addition, the use of pharmacological stress agents can result in unpleasant side effects (see 
section 1.1.3, page 7). 
 
1.1.5. Stress MRI  
Stress magnetic resonance imaging (MRI) is a non-invasive functional test for myocardial 
ischemia. MRI uses a powerful magnetic field and radio frequency pulses to produce detailed 
pictures of the myocardium with high contrast and excellent spatial resolution (Cooper et al., 
2010). These images can be examined on a computer and are used to assess both myocardial 
perfusion defects and wall motion abnormalities. The sensitivity, specificity and main 
limitations of both perfusion and wall motion imaging are summarised in table 1.1. 
 
Stress perfusion MRI assesses myocardial perfusion defects induced by the same 
pharmacological stress agents used in stress echocardiography and MPS with SPECT 
(Nandalur et al., 2007). Stress wall motion MRI images regional wall motion and thickening 
at rest and during pharmacological stress. If myocardial ischemia is present, wall motion and 
thickening will become inhibited.  
 
Nandalur et al., (2007) assessed the sensitivity and specificity of stress perfusion and wall 
motion MRI for coronary artery disease. Both techniques were compared to coronary 
angiography as a reference standard in a total of 37 studies. Stress perfusion MRI was found 
to have a sensitivity and specificity of 91% and 81% respectively. Stress wall motion MRI 
was estimated to have a sensitivity of 83% and specificity of 86%. The sensitivity of stress 
wall motion MRI was improved to 85% when only studies utilizing exercise or dobutamine 
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were included in the analysis.  
 
The main advantages of stress MRI are that it is non-invasive, does not involve exposure to 
radiation and has a high sensitivity and specificity for coronary artery disease when compared 
to other functional tests for myocardial ischemia (table 1.1). The primary disadvantages to 
both stress MRI techniques are that they are not appropriate for patients with ferromagnetic 
intercranial surgical clips, metallic intraocular foreign bodies, pace makers or in those who are 
morbidly obese where accurate images cannot be obtained (Cooper et al., 2010). In addition, 
access to MRI scanners can sometimes be limited, patients who suffer from claustrophobia 
may decline to be tested and the pharmacological stress agents used can cause side effects 
(see section 1.1.3, page 7). 
 
1.1.6. Summary of diagnostic tests for coronary artery disease 
All previously described anatomical and functional tests for myocardial ischemia are 
established diagnostic tests for coronary artery disease. In the UK, the decision as to which 
tests are used in clinical practice is based on the recommendations of the National Institute for 
Clinical Excellence. These recommendations are based on the accuracy of the test, the cost 
effectiveness of the test and the advantages and disadvantages to the patient. In recently 
published guidelines on the diagnosis of coronary artery disease with angina (Cooper et al., 
2010), coronary angiography, MPS with SPECT, stress echocardiography and stress MRI 
were all recommended for use in clinical practice. Despite its wide use in clinical practice, the 
exercise ECG test is no longer recommended due to its low sensitivity and specificity 
compared with other functional tests. It should be noted that all the aforementioned tests have 
limitations, such as exposure to radiation, side effects of stress agents or expense and 
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accessibility to equipment. Therefore, the advent of any new diagnostic test is welcomed, 
provided it delivers the right balance of accuracy to cost benefit and does not place the patient 
at any unnecessary risk.  
 
This thesis is concerned with a novel method of inducing hypocapnia using mechanical 
hyperventilation. Below, the technique is described, along with the physiological effects of 
hypocapnia and the potential applications of this technique in the diagnosis of coronary artery 
disease. The experiments within this thesis investigation were designed to develop this 
technique with its potential clinical applications in mind. Therefore, all experiments have 
been conducted in normal healthy subjects prior to recruiting patients with established 
coronary artery disease. 
  
1.2. Hypocapnia 
In healthy humans at rest, the partial pressure of carbon dioxide in arterial blood (PaCO2) is 
between 35-45mmHg (Ganong, 1997). Therefore, hypocapnia is defined as an abnormally 
low tension of CO2 (<35mmHg) in arterial blood (Steadman, 1972). A PaCO2 of 34mmHg 
represents a very mild form of hypocapnia. In the experiments presented in this thesis, 
hypocapnia was defined as the lowest PaCO2 possible, without inducing tetany and 
paresthesia which are known to occur below 20mmHg (Macefield & Burke, 1991). 
Hypocapnia is caused by an increase in ventilation beyond what is needed to maintain blood 
gases within a normal range (hyperventilation) (Steadman, 1972). Hyperventilation therefore 
causes a greater amount of CO2 to be exhaled than is produced in the body. Hyperventilation 
can be induced voluntarily or by mechanical ventilation.  
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1.2.1. Physiological effects of hypocapnia 
Hypocapnia decreases the concentration of H+ and HCO3- in the blood due to the bicarbonate 
buffering system (Klocke, 1987) (Equation 1.1) causing pH to increase. This increased arterial 
blood pH and the direct effect of decreased CO2 on haemoglobin causes a leftward shift of the 
oxygen dissociation curve (figure 1.1) (Roughton, 1964). This increased affinity of 
haemoglobin for O2 makes it more difficult for oxygen to dissociate into the tissues.  
 
Equation 1.1. Bicarbonate buffering system 
CO2 + H2O ⇔ H2CO3 ⇔ H+ + HCO3- 
 
Hypocapnia (15-22mmHg) also causes tetany and paraesthesia (Barker et al., 1939; 
Edmondson et al., 1975; Kruyswijk et al., 1986; Macefield & Burke, 1991; McCance, 1932; 
Miyagi et al., 1989; Neill & Hattenhauer, 1975; Previtali et al., 1989; Scherf & Schlachman, 
1947; Thompson, 1943; Yasue et al., 1978; Yu et al., 1959) thought to be caused be a 
decrease in arterial Ca2+ (Edmondson et al., 1975). Hypocapnia (17-32mmHg) induces a 
decrease of 20-39% in specific airway conductance (Sterling, 1968; Jamison et al., 1987) due 
to bronchonstriction (indicated by an 13% increase in total respiratory resistance) (Ocain et 
al., 1979). Hypocapnia (18-29mmHg) also causes a reduction of 33-81% in cerebral blood 
flow via cerebral vasoconstriction (Kety & Schmidt, 1946; Weckesser et al., 1999; Yokoyama 
et al., 2008) and decreases respiratory sinus arrhythmia by 33-74% caused by an attenuation 
in the central respiratory rhythm (Cooper et al., 2004; Sasano et al., 2002). The affects of 
hypocapnia on muscular function, airway conductance, cerebral blood flow and central 
respiratory rhythm are not relevant to this thesis investigation and therefore do not require 
further discussion. 
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Studies conducted in both animal models and humans suggest that hypocapnia causes a 
reduction in coronary blood flow via coronary vasoconstriction. For example, hypocapnia 
(23mmHg) causes a reduction in myocardial blood flow by up to 50% in anaesthetized pigs 
(measured by the thermodilution technique) (Karlsson et al., 1994) and a reduction coronary 
blood flow of 23-33% in anaesthetized dogs (measured by electromagnetic and xenon 
clearance techniques) (Vance et al., 1973; Coetzee et al., 1984). In normal healthy humans, 
measurement of coronary blood flow (measured by the nitrous oxide technique and positron 
emission tomography) have revealed that hypocapnia (19-20 mmHg) reduces overall coronary 
blood flow by 30% (Rowe et al., 1962; Yokoyama et al., 2008).  
Figure 1.12. Oxygen dissociation curve shifts to the left at high pH (PaCO2 - 20mmHg)
PaO2 (mmHg)
0 20 40 60 80 100
%
 
sa
tu
ra
tio
n
 
o
f h
a
em
o
gl
o
bi
n
0
20
40
60
80
100
pH 7.6 
pH 7.2
pH 7.4 (normal)
Figure 1.12. Oxygen dissociation curve at different levels of blood pH. A pH of 7.6
corresponds to a decrease in PaCO2 (hypocapnia). From Roughton FJW (1964). 
Transport of oxygen and carbon dioxide. In Handbook of Physiology - Section 3: 
Respiration (Volume 1), eds. Fenn WO & Rahn H, pp. 767-825. American 
Physiological Society, Washington, D.C.
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Figure 1.1. The oxygen dissociation curve shifts to the left at high pH (7.6 [PaCO2 = 
20mmHg]) 
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In patients with coronary artery disease, coronary blood flow has been shown to increase by 
13%  (Wilson et al., 1981), decrease by 12% (Neill & Hattenhauer, 1975) and not change at 
all (Kazmaier et al., 1998). The variability in responses can be explained by the severity of 
hypocapnia induced. Both Wilson et al., (1981) and Neill & Hattenhauer (1975) used 
voluntary hyperventilation to induce hypocapnia. Neill & Hattenhauer (1975) demonstrated a 
decrease in PaCO2 to 19mmHg and this coincided with a decrease 12% in coronary blood 
flow. Wilson et al., (1981) demonstrated an increase in coronary blood flow but did not 
measure PaCO2 or PetCO2 and patients in this study were only hyperventilated for a 
maximum of 6 minutes. It is therefore possible that patients were not sufficiently hypocapnic 
to cause coronary vasoconstriction. For the same reason, the findings of the Kazmaier et al., 
(1998) study should be taken with caution. Although patients were mechanically 
hyperventilated, it seems the lack of changes in coronary blood flow may have been due to the 
fact that PaCO2 only fell to 31mmHg and therefore may not have been severe enough to 
stimulate coronary vasoconstriction. 
 
The reason for and causes of hypocapnia induced coronary vasoconstriction are unknown. In 
the pulmonary vasculature, decreases in PetCO2 result in pulmonary artery vasodilatation 
which increases pulmonary blood flow (Balanos et al., 2003; Dorrington et al., 2010). The 
reason for this increase pulmonary blood flow is that hypocapnia is caused by 
hyperventilation which also increases O2 availability in the alveoli. In order to maintain 
ventilation-perfusion matching, pulmonary vasodilatation must occur to enable increased 
blood flow, allowing greater gaseous exchange at the lungs. In this case, there is an obvious 
reason for hypocapnia induced pulmonary vasodilatation. There is on the other hand, no clear 
advantage to reducing coronary blood flow to the myocardium during hyperventilation. This 
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makes it difficult to postulate the mechanism which might cause coronary vasoconstriction. 
Such mechanisms are speculated below; 
 
Hypocapnia is known to cause vasoconstriction in cerebral vascular bed (Kety & Schmidt, 
1946; Weckesser et al., 1999; Yokoyama et al., 2008). To explain this phenomenon, it has 
been suggested that the decrease in PaCO2 and increase in arterial blood pH that occurs during 
hypocapnia might cause an increase in intracellular Ca2+ in the vascular smooth muscle via 
stimulation of a pathway such as inositol 1,4,5-trisphosphate (Mirro et al., 1992). It is thought 
that this increase in intracellular Ca2+ may cause contraction of the vascular smooth muscle 
resulting in cerebral vasoconstriction. It is possible that a similar mechanism exists in the 
coronary vascular bed causing hypocapnia induced coronary vasoconstriction.  
 
An alternative possible mechanism to explain the reduction in coronary blood flow observed 
during hypocapnia is the availability of the vasodilator, nitric oxide in the coronary 
vasculature. Nitric oxide is a well known regulator of vascular resistance in the coronary 
circulation and its production in the endothelium of the coronary arteries is thought to 
maintain resting coronary artery diameter (Quyyumi et al., 1995; Lefroy et al., 1993). 
Inhibition of nitric oxide production, with substances such as NG-monomethyl-L-arginine (L-
NMMA) have been shown to reduce coronary artery diameter by up to 13% and increase 
coronary vascular resistance by up to 22% (Quyyumi et al., 1995; Lefroy et al., 1993). It can 
therefore be speculated that hypocapnia causes an increase in L-NMMA in the endothelium of 
the coronary arteries by stimulation of an (unknown) pathway. This would reduce nitric oxide 
production, inhibiting baseline coronary artery vasodilatation, causing increased coronary 
vascular resistance and decreased coronary blood flow.  
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It is suspected that coronary vasoconstriction induced by hypocapnia coupled with reduced 
oxygen dissociation into the myocardial tissues causes myocardial ischemia (Laffey & 
Kavanagh, 2002; Neill & Hattenhauer, 1975; Rutherford et al., 2005). If this is the case, 
hypocapnia may be a useful alternative type of myocardial stress to be utilised in non-invasive 
functional diagnostic testing for coronary artery disease with stable angina. One advantage of 
using hypocapnia over exercise stress to induce myocardial stress is that it does not require 
any physical exertion and therefore would be appropriate for use in patients with limited 
exercise capacity. In addition, inducing hypocapnia may be more preferable than using 
pharmacological stress agents because it has no known side effects and can be accurately 
controlled throughout the test procedure. Other advantages to using hypocapnia as a form of 
myocardial stress are that it utilises equipment that is commonly available in a clinical setting 
(mechanical ventilators), is quick to perform (takes no longer than an hour to perform as a 
test) and therefore could be considered as cost effective, provided that it is found to have a 
high sensitivity and specificity for coronary artery disease. 
 
It was the aim of this thesis investigation to extent what is already known about the effects of 
hypocapnia on cardiac electrical activity and heart function, measured by established 
techniques such as the ECG and echocardiogram. Previous studies have investigated the 
effects of hypocapnia, induced by voluntary hyperventilation, on the ECG. However, the use 
of voluntary hyperventilation to induce hypocapnia is limited when studying its effects on the 
ECG (Rutherford et al., 2005; see below, sections 1.2.2-1.2.3). This thesis investigation aims 
to eliminate these limitations using a novel method of mechanical hyperventilation to induce 
hypocapnia. 
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1.2.2. Voluntary hyperventilation vs. mechanical hyperventilation 
Voluntary hyperventilation is most commonly used in studies examining the effects of 
hypocapnia. However, this technique presents a number of limitations. Primarily, it is difficult 
to induce a consistent level of hypocapnia during voluntary hyperventilation because tidal 
volume and breathing frequency cannot be controlled. This issue can be resolved by sampling 
PetCO2 instantaneously and automatically adjusting the concentration of CO2 in inspired air 
to compensate for changes in breathing (Balanos et al., 2003; Talbot et al., 2008; Dorrington 
et al., 2010). However, even if this method is utilised, inconsistent inflation volumes still limit 
the use of voluntary hyperventilation in studies using the ECG because alterations in inflation 
volume can cause changes in ECG wave amplitudes, independently of the physiological 
effects of hypocapnia (Rutherford et al., 2005). An increase in chest inflation (of up to 0.6L) 
causes an increase in the distance of the ECG electrodes from the heart, causing a decrease in 
ECG wave amplitudes (R and T waves) of up to 0.2-0.3mV. Mechanical hyperventilation 
enables tidal volume and breathing frequency to be kept constant at a predefined level 
(Cooper et al., 2004), which is advantageous because it enables a consistent and prolonged 
hypocapnia to be induced. This also eliminates the problems associated with inconsistent 
inflation volumes and the ECG (Rutherford et al., 2005). 
 
Voluntary hyperventilation itself, increases metabolic rate (through increased work of 
respiratory muscles) creating a paradox where CO2 production is increased making 
hypocapnia more difficult to induce. Mechanical hyperventilation unloads the effort of the 
respiratory muscles, reducing metabolic rate, therefore enabling significant reductions in 
PaCO2 with only small increases in tidal volume and breathing frequency. Therefore, 
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mechanical hyperventilation represents a more effective technique for inducing hypocapnia 
and studying its effects on physiological systems within the body (Cooper et al., 2003; 2004).  
 
1.2.3. Voluntary hyperventilation and the ECG 
Several studies that utilise voluntary hyperventilation have suggested that hypocapnia causes 
ischemic ECG changes in both normal subjects and patients suffering from coronary artery 
disease.  
 
Normal subjects 
Table 1.2 shows that in normal subjects, hypocapnia (14-24mmHg) induced by voluntary 
hyperventilation causes; 
– a decrease in the amplitude of the T wave by up to 0.4mV (lead II) 
– ST segment elevation of up to 0.15mV (Leads II, III)  
– QTc prolongation of up to 0.4 seconds  
 
The effects of voluntary hyperventilation on T wave were not consistent. Changes were only 
evident in 8-57% of subjects and therefore cannot be considered reproducible (Barker et al., 
1939; Golden et al., 1975; Joy & Trump, 1981; Kemp & Ellestad, 1968; Lary & 
Goldschlager, 1974; McCance, 1932; Wasserberger et al., 1956). In addition, many studies 
did not measure end tidal CO2 (PetCO2) and so the degree of induced hypocapnia cannot be 
quantified (McCance, 1932; Thompson, 1943; Christensen, 1946; Scherf & Schlachman, 
1947; Wasserberger et al., 1956; Kemp & Ellestad, 1968; Biberman et al., 1971; Lary & 
Goldschlager, 1974; Joy & Trump, 1981; Jacobs et al., 1974).  
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Table 1.2 shows the lack of consistent changes in the T wave and ST segment during 
voluntary hyperventilation in normal subjects.  
Table 1.2. Values represent mean changes from resting ECG in mV. * = <50% change, 
** = >50% change, *** = >100% change from the resting ECG. Studies are ranked in 
order of those that demonstrate the largest T wave ST segment changes (largest first). 
 
It is possible that ECG changes were caused by inconsistent inflation volumes that occur 
during voluntary hyperventilation (Rutherford et al., 2005). This is indicated in studies where 
changes in T wave amplitude were matched by proportional changes in the R wave (table 1.2) 
(Barker et al., 1939; Scherf & Schlachman, 1947; Christensen, 1946).  
 
 
Author Duration of 
hyperventilation
Hypocapnia
?
ECG 
lead 
Mean T wave change Mean ST segment 
changes
QTc 
interval
Notes
Christensen, 
1946  (n = 3)
3-8 minutes No data I, II, III Lead I:  -0.2mV *** 
Lead II: -0.4mV *** 
Lead III: -0.16mV ***
Lead I: 0 mV     
Lead II: -0.15mV 
Lead III: -0.15mV 
No data Similar R wave 
changes
Barker et al. , 
1939  (n = 7)
8-16 minutes No data I, II, III Lead I:  -0.13mV ** 
Lead II: -0.08mV * 
Lead III: +0.01mV ***
No data  +11ms * Similar R wave 
changes, T wave 
changes only seen in 
4/7 subjects (57%)
McCance, 
1932  (n = 2)
No data No data I, II, III Lead I:  -0.35mV ** 
Lead II: -0.25mV ** 
Lead III: +0.1mV **
No data No data T wave changes were 
seen in 1/2 (50%) of 
subjects
Biberman et 
al. , 1971
(n = 12)
30-60 seconds 24 mmHg II, V4 Lead II: -0.05mV * No data  +40ms *
Scherf &
Schlachman, 
1947  (n = 35)
5-15 minutes No data I, II, III Lead I:  -0.03mV*            
Lead II: -0.03mV*            
Lead III: +0.01mV*
No data No data Similar R wave 
changes
Golden et al. , 
1975   (n = 27)
3 minutes 14 mmHg I, II, III Mean change: 
+0.004mV *
No data No data Changes of -0.2mV 
in 6/72 subjects (8%)
Joy & Trump,
1981  (n = 103)
15-30 seconds No data 12 leads No data No data No data T wave/ST segement 
changes in 55/103 
(53%) subjects
Kemp &
Ellestad, 1968
(n = 305)
30 seconds No data V5 No data No data No data T wave changes were 
seen in 73/305 (24%) 
of subjects
Lary &
Goldschlager, 
1974  (n = 46)
40-90 seconds No data 12 lead No data No data No data T wave changes were 
seen in 7/46 (15%) 
of subjects
Thompson, 
1943  (n = 25)
90 seconds No data I, II, III No data No data No data
Wasserberger 
et al. , 1956
(n = 350)
10-15 seconds No data 12 lead No data No data No data T wave changes were 
seen in 37/350 (11%) 
of subjects
 20
Patients with coronary artery disease 
Studies examining the effects of hypocapnia induced by voluntary hyperventilation on the 
ECG of patients with coronary artery disease have inconclusive findings. This is likely to be 
caused by the problems associated with voluntary hyperventilation (stated in section 1.2.2). 
Clinically significant ST segment and T wave changes associated with ischemia have been 
reported during voluntary hyperventilation (for 30 seconds – 5 minutes) in patients with 
coronary artery disease (Kemp & Ellestad, 1968; Lary & Goldschlager, 1974; Joy & Trump, 
1981; Ardissino et al., 1987). In these studies, clinically significant ECG changes are referred 
to as ST segment elevation/depression of >0.1mV and T wave inversion (<-0.1mV). 
Hyperventilation is described but the degree of hypocapnia was not measured or quantified. 
These findings were not consistent in all patients tested. In 114 patients, Kemp & Ellestad 
(1968) reported 11 cases (10%) where voluntary hyperventilation caused ischemic T wave 
changes. Others have demonstrated clinically significant ST segment and T wave changes in 
up to 70% of patients suffering from known coronary artery disease (diagnosed by coronary 
angiography) during voluntary hyperventilation (Jacobs et al., 1974; Joy & Trump, 1981; 
Ardissino et al., 1987).  
 
1.2.4. Mechanical hyperventilation and the ECG 
The effects of hypocapnia, induced by mechanical hyperventilation, on the ECG have only 
been successfully investigated in one previous study. Rutherford et al., (2005) demonstrated a 
statistically significant decrease in T wave amplitude (of 0.1mV) in 13/15 healthy subjects 
(87%) during hypocapnia (20 mmHg), induced by mechanical hyperventilation. They used a 
digital ECG recording system that averages two minutes of recorded ECG waveforms and 
demonstrated a reduction in T wave amplitude in lead I, independent of R wave changes. It 
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was suggested that this T wave reduction was caused by a decrease in O2 availability in the 
myocardium as a result of hypocapnia induced coronary vasoconstriction and decreased O2 
dissociation into the tissues. By inducing hypocapnia with mechanical hyperventilation, tidal 
volume and breathing frequency could be accurately controlled and the effects of varied chest 
inflation on the ECG were eliminated. These effects were demonstrated in a single lead ECG 
with the limb electrodes placed in the modified electrode placement. It is unclear whether this 
modified electrode placement affected the wave amplitudes recorded in this study.  
 
1.3. Summary & thesis objectives 
The main objective of this thesis investigation was to study the effects of hypocapnia on 
cardiac electrical activity and heart function in normal subjects. In addition, it was of interest 
to study the effects of hypocapnia in patients suffering from coronary artery disease with 
stable angina to establish whether this technique has any value as a diagnostic test. The effects 
of hypocapnia on both normal subjects and patients were investigated using mechanical 
ventilation as described by Rutherford et al., (2005). Since Rutherford et al., (2005) used a 
modified electrode placement, it was of interest to establish to what degree this affects the 
ECG waveform compared to the standard electrode placement. Much debate still exists as to 
the extent of ECG changes that occur. Therefore, the first aim of this thesis investigation was 
to identify to what degree the modified electrode placement causes changes in the ECG 
waveform. 
 
The 12 lead ECG allows the regional effects of hypocapnia to be assessed across the left 
ventricle. The effects of hypocapnia, induced by mechanical hyperventilation on the 12 lead 
ECG have never been fully assessed. The second objective of this thesis investigation was to 
 22
repeat the method of inducing hypocapnia by mechanical hyperventilation (used by 
Rutherford et al., 2005) and measure its effects on cardiac electrical activity using a 12 lead 
ECG in normal subjects. It was hoped that this would confirm the findings of Rutherford et 
al., (2005) and provide new information on the overall effects of hypocapnia across the heart. 
In addition to measuring R and T wave amplitudes, additional measurements of ST segment 
height and QTc interval duration were made and used to indicate whether ECG changes 
during hypocapnia were of ischemic origin. Echocardiograms were also recorded as a 
additional measure of heart function, to confirm any ischemic ECG changes seen with 
electrocardiography. 
 
In the event that small, potentially ischemic ECG changes did occur during hypocapnia, 
normal subjects were also hyperventilated in 15% inspired O2. Inspired hypoxia has been used 
previously to induce myocardial ischemia and ECG changes in both normal subjects and 
patients suffering from coronary artery disease (Katz et al., 1934; Levy et al., 1938; 1939; 
1941; Barach et al., 1941; Turner & Morton, 1952; Haarstad & Broch, 1958; Broch, 1972b). 
These effects were only evident when inspired O2 was at 7.5-10% and O2 saturation fell 
below 70% (Haarstad & Broch, 1958). Hypoxia of this severity is uncomfortable and has a 
number of adverse side effects (Stewart & Carr, 1954). In the present investigation, it was of 
interest to see whether a safe, comfortable level of inspired O2 (equivalent to the O2 inspired 
from air at an altitude of 6,700 feet [Ward et al., 2000] or on routine commercial aircraft 
flights [Cottrell, 1988]) would be enough to augment any potentially ischemic ECG changes 
seen during hypocapnia in 21% inspired O2. 
 
The final study of this thesis investigation was a pilot study looking at the affects of 
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hypocapnia, induced by mechanical hyperventilation, on the ECG of patients with known 
coronary artery disease. The aim of this final investigation to was see if consistent, clinically 
significant ECG changes, similar to those seen during other provocative tests for coronary 
artery disease, can be induced by hypocapnia.  
 
The following chapter will consider the general methods of experiments conducted in this 
thesis investigation. Subsequent self contained chapters will examine each aim of the thesis, 
and methods of these studies will only be summarised. The final chapter of the thesis will 
summarise the main findings of the thesis investigation, the clinical implications, the main 
strengths and limitations of the studies conducted and what these findings mean for future 
experiments conducted in this area. 
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Chapter 2 
 
General Methods 
 
2.1. Proposed experiments 
1) Since Rutherford et al., (2005) used a modified electrode placement to compare the effects 
of hypocapnia on the ECG, the effects of modifying the ECG electrode placement on the ECG 
waveform was investigated. Wave amplitudes recorded in both standard and modified 
electrode placements were compared and quantified in the context of the most up to date 
clinical guidelines on normal ECG waveforms.  
2) The effects of hypocapnia on the single lead ECG in normal healthy subjects were 
confirmed using the methods of Rutherford et al., (2005). In addition, the effects of 
hypocapnia on overall cardiac electrical activity were examined using a 12 lead ECG and 
global heart function using echocardiography.  
3) Subjects were hyperventilated in 15% inspired O2 to see whether this accentuated ECG 
changes during hypocapnia in 21% inspired O2.  
4) The effects of hypocapnia, induced by mechanical hyperventilation, on the ECG of patients 
suffering from coronary artery disease were investigated in a final pilot study.  
 
2.2. Participants 
The number of subjects required for each experiment was estimated on the basis of the 
findings of Rutherford et al., (2005). They found statistically significant ECG changes of 
0.1mV in 15 normal healthy subjects during mechanical hyperventilation in hypocapnia. 
Similar changes were anticipated in this thesis investigation and therefore an attempt was 
made to recruit at least 15 subjects for each experiment. For experiments comparing standard 
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and modified electrode placements and those studying the effects of hypocapnia on the ECG 
and echocardiogram, it was possible to study 18 normal healthy subjects, aged 24 ± 3 years 
old (20-30 years old) (13 male). In experiments studying the effects of hypocapnic hypoxia on 
the ECG, larger wave amplitude changes were anticipated and therefore fewer subjects were 
required. Experiments were completed in nine normal healthy subjects, aged 23 ± 2 years old 
(20-26 years old) (8 male). All experiments in mechanical hyperventilation conducted in the 
same subjects were carried out on separate days. All normal healthy subjects were 
undergraduate or postgraduate students from the School of Sport & Exercise Sciences at the 
University of Birmingham. All subjects were free from any known cardiovascular and 
respiratory disease and gave informed consent to participate. All experiments were approved 
by the Walsall Local Research Ethics Committee. 
 
For experiments studying the effects of hypocapnia on the ECG of those suffering from 
coronary artery disease, eligible patients were identified by a consultant cardiologist at the 
University Hospital Birmingham. Patients were considered eligible for participation if they 
had undergone ECG exercise stress testing and had a normal ECG at rest with ischemic 
changes on exertion. Identified patients (and normal subjects) were excluded if they suffered 
from asthma, epilepsy, diabetes, renal failure, morbid obesity or had suffered from a cold, flu, 
sore throat, blocked nose, nose bleed or earache within the last seven days. Once identified, 
patients were contacted by phone and invited to attend an informal, introductory visit to the 
hospital laboratory where the experimental procedure was explained and informed consent 
was received. For every patient identified, permission for their participation was obtained 
from their GP. Over a period of two years, 16 patients were identified as eligible to participate 
in the experiment. Four of these patients (aged 61 ± 8 years old [42-74 years old, 4 male]) 
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consented to take part and completed the full experimental protocol. In five patients, 
permission to participate was denied by their GP. The remaining seven patients declined to 
participate for personal reasons. 
 
All four patients recruited had undergone a coronary angiogram to determine the extent of 
their disease and were awaiting either coronary angioplasty or a coronary artery bypass graft 
after participation in the experiment was complete. All patients were given a medical 
examination prior to participation in the study by the consultant cardiologist. Full patient 
details and past medical history can be seen in the appendix.  
 
In each experiment, subjects lay semi-recumbent on a bed and were encouraged to listen to 
music or the radio through headphones to enable them to relax. In experiments using 
mechanical hyperventilation, subjects were given sufficient opportunity to acclimatise to the 
technique during preliminary visits and data were not collected until they had confirmed that 
they felt comfortable with the procedure. In addition to the 18 normal subjects who did 
participate in experiments involving mechanical hyperventilation, two who were unable to 
relax during mechanical hyperventilation were withdrawn from the study.   
 
2.3. Mechanical ventilation 
For experiments using positive pressure mechanical hyperventilation to induce hypocapnia, 
subjects were connected to a mechanical ventilator (Engstrom Erica II) via a rubber face mask 
which was attached to the face with head-straps. For experiments using hypocapnic hypoxia, 
this ventilator was replaced by an updated model (Däger Evita II), with the same features as 
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the previous model. Each subject was ventilated with disposable airway filters and sterilised 
masks. The ventilators were programmed with the same settings for all experiments. 
 
The mechanical ventilator was set to deliver hyperventilation by the same method as Cooper 
et al., (2004). Subjects were ventilated in synchronised intermittent mandatory ventilation 
mode (SIMV) via intermittent positive pressure ventilation (IPPV) which ventilates at a preset 
frequency and tidal volume but allows subjects to spontaneously trigger inspiration if 
necessary (Shneerson, 1996). If no breath is initiated by the subject, a mandatory breath is 
delivered at a predefined breathing frequency and tidal volume. During spontaneous 
breathing, contraction of the diaphragm and respiratory muscles increases the size of the 
thoracic cavity causing a negative intrathoracic pressure which is lower than atmospheric 
pressure. Air flows along the resulting pressure gradient and into the lungs (inspiration). 
During IPPV, a positive pressure is created in the ventilator facemask which is greater than 
the intrathoracic pressure. This air pressure is sufficient to overcome the elastic and flow 
resistive properties of the lungs and chest and create a pressure gradient from the upper 
airways to alveoli (Hillman, 1986). As in spontaneous breathing, expiration during IPPV is a 
passive process caused by the elastic recoil of the lungs.  
 
The preset values for breathing frequency and tidal volume used in these experiments were 
higher than average breathing rates at rest. Cooper et al., (2004) found that a constant 
breathing frequency of 16 br.pm and a tidal volume of ~1.3 litres achieves a reduction in 
PetCO2 to approximately 20mmHg. During preliminary experiments, in which ECG data were 
not recorded, tidal volume was adjusted in each subject to identify the level necessary to 
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induce a drop in PetCO2 of 20mmHg. When ECG data were being recorded, breathing 
frequencies and tidal volumes were kept constant at all stages of the experiment. 
 
Subjects were hyperventilated in hypocapnic (low PetCO2, ~20mmHg), normocapnic (normal 
PetCO2, ~40mmHg) and hypocapnic hypoxic conditions (low inspired O2, 15%, and low 
PetCO2, ~20mmHg). Hypocapnia was achieved by ventilating subjects in room air. Because 
breathing frequency and tidal volume were set above normal resting values (frequency at rest 
= 8-12 br.pm; tidal volume at rest = ~0.8 litres), an imbalance in the proportion of CO2 
produced and the proportion of CO2 exhaled occurred. This caused PetCO2 to fall. If PetCO2 
decreased below 20mmHg, air from a cylinder containing 5% CO2 in medical air (21% O2, 
79% N2, i.e. room air) was added to inspired air to return PetCO2 to 20mmHg. PetCO2 was 
not allowed to fall below 20mmHg because at levels below this level, paraesthesiae and tetany 
have been shown to occur (Macefield & Burke, 1991). A PetCO2 of 20mmHg typically took 
10-15 minutes to induce. Once PetCO2 was stable at the desired level, subjects were 
ventilated for a further 10 minutes before ECG or echocardiographic recordings were made. 
 
Because the preset breathing frequencies and tidal volumes were constant throughout the 
experiment, PetCO2 always fell to 20mmHg when subjects where ventilated in normal room 
air. To enable assessment of the ECG in baseline conditions (normocapnia), CO2 was added 
to inspired air from a cylinder containing 5% CO2 in 95% medical (room) air. To maintain 
normal PetCO2, the percentage of CO2 in inspired air was adjusted by a dial on the ventilator 
head stage. This elicited complete control of PetCO2 throughout each experiment. Because 
resting PetCO2 varies between individuals, baseline normocapnic conditions were adjusted for 
each subject based on measurements of PetCO2 made during spontaneous breathing prior to 
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mechanical hyperventilation. Therefore, during normocapnia, PetCO2 was not fixed to 
40mmHg. Inspired O2 was maintained at 21% (room air) throughout all experiments except in 
those which required reduced O2 in inspired air. Once PetCO2 was stable at the desired 
baseline level, subjects were ventilated for a further 10 minutes before ECG or 
echocardiographic recordings were made.  
 
In hypocapnic hypoxia conditions, the 5% CO2 in medical (room) air cylinder was replaced 
by a cylinder containing 15% O2 in 85% N2. Subjects breathed this hypoxic gas mixture at the 
same breathing frequency and tidal volume as before, without the addition of CO2. This 
caused PetCO2 to decrease to ~20mmHg. After PetCO2 had been reduced sufficiently, 
subjects were ventilated in hypocapnic hypoxia for 10 minutes before ECG recordings were 
made. 
 
2.4. Measuring instantaneous PetCO2 
PetCO2 was recorded from expiration by infra-red spectrography using an in-line capnograph 
(Hewlett Packard 78354A). This capnograph shines infra-red light through an optical window, 
containing a sample of expired air. CO2 absorbs infra-red light with a wavelength of 4.3µm. 
The amount of infra-red light absorbed at this wavelength is measured by an infra-red detector 
and this is compared with a known standard value for absorption of resting concentrations of 
CO2.  
 
In the present studies, PetCO2 was used as a non-invasive indicator of the partial pressure of 
CO2 in arterial blood (PaCO2). PetCO2 was taken as the plateau at the peak of the expiratory 
waveform from each breath. The advantage of using PetCO2 to indicate PaCO2 is that it 
 30
avoids need to take invasive, arterial blood samples and provides an instantaneous measure 
which can be used to control PaCO2 with great sensitivity.  
 
At rest in healthy individuals, PetCO2 indicates PaCO2 accurately to within 2-5mmHg 
(Bhavani-Shankar et al., 1992; Frakes, 2001). Intra-patient values and changes in PetCO2 are 
therefore considered reliable indicators of PaCO2 (Frakes, 2001). This is satisfactory because 
within-subject changes in PaCO2 were of primary interest in the present study. Capnography 
was used in resting normal subjects and stable patients who did not suffer from any 
respiratory or neurological disorders. Therefore, PetCO2 was considered an acceptable 
measure of intra-subject changes in PaCO2.  
 
The Hewlett Packard 78354A capnograph was routinely calibrated by placing reference cells 
containing 0 mmHg and 56.2 mmHg of CO2 into the optical sampling window and measuring 
the recorded values. 
 
2.5. Measuring instantaneous blood pressure 
Blood pressure was measured continuously throughout each experiment by a finger 
photoplethysmograph (Finapres 2300, Ohmeda, Englewood, CO, USA). The Finapres 
measures continuous blood pressure by measuring arterial diameter in the finger with an 
infrared photoplethysmograph. This information is relayed to an electropneumatic 
servosystem which inflates a finger cuff (placed on the middle finger) to a set point pressure 
which is halfway between intra arterial systolic and diastolic pressures (Imholz et al., 1998). 
Changes in vessel diameter caused by changes in intra arterial pressure are detected by the 
infrared photoplethysmograph and the cuff pressure is adjusted accordingly. The transmural 
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pressure (pressure difference across the arterial wall in the finger) therefore remains constant 
(at zero) and thus the cuff pressure is the same as the intra arterial pressure giving a 
continuous measure of systolic, diastolic and mean arterial blood pressure (Imholz et al., 
1988). 
 
The Finapres automatically calibrates itself every ~70 beats (for 2-3 beats) (Imholz et al., 
1990) to compensate for changes in finger size, packed cell volume, colour of the blood, 
smooth muscle tone and red blood cells washed out of the microcirculation under the cuff 
(Imholz et al., 1988).  
 
The Finapres produces an acceptable, continuous estimate of relative changes in intra arterial 
pressure in normal resting subjects and patients (Imholz et al., 1988; van Egmond et al., 
1985). However, when Finapres measurements are compared to intra-arterial pressure 
measured in the brachial artery, the Finapres may overestimate (by 7 ± 11mmHg) or 
underestimate absolute values (by 13 ± 10mmHg) (Wesseling et al., 1985; Imholz et al., 
1988; van Egmond et al., 1985; 1990). In the present experiments, all subjects were known to 
be normotensive and only relative changes in blood pressure were of interest. To maximise 
the accuracy of the Finapres, an attempt was made to meet the following conditions during its 
use; 
– Subjects should be resting 
– Ambient temperature should be >22°C 
– The correct cuff size should be identified and used 
– The hand should be at the same level as the heart 
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– Hands should be kept warm to ensure adequate blood supply to the fingers 
(Imholz et al., 1998) 
 
In the present study, all subjects and patients were laid semi-recumbent on a bed with their 
hand elevated (as appropriate) to the same level as the heart. In some cases, subjects had very 
cold hands. In these instances an attempt was made to warm the hand by placing it on a bean 
bag (heated in a microwave) and wrapping in a blanket. 
 
2.6. Measuring air flow in spontaneous breathing 
For experiments using 15% inspired O2, the effects of inspiring 15% O2 on breathing 
frequency, tidal volume and metabolic rate were assessed. Spontaneous breathing 
characteristics were recorded using an ultrasonic phase shift flowmeter (BDRL Flowmetrics, 
Birmingham, UK). The flowmeter has two ultrasonic transducers which measure the phase 
shift in the ultrasonic signal that occurs during each respiratory cycle. This is converted into a 
voltage for the mean velocity of air through the flowmeter tube. Before its use in each 
experiment, the flowmeter tube was placed vertically against a flat surface so that no air could 
flow through it. The flowmeter readings were checked and if necessary, manually adjusted to 
zero. 
 
Subjects wore a nose clip and breathed through a three-way mouth piece connected to the 
flowmeter and an in-line capnograph (Hewlett Packard 78354A) (for measuring end-tidal 
CO2) (figure 2.1). A Douglas bag (containing a certified gas mixture of 15% O2 in 85% N2) 
with a three-way valve was connected to the flowmeter and this allowed the experimenter to 
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switch the subject’s inspired air between the Douglas bag and room air without their 
knowledge.  
 
Data were recorded by the Spike2 data acquisition software via a CED power 1401 PC 
interface (Cambridge Electronic Design, UK). Data from the flowmeter was used to calculate 
breathing frequency and tidal volume. The flowmeter was calibrated using a volume syringe 
which passes known volumes of air through the apparatus. The flowmeter was calibrated with 
0.2 litre, 0.5 litre, 0.8 litre and 1.0 litre volumes of air. This was repeated 5 times. A mean of 
all the measured values for each known volume was calculated and compared to the expected 
values. Any discrepancies between actual and measured values were corrected by a 
calibration factor that was calculated by dividing the actual value by the mean recorded value. 
This calibration factor was subsequently used to correct data recorded from human subjects. 
 
Flowmeter 
Capnograph 
Inspired air 
 
Expired air 
Connecting 
tube 
Subject 
3 way valve 
15% 
O2 Douglas Bag 
Room air 
3 way mouth 
piece 
Key 
Figure 2.1. Flowmeter apparatus 
Figure 2.1. Apparatus setup for experiments using flowmeters and Douglas bags 
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2.6.1. Airflow Analysis 
Data from the flowmeter and capnograph were recorded on the Spike2 data acquisition 
software and analysed offline. The flowmeter produces a continuous waveform representing 
the flow of air during inspiration and expiration. Inspiration is represented by a flow peak on 
the breathing trace. Spike2 allows the partial pressure of CO2 in expired air to be recorded 
simultaneously and the resulting peak partial pressures on the CO2 trace correspond to each 
expiratory phase on the breathing trace. A Spike2 data analysis script was used to calculate 
instantaneous breathing frequency, tidal volume, minute ventilation (VE), instantaneous CO2 
production (VCO2) and VE/VCO2 ratio. 
 
Instantaneous breathing frequency 
The Spike2 analysis script was programmed to measure the interval duration of each 
respiratory cycle from the beginning of inspiration to the end of expiration for each breath 
throughout the recording period. Instantaneous breathing frequency was calculated by 
dividing 60 (seconds) by the duration of each respiratory cycle. Calculated values were 
manually checked by measuring duration of respiratory cycles from different data files and 
dividing 60 by this measured value. 
 
Tidal volume 
The total area under each inspiratory peak (on the flow trace) was calculated as a measure of 
tidal volume. The flowmeter was zeroed before each experiment by blocking one end of the 
sampling tube (causing zero flow through the tube) and adjusting the recorded value to zero 
on the flowmeter head stage. Data was not standardised and was presented as volumes of gas 
at body temperature and atmospheric pressure, saturated with water (BTPS). Volume 
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Partial pressure of gas in air 
     Barometric pressure ( )  X  100 
X 
(Volume[BTPS] X Barometric pressure[BTPS]) – pH2O[BTPS] 
760 ( )
  
273 
(273 + ambient temperature)   ( 
measurements were calibrated using a volume syringe which passes known volumes of air 
through the apparatus. Measured volumes were compared to these known volumes. 
 
Instantaneous minute ventilation  
Instantaneous VE was calculated by multiplying the tidal volume of each breath by its 
instantaneous breathing frequency. 
 
Instantaneous CO2 production 
The Spike2 script calculated the instantaneous CO2 production in each expired breath from 
the tidal volume recorded on the flow trace and the partial pressure of CO2 in expired air 
recorded by the capnograph. This script converted the partial pressure of CO2 in expired air 
into a % of air (equation 2.1) and multiplied this by the tidal volume of each breath. Data was 
standardised at a temperature of 0°, barometric pressure of 760 mmHg and unsaturated with 
water (dry) (STPD) using equation 2.2. Instantaneous VCO2 was used as an indicator of 
metabolic rate. 
 
Equation 2.1. 
       % of gas in air     =  
 
Equation 2.2. 
Volume at STPD =
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VE/VCO2 ratio  
In was of interest to know whether changes in VE were due to changes in metabolic rate or 
changes in inspired O2. Changes in VE caused by alterations in inspired O2 are evident by the 
presence of hypo/hyperventilation. This can be estimated using the VE/VCO2 ratio which is 
calculated by dividing VE by VCO2. An increase in the VE/VCO2 ratio indicates that the 
subject is hyperventilating. A decrease in the VE/VCO2 ratio indicates that the subject is 
hypoventilating. 
 
2.7. Measuring O2 saturation 
For experiments where 15% O2 was inspired, a pulse oximeter (N-200 series oximeter, 
Nellcor) was used to measure O2 saturation in arterial blood. Pulse oximetry was used because 
it allows accurate estimations of arterial O2 saturation, non-invasively (Yelderman & New, 
1983). In addition, it provides an instantaneous measure of O2 saturation which allows 
changes over time to be investigated. 
 
The pulse oximeter uses a finger cuff containing two light emitting diodes (LEDs) which 
transmit red light at a wavelength of 0.66µm and infrared light with a wavelength of 0.94µm 
(Yelderman & New, 1983) through the arteries in the finger. Light of these wavelengths is 
absorbed by oxyhaemoglobin and deoxyhaemoglobin. The amount of light absorbed at each 
wavelength is calculated by the Beer-Lambert law which relates the amount of transmitted 
light from the LED to the amount of light absorbed and not absorbed by haemoglobin (Grace, 
1994). An ‘R’ ratio is calculated from absorbance values of each wavelength using equation 
2.3. O2 saturation is calculated from the R ratio by relating the ratio to a known equivalent O2 
saturation.  
 37
Equation 2.3. 
    R ratio =  
 
A = absorbance of light a predetermined wavelength, C = concentration of haemoglobin in 
arterial blood, D = distance of transmitted light from the LED 
 
 
Measurements made within the range of 100-70% saturation correlate well with measures  
of O2 from arterial blood samples (Yelderman & New, 1983). In standard pulse oximeters, it 
is thought that any measured values below 80% should be taken with caution (Grace, 1994). 
In the present study, saturation did not fall below 90% and thus values were considered 
acceptable. 
 
The pulse oximeter is calibrated by the manufacturer using healthy control subjects and is said 
to be accurate to within ± 2% (Kidd & Vickers, 1989). In clinical or research settings, pulse 
oximeters cannot be manually adjusted by an experimenter (Grace, 1994; Huch et al., 1988). 
In the present experiments, only healthy subjects were used and therefore, the manufacturer’s 
calibration was considered acceptable.  
 
2.8. Measuring plasma electrolytes 
During experiments in hypocapnia venous blood samples were taken from 14 normal subjects 
and analysed for plasma electrolyte concentrations and blood pH. These 10ml samples were 
taken by a trained nurse from the antecubital vein, at the end of normocapnia and hypocapnia 
during mechanical hyperventilation. Each sample was analysed for blood pH and ionized K+ 
and Ca2+ concentrations using a Rapid Lab 865 blood gas analyzer. The Rapid Lab 865 
analyzer automatically calibrated itself at regular intervals specified by hospital staff for 
AC0.66µm / DC0.66µm 
AC0.94µm / DC0.94µm 
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clinical use. Ionized electrolyte concentrations were measured because it is ionized 
component of electrolyte concentrations which have the greatest physiological effects around 
the body (Calvi & Bushinsky, 2008). 
 
2.9. Electrocardiography 
2.9.1. Background in electrocardiography 
The ECG monitors the electrical activity of the heart, non-invasively. A standard ECG 
consists of 12 leads, each of which measures the electrical activity within the myocardium 
from 12 different electrical axes. The 12 lead ECG was used in the present investigation to 
study the effects of hypocapnia on cardiac electrical activity in normal subjects and patients 
suffering from coronary artery disease. 
 
Myocardial excitation 
Contraction of the heart is achieved by an electrical conduction system that propagates 
through the myocardium. The purpose of this conduction system is to co-ordinate contraction 
of the atria, followed by a sufficient delay before coordinated contraction of the ventricles. 
This delay maximises the flow of blood into the ventricles and subsequently around the body 
(Noble, 1975). Stimulation of this conduction system begins at the pacemaker sinoatrial node 
(SA node) (Noble, 1975).  
 
The action potential generated in the SA node excites surrounding myocytes (cardiac muscle 
cells) in the atria causing them to contract almost simultaneously. This action potential travels 
through the atria until it reaches the atrioventricular (AV) node. Here, the signal travels down 
the bundle of His (including the left & right branch bundles) to the apex of the heart. 
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Ventricular systole is caused by contraction of the cardiac myocytes as the action potential 
travels through the ventricle walls via the Purkinje fibres (Noble, 1975).  
 
In humans, the resting membrane potential in the SA node is -60mV. At the start of an action 
potential, gradual inflow of Na+ along the Na+ concentration gradient causes this membrane 
potential to rise (depolarisation) (Noble, 1975). When the membrane potential reaches a 
threshold value of -40mV, voltage regulated calcium channels open and Ca2+ flows down the 
Ca2+ concentration gradient into the cytosol. This causes the membrane potential to rapidly 
increase until there is no longer a concentration gradient between intracellular and 
extracellular Na+ and Ca+. At this point, K+ channels open and K+ flows out of the cell along 
its concentration gradient. This process is called repolarisation and restores the membrane to 
its resting potential of -60mV.  
 
The action potential that occurs in cardiac myocytes differs from the pacemaker potential in 
the SA node. The resting membrane potential in a cardiac myocyte is -90mV and only 
changes when voltage-sensitive Na+ channels are opened by an electrical stimulus from the 
SA node (Page, 1962). Na+ enters the myocyte along its concentration gradient causing the 
membrane potential to increase to 30mV, at which point Na+ channels close. Depolarisation is 
prolonged (plateaus) by the influx of Ca2+ through calcium channels. There, Ca2+ binds to 
troponin causing contraction of the myocyte via excitation-contraction coupling (interaction 
of actin and myosin filaments). At the end of the plateau, K+ channels open and K+ flows 
down its concentration gradient out of the cell restoring the resting membrane potential  
(Page, 1962). Excitation of one myocyte stimulates contraction of the adjacent myocyte 
(Wagner, 2008). This allows contraction of the entire muscle in a chain reaction directed by 
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the conduction pathway. The SA node reaches its threshold potential before that of the bundle 
of His, the Purkinje fibres and the cardiac myocytes. Therefore, it is the SA node which 
dictates the rate at which the heart beats (Noble, 1975). 
 
The electrical activity occurring in each myocyte forms part of the total pattern of electrical 
activity across the myocardium which can be monitored using an ECG. The ECG is therefore 
a composite of electrical activity recorded in many different parts of the myocardium. This 
ECG waveform can be used to identify the different events of the cardiac cycle (figure 2.2).  
SA node 
stimulation 
Atria  
depolarisation 
AV node 
stimulation  
Ventricular repolarisation  
Ventricular 
depolarisation  
Bundle of His 
stimulation  
Figure 2.2. Time points of electrical activity within the heart 
Figure 2.2 shows a typical ECG waveform (lead I) and the time points at which 
electrical events occur in the myocardium (adapted from Wagner (2008). Marriott’s 
Practical Electrocardiography, 11th edition). 
Atria repolarisation 
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Figure 2.3. ECG wave amplitudes and durations 
Figure 2.3. ECG wave amplitudes (measured from the isoelectric line) and interval 
durations. The level of the isoelectric line taken from the electrically neutral point 
from the end of the P wave to the beginning of the Q wave. 
1.50 
1.25 
1.00
0.75 
0.50 
0.25 
0.00
-0.25 
-0.2
 
-0.1
 
0.0 0.1 0.2 0.3 0.4 
Time (seconds) 
P-R interval 
Q duration 
QRS duration 
QT interval 
1.50
1.25 
1.00
0.75 
0.50 
0.25
0.00
-0.25 
-0.2
 
-0.1
 
0.0 0.1 0.2 0.3 0.4 
Time (seconds) 
P amplitude 
Q amplitude S amplitude 
RS amplitude R amplitude 
J point 
ST(80) point 
T amplitude 
Isoelectric line 
Wave 
Amplitude 
(mV) 
 42
Firing of the SA node and atrial depolarisation is represented by the P wave (figure 2.2, 2.3) 
(Wagner, 2008). This is followed by atrial repolarisation, but this is hidden on the ECG trace 
by the events of the QRS complex, which occur further down the cardiac conduction pathway 
(Braunwald et al., 2001). Stimulation of the AV node and the bundle of His occur during the 
P-R segment. This is followed by septal, apical and left & right ventricular depolarisation 
which are represented by the Q, R and S waves (figure 2.2, 2.3) (Wagner, 2008). The T wave 
represents the process of ventricular repolarisation (figure 2.2, 2.3). The QT interval therefore 
represents the duration of ventricular activation and recovery (figure 2.2, 2.3). Between the 
QRS complex and the T wave is the ST segment (figure 2.3). This represents an electrically 
neutral period between ventricular activation and recovery (figure 2.2) (Wagner, 2008). 
 
Calculating the ECG 
The ECG is based on the principles of Einthoven (1912), Wilson et al., (1934) and 
Goldberger (1942). The standard 12 lead ECG is made up of 3 limb leads, 3 augmented limb 
leads and 6 chest leads derived from 10 electrodes placed in standardised positions (figure 
2.4). Each lead views the same electrical events in the heart from a different position (figure 
2.5). Leads I, II and III make up the three limb leads of ‘Einthoven’s Triangle’ (Einthoven, 
1912) (equation 2.4). These bipolar leads are derived from 4 electrodes placed on the limbs 
(figure 2.4) and represent the potential difference between two of these limb electrodes, 
creating three different electrical views of the heart across the frontal plane (figure 2.5). The 
electrical potential at each electrode is calculated from the difference between the exploring 
electrode and a reference electrode placed on the right leg (RL). Lead I is calculated from the 
potential difference between the left and right arm electrode. Electrical currents in the cardiac 
muscle moving towards the positive electrode (left arm [LA]) are depicted as a positive 
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deflection on the ECG trace. Electrical currents moving towards the negative electrode (right 
arm [RA]) are illustrated as a negative deflection.  This is the case for all of Einthoven’s limb 
leads where Lead II is the potential difference between the left leg (LL) and the RA electrodes 
and Lead III is the difference between the LL and LA electrodes. Kirchhoff’s law states that 
in a closed electrical circuit, such as the equilateral triangle formed of Einthoven’s limbs 
Figure 2.4. The left arm (LA) and right 
arm (RA) electrodes are placed on the 
left and right wrists. The left leg (LL) 
and right leg (RL) electrodes are placed 
on the left and right shins. The V1 chest 
electrode is placed on the right of the 
sternum in the 4th intercostal space. V2 is 
positioned on the left of the sternum in 
the 4th intercostal space. V4 is placed on 
the mid-clavicular line in the 5th 
intercostal space. V3 is placed between 
V2-4. V5 is placed laterally to V4 on the 
same horizontal plane on the anterior 
axillary line. V6 is positioned laterally to 
V5 on the same horizontal plane on the 
mid axillary line. Adapted from Wagner 
(2008). Marriott's Practical 
Electrocardiography. 11th ed. 
Figure 2.4. Standard ECG electrode placement 
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leads, the sum of all the electrical current flowing in all directions must equal zero (Kligfield 
et al., 2007). It is possible then, to calculate the wave amplitude at any point in the cardiac 
cycle in one limb lead from the same amplitudes in the other two limb leads. This theory 
defines Einthoven’s Law which states, “the difference between the electrical tensions of 
Lead II Lead III 
aVF 
aVR 
.
V1 V2 
V3 
V4 
V5 
V6 
. Lead I 
Frontal plane 
Transverse plane 
Figure 2.5. Electrical axes of the heart on the frontal and transverse planes. The 
arrows of each electrical axis point in the direction of the positive pole (electrode) of 
each lead. GCT = Goldberger central terminal (negative pole), WCT = Wilson central 
terminal (negative pole).  Adapted from Wagner (2008). Marriott's Practical 
Electrocardiography. 11th ed. 
Figure 2.5. ECG electrical planes and axes 
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Leads I and II must be equal to the electrical tension of Lead III” (equation 2.5) (Einthoven, 
1912). 
 
Equation 2.4. - Einthoven’s limb leads 
Lead I = LA – RA 
Lead II = LL – RA 
Lead III = LL – LA 
Equation 2.5. - Einthoven’s law 
Lead III = Lead II - Lead I 
 
Leads aVR, aVL and aVF were derived from Wilson’s original Vr, Vl & Vf leads (Wilson et 
al., 1934). Leads Vr, Vl and Vf are unipolar leads that use the limb electrodes as exploring 
electrodes and a central terminal as a reference point. The central terminal is calculated as the 
mean of the electrical potential at each of the three exploring limb electrodes (equation 2.6). 
These leads have significantly smaller wave amplitudes compared to the limb leads because 
they include the exploring electrode within their own central terminal reference point. 
Including the electrical potential from the exploring electrode in the reference point causes it 
to be subtracted, in part, from the electrical potential of the exploring electrode when the lead 
is derived. This reduces the amplitude of the waveforms. Goldberger (1942) proposed a 
revised central terminal that does not include the extremity electrode from which the ECG 
lead is recorded. This produces an augmented electrical signal and is used to calculate the 
three ‘augmented’ limb leads (equation 2.7). These augmented limb leads monitor the 
electrical activity across the frontal plane of the heart and are calculated by creating an 
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indifferent electrode from two of the limb electrodes and using this as a negative reference to 
the remaining limb exploring electrode (equation 2.7).  
 
Equation 2.6. - Wilson’s central terminal 
Central terminal =
3
LLLARA ++
 
Equation 2.7. - Goldberger’s augmented limb leads 
Lead aVR = RA – 




 +
2
LLLA
 
Lead aVL = LA – 




 +
2
LLRA
 
Lead aVF = LL – 




 +
2
RALA
 
Equation 2.8. - The precordial leads 
V1 = V1 – 




 ++
3
LLLARA
   V2 = V2 – 




 ++
3
LLLARA
 
V3 = V3 – 




 ++
3
LLLARA
   V4 = V4 – 




 ++
3
LLLARA
 
V5 = V5 – 




 ++
3
LLLARA
   V6 = V6 – 




 ++
3
LLLARA
 
 
The precordial leads are derived from the central terminal (equation 2.6) and 6 unipolar 
exploring electrodes (figure 2.4) that are placed across the chest to provide a view of the 
heart’s electrical activity across the transverse plane (figure 2.5) (equation 2.8) (Wilson et al., 
1934). In this thesis, the limb and augmented limb leads are referred to as the frontal plane 
leads. The precordial leads are referred to as the transverse plane leads.  
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Gender Differences in the ECG 
It is thought that ECG waveforms are altered in normal resting subjects of different ages and 
gender as a result of differing testosterone levels which affect the ventricular repolarisation 
phase of the cardiac cycle (Bidoggia et al., 2000; Macfarlane, 2001; Surawicz & Parikh, 
2002). In a study of 500 normal healthy subjects (250 male), male T wave amplitudes in the 
transverse plane leads were found to be to 0.3 ± 0.1mV (P < 0.001) larger than female T wave 
amplitudes (Bidoggia et al., 2000). In addition, the height of the ST segment is also higher in 
men than women (0.3mV in men vs. 0.1mV in women in lead V2, [no standard error or 
statistical analysis presented]) (Macfarlane, 2001). The gender specific effects on the ECG are 
most prominent in the transverse plane leads (V1-4) (Bidoggia et al., 2000) with the largest 
differences (of 0.2mV) in found in V2 (Macfarlane, 2001). ‘Male ECG characteristics’ tend to 
appear in men aged >17 years and decline from >25 years (Surawicz & Parikh, 2002). The 
gender difference in T wave amplitude and ST segment height therefore decreases with age 
due to a decrease in wave amplitude in males (e.g. ST difference of 0.2mV in normals aged 
<29 years vs. 0.1mV in normals aged >50 years [Macfarlane, 2001]). These gender and age 
specific changes in T wave amplitude and ST height appear to coincide with changes in blood 
testosterone levels which, in men, rise during puberty and decline with old age (Surawicz & 
Parikh, 2002). Age specific changes are therefore less evident in women whose blood 
testosterone levels are much lower and more stable. In this thesis investigation, it was 
important to be aware of these gender and age differences in the ECG because they affect the 
clinical thresholds used to define the presence or absence of clinically significant changes in 
the ECG. Because both male and female subjects participated in all experiments, both non-
specific and gender-specific clinical thresholds were used to analyse changes in the ECG. 
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Myocardial ischemia and the ECG 
Myocardial ischemia causes changes in the propagation of electrical activity throughout the 
heart causing changes in the ECG waveform morphology. The clinical significance of these 
ischemic ECG changes depend on the location and severity of the ischemic episode (Wagner, 
2008). If a myocardial cell becomes ischemic, it remains in a resting state in order to survive. 
This involves uncoupling from electrical activation by adjacent myocardial cells (Wagner, 
2008). The lack of electrical activity in these areas results in an ‘injury current’ which shifts 
the electrical axis of cardiac activity away from the ischemic region (Wagner, 2008). This 
causes noticeable ECG changes such as T wave inversion (change in the polarity of the T 
wave) and ST segment depression below -0.1mV (Wagner et al., 2009). Such changes 
represent mild ischemia in the subendocardial layer (innermost layer) of the myocardium 
(figure 2.6a). If the ischemia is transmural (affecting an entire region of myocardium caused 
by decreased O2 supply resulting from total occlusion of the coronary artery [figure 2.6b]), the 
injury current is directed towards the affected region causing hyperacute T waves (> ~0.5 mV 
in the frontal plane leads and > ~1mV in the transverse plane leads) and ST segment elevation 
(>0.1-0.25mV) (2009; Wagner, 2008). Sustained transmural ischemia leads to myocardial 
injury and ultimately cell death (myocardial infarction).  
 
Figure 2.6. Affected regions of the left ventricle during subendocardial and 
transmural ischemia in the lateral wall  
Subendocardial ischemia Transmural ischemia 
(a) (b) 
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T wave changes alone are not considered reliable indicators of ischemia because clinically 
significant T wave changes can occur in normal healthy subjects with normal coronary 
arteriograms (Taggart et al., 1979) and sometimes fail to appear in patients suffering from 
myocardial ischemia (Wagner, 2008). However, it is thought that T wave inversion and 
hyperacute T waves, when followed by ST segment depression/elevation, represent the 
earliest phases of subendocardial/transmural ischemia (Birnbaum et al., 1993; Wagner, 2001; 
Sclarovsky et al., 1988; 2008). QT interval prolongation is also thought to provide an early 
indication of transmural myocardial ischemia (Kenigsberg et al., 2007). 
 
The 12 lead ECG enables the identification of the ischemic region within the heart and the 
occluded artery supplying that region. The left ventricle can be divided into septal, anterior, 
lateral and inferior walls (Wagner, 2008). Each ECG lead monitors the electrical activity in 
these ventricular walls. The distribution of coronary arteries across the left ventricle can vary 
from patient to patient. Typically, septal and anterior walls are supplied by the left anterior 
descending artery (LAD). The left circumflex artery (LCX) perfuses the lateral region and 
some portions of the anterior wall. The right coronary artery (RCA) and the posterior 
descending artery (PDA) supply the inferior wall of the left ventricle (Wagner, 2008). 
Therefore, an occluded coronary artery can be located by identifying the ECG leads in which 
ischemic changes occur and correlating that with the coronary arteries that supply that region 
of the heart. The nature of the ECG changes that occur depend on whether the myocardial 
ischemia is caused by an increase in myocardial O2 demand or a reduction in O2 supply. 
Diagnosis of ischemia is only indicated when ECG changes occur in 2 or more anatomically 
contiguous leads (Wagner et al., 2009).  
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2.9.2. Recording the ECG 
All ECGs were recorded using the apparatus described below. This apparatus allows the ECG 
to be recorded and measured without losing potentially important ECG information through 
unnecessary filtering. In addition, it allows continuous 12 lead ECG recordings which can be 
averaged using specially designed software. This software enables exact measurement of 
ECG wave amplitudes which are not influenced by human error or bias.  
 
Two-minute ECG recordings were made after 10 minutes mechanical hyperventilation in each 
condition (i.e. normocapnia, hypocapnia, hypocapnic hypoxia). ECG waveforms were 
averaged across this two minute period (creating a single average waveform for ~120 cardiac 
cycles). This was done because it creates a waveform that is typical of the ECG trend but is 
not affected by individual anomalous beats. In all experiments, ECG leads were connected to 
Blue sensor electrodes (P-00-S/50, Ambu) which were used because they provide good 
adherence to the skin. To achieve the optimum recording of ECG signals with minimal 
impedance, the stratum corneum layer of the epidermis on the skin surface (layer of dead skin 
cells which do not conduct electricity well) was removed from all electrode sites using Nu-
prep abrasion gel (Smith, 1984). Acetone was used to remove any skin oils that might 
increase contact impedance at the electrode site.  
 
Analogue ECG data was recorded by two D360 patient isolated amplifiers connected to a 
power1401 CED system (figure 2.7). Each D360 patient isolated amplifier has an external 
unit with 8 analogue inputs. The electrical potential at each exploring electrode was recorded 
in reference to a common electrode placed on the right leg. The 3 limb electrodes were 
connected to the first D360 amplifier and the 6 precordial exploring electrodes were 
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connected to the second (figure 2.7). The right leg electrode was connected to all 9 inputs. 
Each channel on the D360 was connected to an individual port on the power1401 CED digital 
converter. The power1401 digitises the analogue signals recorded from the ECG electrodes, 
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D360 Amplifier (1) 
Common  
RA electrode 
+ - 
1 
2 
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4 
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D360 Amplifier (2) 
Common  
LA electrode 
LL electrode 
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Power 1401 
Port 0 
Port 1 
Port 2 
Port 3 
Port 4 
Port 5 
Port 6 
Port 7 
Port 8 
Port 9 
Figure 2.7. ECG electrodes are connected to a D360 amplifier and recorded as an 
analogue signal before being converted into a digital waveform by a power 1401 
connected to a PC. 
 
PC 
Figure 2.7. ECG apparatus setup 
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allowing them to be viewed on a PC using CED Spike2 data acquisition software. This 
apparatus enables several channels of data to be recorded simultaneously.  
 
The ECG was recorded with a frequency bandwidth of 0.005-1000 Hz. This was set to ensure 
that all aspects of the true ECG signal could be recorded. Signals were sampled by the 
power1401 at a predetermined frequency which was set high enough to prevent distortion of 
the final digitally reconstructed signal. It is known that to prevent this aliasing, the minimum 
sampling rate of any signal should be at least twice that of the highest required frequency 
component (Nyquist, 2002). Thus, for a high frequency component of 1000 Hz, we sampled 
at 2500 Hz. 
 
The ECG signal was recorded from each electrode without the application of high and low 
pass filters or 50 Hz notches. Standard digital ECG machines sample the ECG signal from 
electrodes on the body surface and apply high pass filters to the signal to eliminate baseline 
drift (caused by respiration) and low pass filters to eliminate muscle artefact and mains noise 
(Kligfield et al., 2007). The low frequency cut-off is normally set to 0.5 Hz (corresponding to 
a heart rate of 30 bpm) but this can cause distortion to the ECG, particularly in the ST 
segment (Kligfield et al., 2007). High frequency cut-offs of 150 Hz are considered acceptable 
in normal adults but these can eliminate higher frequency components of the QRS complex 
thus invalidating some wave amplitude measurements. Some clinical ECG machines contain a 
50 Hz notch filter which targets and attenuates frequencies of 50 Hz to eliminate mains noise. 
However, the application of a 50 Hz notch to the data is a crude form filtering which can 
eliminate waveforms of adjacent frequencies which may contain important ECG information.  
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The recorded ECG signal contained 50 Hz mains noise and a harmonic series of this noise. 
This can distort the ECG signal making it difficult to identify the different waves of the ECG 
(figure 2.8). Offline power spectral analysis was performed on the recorded signal from each 
electrode to reveal the frequency components of this 50 Hz harmonic series. In figure 2.9a, 
these components are represented by the black bins and can be seen at frequencies of 50 Hz 
(×1), 100 Hz (×2), 150 Hz (×3), 250 Hz (×5), 350 Hz (×7) and 550 Hz (×11). This harmonic 
series was seen in signals recorded from each ECG electrode. Because the frequency of these 
harmonics was known, it was possible to remove them from the data using a Spike2 analysis 
script. This script creates a sine wave that matches the frequency of the harmonic series in the 
data every 5 sinusoidal cycles and subtracts it. This sine wave has the correct wave amplitude 
and phase shift and is calculated from a combination of sine and 
0.5
0.0
-0.5
C6
1.0
0.5
0.0
-0.5
C5
1.0
0.5
0.0
-0.5
C4
0.5
0.0
-0.5C
3
1
0
-1C
2
0.5
0.0
-0.5
-1.0
C1
0.10
0.05
0.00
-0.05
LL
0.25
0.00
-0.25
-0.50
R
A
0.4
0.2
0.0
-0.2
LA
173.0 173.5 174.0 174.5 175.0 175.5 176.0 176.5
s
(a) Pre signal processing (b) Post signal processing 
Figure 2.8. Raw data from one subject showing a) the effects the 50Hz harmonic series 
on the ECG signal recorded from each electrode and b) the ECG signal after the 50Hz 
harmonics have been removed. 
Figure 2.8. Effects of 50 Hz mains noise on the on the ECG signal 
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cosine waves. The matching sine wave is continually readjusted every 5 sinusoidal cycles to 
ensure that the waveform removed most accurately matches the harmonic series within the 
data. The resulting ECG signal is free from the unwanted harmonic series (figure 2.9b). The 
advantage of processing the ECG in this way is that it allows waveforms, specifically 
identified as undesirable, to be removed from the ECG signal without losing components of 
the signal which are important to the final waveform morphology. This improves confidence 
in fine wave amplitude measurements made when comparing ECG final waveforms.  
 
The recorded ECG signals were processed and then converted into the 12 leads of the ECG 
using the methods of Einthoven (1912), Goldberger (1942) and Wilson (1934) (equations 2.4, 
2.7 & 2.8, page 46). The affects of processing the ECG signal after the 12 leads had been 
0.00020 
0.00018 
0.00016 
0.00014 
0.00012 
0.00010 
0.00008 
0.00006 
0.00004 
0.00002 
0
0 100
Frequency (Hz) 
Figure 2.9. a) shows the different frequencies recorded in the ECG signal from the 
left leg electrode in one subject. The ECG frequencies are represented by the white 
bins (below 50Hz). The black bins represent the 50Hz mains noise and 50Hz 
harmonics. b) shows the frequencies recorded after the Spike2 scripts have been 
applied. 
(a) Pre signal 
processing 
(b) Post signal 
processing 
 
200 300 400 500 600 0 100 200 300 400 500 600 
Figure 2.9. Power spectral analysis of the ECG signal 
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derived was considered, but this had no affect on ECG wave amplitudes or durations and 
therefore was not pursued further.  
 
2.9.3. ECG analysis 
Spike2 analysis scripts were run on each two minute data set to obtain an averaged ECG 
waveform of ~120 beats. The difference between two averaged waveforms (recorded in 
different conditions) was calculated by subtracting the waveform of the first time period from 
the waveform of the second time period (figure 2.10). The script repeats this process in each 
of the 12 ECG leads. The advantage of averaging the ECG waveform in this way is that it 
eliminates any effects on wave amplitude caused by the respiratory cycle (due to changing 
chest inflation) and provides a waveform that represents the overall trend of cardiac events 
during the period of ECG recording. 
 
V5 
 
V6 
 
Condition 1 Condition 2 Difference 
Figure 2.10. Data from subject 1 showing the averaged waveform in each lead for 
condition 1 and condition 2. The difference between the two conditions is shown in the 
third column.  i.e., a negative wave represents a decrease from condition 1 to condition 2. 
 
 
0.5 
0.5 
0.0 
0.0 
-0.5 
V4 
 
0.5 
0.0 
-0.5 
V3 
 
0.2 
0.0 
-0.5 
V2 
 
0.5 
0.0 
-0.5 
V1 
 
0.5 
0.0 
-0.5 
aVF
 
 
0.5 
0.0 
aVL
 
 
0.2 
0.0 
-0.5 
aVR
 
 
0.2 
0.0 
III
 
 
0.5 
0.0 
II
 
 
0.5 
0.0 
-0.5 
I
 
 
0.2 
0.0 
-0.2 
Time (seconds) 
0 2.5 5 7.5 10 12.5 
Figure 2.10. Averaged waveforms in two conditions from one subject 
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Calculating the wave amplitudes and durations 
Automated Spike2 analysis scripts were used to calculate wave amplitudes and interval 
durations. These scripts were programmed to identify the peaks of each wave in the order that 
they appear in the cardiac cycle. Double and triple differentiation of the ECG waveform was 
calculated and used to identify the beginning of the Q wave, the J point and the end of the T 
wave (for use when measuring interval durations) (figure 2.11). Every file was manually 
checked to ensure that each ECG wave had been correctly recognised. All wave amplitude 
measurements were calculated by the computer software.  
 
The amplitudes of the R and T waves and the J and ST(80) points (figure 2.3, page 41) were 
calculated from the averaged waveforms. The Spike2 script was programmed to measure each 
wave height (in mV) from zero and the time at which the peaks occurred. The isoelectric line 
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Figure 2.11. Double differentiation (c) of the ECG waveform (a) was used to 
calculate the points of inflection at the beginning of the Q wave, the J point (shown) 
and the end of the T wave. 
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Figure 2.11. Double differentiation of the ECG waveform 
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is considered to be an electrically neutral period in the cardiac cycle and is measured from the 
period between the end of the P wave and the beginning of the Q wave (figure 2.3, page 41) 
(Braunwald et al., 2001). This isoelectric line was subtracted from all wave heights to give the 
wave amplitude (figure 2.3, page 41).  
 
The ST segment was calculated from the J point height and 80 milliseconds after the J point 
(ST [80]) (Braunwald et al., 2001). The QRS axis was calculated in MS excel using equation 
2.9.  
 
Equation 2.9. 
QRS axis    =     (tan-1(b/a)) + (axis θ of a) 
Where (a) is the amplitude of the RS wave (R wave + S wave) in the frontal plane lead with 
the largest QRS complex and (b) is the height of the RS wave in the corresponding isoelectric 
lead (e.g. lead I is isoelectric to aVF, lead II is isoelectric to aVL and lead III is isoelectric to 
aVR).  
 
(Houghton et al., 2003) 
 
The QT interval represents the duration of ventricular activation and recovery. It was 
measured from the beginning of the Q wave to the end of the T wave (figure 2.3, page 41). 
The QT interval was corrected for changes in heart rate using Bazett’s formula (equation 
2.10). The accuracy of this formula has been questioned when it is used for subjects with 
exceptionally high or low resting heart rates (Wagner, 2008; Rautaharju et al., 2009). 
However, it was deemed appropriate for the present studies because participating subjects’ 
heart rates were always within a normal range (57-62 bpm). Bazett’s formula is also the most 
widely used correction for the QT interval in normal clinical practice (Kenigsberg et al., 
2007). 
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Equation 2.10. 
QTc = 
int
int
RR
QT
−
   (Bazett, 1920) 
 
2.9.4. Calibration 
The ECG was calibrated using a patient simulator calibration box (Dynatech Nevada Inc., 
Model 212B, Nevada, USA) which produces an ECG signal comparable to that recorded at 
the limb electrodes. Standardised ECG wave amplitudes from the patient simulator box were 
compared to the measured wave amplitudes from the ECG apparatus used in the present 
study, after signal processing (table 2.1). The wave amplitudes recorded using the present 
apparatus accurately represented those produced by the patient simulator to within 0.02 ± 
0.0mV. 
 
Table 2.1. Actual and measured R and T wave amplitudes from the patient simulator 
calibration box. 
 
Wave ECG Lead Actual wave 
amplitude 
Measured wave 
amplitude 
Difference 
R wave I 1.00mV 1.01 ± 0.0mV 0.01 ± 0.0mV 
II 1.30mV 1.30 ± 0.0mV 0.00 ± 0.0mV 
III 0.30mV 0.29 ± 0.0mV 0.01 ± 0.0mV 
T wave I 0.25mV 0.25 ± 0.0mV 0.00 ± 0.0mV 
II 0.30mV 0.32 ± 0.0mV 0.02 ± 0.0mV 
III 0.05mV 0.07 ± 0.0mV 0.02 ± 0.0mV 
 
To confirm that measurements made in the present study were comparable with both previous 
studies and measurements made in a clinical setting, ECGs were recorded from each subject 
using the D360 ECG apparatus and a standard clinical ECG machine (Philips Hewlett Packard 
Pagewriter 200) without disconnecting the electrodes. ECG wavelengths from each lead in 
both recordings were compared in each subject. The largest difference between the R waves 
recorded in all leads using both apparatus was 8% (0.07 ± 0.01mV in V4, P > 0.90) (table 
interval 
interval 
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2.2). On the ECG printout from the clinical machine, this difference corresponds to 0.7mm. In 
the T wave, the largest discrepancy was 4% (0.04 ± 0.00mV change in Lead I, P < 0.05) 
(table 2.2) and this would represent a 0.4mm difference on a paper ECG trace. Because ECG 
measurements could not be made simultaneously with both machines, a small degree of error 
was expected. In addition, wave amplitudes recorded with the standard clinical ECG machine 
were measured by hand and thus were subject to small human error. A maximum 
disagreement of 1mm was therefore considered acceptable. 
 
Table 2.2. Comparison of ECG wave amplitudes measured from the Phillips HP 
Pagewriter 200 and the ECG apparatus used in this study in 18 subjects 
 
 
Wave ECG Lead Phillips 
Pagewriter 200 
wave amplitude 
(mV) 
Current ECG 
apparatus wave 
amplitude (mV) 
Difference 
(mV) 
R wave I 0.66 ± 0.1 0.68 ± 0.1 0.02 ± 0.00 
II 1.04 ± 0.1 1.00 ± 0.1 0.04 ± 0.01 
III 0.53 ± 0.1 0.54 ± 0.1 0.01 ± 0.00 
aVR -0.83 ± 0.1 -0.84 ± 0.1 0.01 ± 0.00 
aVL 0.25 ± 0.0 0.29 ± 0.0 0.04 ± 0.01 
aVF 0.74 ± 0.1 0.71 ± 0.1 0.03 ± 0.01 
V1 0.24 ± 0.0 0.25 ± 0.0 0.01 ± 0.00 
V2 0.55 ± 0.1 0.54 ± 0.1 0.01 ± 0.00 
V3 0.82 ± 0.1 0.75 ± 0.1 0.07 ± 0.01 
V4 1.37 ± 0.2 1.30 ± 0.1 0.07 ± 0.01 
V5 1.52 ± 0.1 1.54 ± 0.1 0.02 ± 0.01 
V6 1.24 ± 0.1 1.27 ± 0.1 0.03 ± 0.01 
T wave I 0.33 ± 0.0 0.37 ± 0.0 0.04 ± 0.00 
II 0.36 ± 0.0 0.39 ± 0.0 0.03 ± 0.00 
III 0.04 ± 0.0 0.03 ± 0.0 0.01 ± 0.00 
aVR -0.34 ± 0.0 -0.36 ± 0.0 0.02 ± 0.00 
aVL 0.15 ± 0.0 0.17 ± 0.0 0.02 ± 0.00 
aVF 0.20 ± 0.0 0.20 ± 0.0 0.00 ± 0.00 
V1 0.05 ± 0.0 0.03 ± 0.0 0.02 ± 0.01 
V2 0.63 ± 0.1 0.63 ± 0.1 0.00 ± 0.00 
V3 0.62 ± 0.1 0.60 ± 0.1 0.02 ± 0.01 
V4 0.56 ± 0.1 0.56 ± 0.1 0.00 ± 0.00 
V5 0.47 ± 0.0 0.49 ± 0.1 0.02 ± 0.01 
V6 0.37 ± 0.0 0.40 ± 0.0 0.03 ± 0.01 
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2.9.5. Clinical Thresholds 
Table 2.3. Summary of AHA/ACCF/HRS clinical thresholds for abnormality (non 
gender specific). Thresholds apply to all leads unless stated otherwise 
 
ECG measurement Clinical threshold 
- Frontal plane 
Clinical threshold 
- Transverse plane 
Wave amplitude   
  
 
ST segment height Elevation of >0.1mV 
Depression of < -0.1mV 
Elevation of >0.2mV in V2-3 
Elevation of >0.1mV in V1 & V4-6 
Depression of < -0.05mV in V2-3 
Depression of < -0.1mV in V1 & V4-6 
 
T wave amplitude >0.5mV >1.0mV 
 
Interval duration   
QTc interval > 0.43s > 0.43s 
 
Electrical axis 
 
QRS axis 
 
 
< > -30° to +90° 
 
 
 
No clinical threshold  
 
All recorded ECG measurements were quantified according to current clinical thresholds set 
out by the American Heart Association (AHA), the American College of Cardiology 
Foundation (ACCF) and the Heart Rhythm Society (HRS) (Surawicz et al., 2009; Wagner et 
al., 2009; Rautaharju et al., 2009). Additional clinical guidelines on specific T amplitudes 
were taken from Wagner (2008). A summary of these clinical guidelines can be seen in table 
2.3. The clinical thresholds presented here are for markers of ischemia within the 
myocardium. These were of primary interest in the experiments in this thesis investigation. 
 
Due to the effects of gender on the ventricular repolarisation phase of the cardiac cycle, T 
wave amplitudes and ST segment height in the transverse plane leads were compared 
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collectively to the non gender specific clinical thresholds in table 2.3 and in addition, data was 
separated and compared to gender specific clinical thresholds summarised in table 2.4.  
 
Table 2.4. Summary of gender specific AHA/ACCF/HRS clinical thresholds for 
abnormality in the transverse plane leads.  
 
ECG measurement Clinical thresholds 
- Men 
Clinical thresholds 
- Women 
T wave amplitude 
V1 
V2 
V3 
V4 
V5 
V6 
 
 
>0.65mV 
>1.45mV 
>1.35mV 
>1.15mV 
>0.90mV 
>0.65mV 
 
 
>0.20mV 
>0.85mV 
>0.85mV 
>0.85mV 
>0.70mV 
>0.55mV 
 
ST segment height 
V1 
V2-3 
V4-6 
 
 
Elevation of >0.10mV 
Elevation of >0.25mV 
Elevation of >0.10mV  
 
 
Elevation of >0.10mV  
Elevation of >0.15mV  
Elevation of >0.10mV  
 
 
 
2.10. Echocardiography 
2.10.1. Background in echocardiography 
Echocardiograms visualise the structure and function of the heart non-invasively and can be 
used to identify wall motion abnormalities and diastolic dysfunction associated with 
myocardial ischemia caused by coronary artery disease. Echocardiography was used in this 
thesis investigation to study the potentially ischemic effects of hypocapnia on wall motion 
(measured with M-mode and tissue Doppler analysis) and diastolic function (measured with 
Doppler blood flow analysis). 
 
An echocardiographic machine utilizes an ultrasonic transducer placed on the chest wall and 
creates images which are displayed on a computer screen. Ultrasonic transducers emit waves 
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Velocity of sound waves 
      Wave transit time 
with a frequency of ~2,000,000 cycles per second (2 MHz) in intermittent bursts 
(Feigenbaum, 1981). In the interval between each burst, the transducer becomes a receiver 
waiting for reflected echo waves. Ultrasonic waves hit structures of different media (e.g. soft 
tissue, muscle, red blood cells) and are reflected back towards the transducer. The distance of 
the structure from the ultrasonic transducer is calculated (by equation 2.11) and converted into 
an electrical impulse which is passed through a signal amplifier and displayed as an 
echocardiographic image on the computer screen. 
 
 
Equation 2.11. 
 
Distance     =  
       
 
Where the velocity of sound was taken as 1540 ms-1 and the wave transit time represents the 
time it takes for a wave to be emitted from the transducer and be reflected back off a medium 
within the body 
 
 
Figure 2.12. Two-dimensional echocardiographic imaging planes. RV = right 
ventricle, LV = left ventricle, RA = right atria LA = left atria, PA = pulmonary 
artery (From Henry et al. (1980). Report of the American Society of 
Echocardiography Committee on Nomenclature and Standards in Two-dimensional 
Echocardiography. Circulation, 62(2): 212) 
Figure 2.12. Echocardiographic imaging planes of the heart  
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Different modes of echocardiography require different transducer positions and these 
positions have been standardised to elicit consistency with recordings in both clinical and 
research settings (Henry et al., 1980). The heart is viewed on 3 anatomical planes (long axis, 
short axis and four chamber plane) (figure 2.12) from 4 ‘viewing windows’. The long axis 
plane can be viewed from the apical, parasternal or suprasternal chest locations (figure 2.13a). 
The short axis plane can be viewed from the parasternal or subcostal locations of the chest 
Figure 2.13. Echocardiographic views of the heart  
Figure 2.13. Transducer orientations of the three echocardiographic planes of the 
heart. RV = right ventricle, LV = left ventricle, RA = right atria LA = left atria, AO 
= aorta (From Henry et al. (1980). Report of the American Society of 
Echocardiography Committee on Nomenclature and Standards in Two-dimensional 
Echocardiography. Circulation, 62(2): 212) 
(a) 
(b) (c) 
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(Figure 2.13b). The four chamber plane can be viewed from either the apical or subcostal 
chest positions (figure 2.13c).  
 
Echocardiography was used in experiments studying the effects of hypocapnia on heart 
function in normal subjects. All echocardiography measurements were made by a trained 
echocardiography technician using a Phillips SONOS 7500 ultrasound system (M2424A, 
Andover, Massachusetts, USA). Subjects lay recumbent, on their left side, causing the heart to 
move closer to the chest wall, making it easier to image. Recorded data was saved and 
analysed offline by an independent echocardiography technician who was blinded to the 
different conditions. Analysis was done using the pre-programmed analysis tools built into the 
echocardiographic machine software.  
 
Three different modes of echocardiography were recorded: Two-dimensional directed M-
mode, Doppler blood flow & tissue Doppler echocardiography. The methods of these modes 
are described below. 
 
2.10.2. M-mode echocardiography 
Two-dimensional directed M-mode echocardiography depicts the motion of the left ventricle 
walls (calculated by the change in distance of object in relation to the transducer) over time 
(Feigenbaum, 1981). M-mode images have no resemblance to a specific anatomical structure 
but depict a pattern of motion from the target myocardial structure throughout the cardiac 
cycle (Arvan, 1984). M-mode echocardiography allows for more subtle changes in wall and 
valve motion to be studied.  
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In this thesis investigation, M-mode echocardiographs were recorded from the parasternal 
long axis view (figure 2.13a). The area of the heart to be imaged was determined from an M-
mode cursor which is placed on the target location of a two-dimensional long axis 
echocardiographic image (figure 2.14). In this case, the cursor was placed at the level of the 
tips of the mitral valve, dissecting the left ventricle. From this position, movement of the 
intraventricular septum and left ventricular posterior wall can be recorded (figure 2.14). Wall 
motion in the left ventricle was determined by measuring the distance between the 
intraventicular septum and the posterior wall (LVID) and comparing this difference between 
diastole (LVIDd) and systole (LVIDs) (figure 2.14). Fractional shortening (FS) is a measure 
of degree to which the left ventricle gets smaller during myocardial contraction. It was 
calculated from the LVID using equation 2.12. 
M-mode cursor 
dissects the left 
ventricle at the 
level of the 
mitral leaflets 
LVIDs LVIDd 
Intraventricular septum 
Posterior wall 
Long 
axis view 
 
Left 
ventricle 
 
Figure 2.14. M-mode echocardiogram of the left ventricle.  
Figure 2.14. Transmitral M-mode echocardiogram. Measures left ventricle 
intraventricular diameter in diastole (LVIDd) and systole (LVIDs). 
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Equation 2.12. 
100×




 −
=
LVIDd
LVIDsLVIDdFS
 
 
Two-dimensional M-mode echocardiographic measurements were made in both baseline and 
hypocapnic conditions during each trial. LVID was compared in diastole and systole to allow 
estimation of the degree of wall motion during myocardial contraction. Normal mean values 
for LVID during diastole are 4.6 ± 0.5cm and 2.9 ± 0.5cm during systole (1.7 ± 0.5cm 
difference) (table 2.5) (Salcedo, 1978). Normal mean values for FS are 37 ± 7% and any 
reduction below 25% is considered clinically significant (Weyman, 1982). During myocardial 
ischemia, the LVID difference and FS will decrease as wall motion becomes inhibited in the 
ischemic region (Braunwald et al., 2001). 
 
Table 2.5. Normal clinical values for echocardiographic measurements made in M-
mode, Doppler blood flow mode and tissue Doppler mode.  
 
Measurement Normal values 
M-mode echocardiography  
LVIDd 4.6 ± 0.5cm  
LVIDs 2.9 ± 0.5cm
 
Fractional Shortening >25% (mean 37 ± 7%) 
  
Doppler echocardiography  
E/A ratio >1 
Deceleration time <220ms (mean 200 ± 40ms) 
  
Tissue Doppler echocardiography  
Septal wall velocity (diastole) 11.4 ± 2.6cm/s 
Septal wall velocity (systole) 7.1 ± 1cm/s 
Lateral wall velocity (diastole) 15.4 ± 3.9cm/s 
Lateral wall velocity (systole) 10.0 ± 2.2cm/s 
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2.10.3. Doppler echocardiography 
Doppler echocardiography measures the velocity of blood flow into the left ventricle. It is 
based on the principles of the ‘Doppler effect’. Changes in the frequency of sound waves as a 
result of movement of the source relative to the target are known as Doppler shifts (Arvan, 
1984). As the source moves towards a stationary target, the frequency of sound waves 
becomes larger; as the source moves away from the target, the frequency becomes smaller. In 
the case of Doppler echocardiography, the source is stationary (echocardiographic transducer) 
and the target is moving (red blood cells) (Arvan, 1984). Ultrasonic waves are emitted from 
the transducer at a known frequency. If these waves strike a target that is stationary, they are 
reflected back at the same frequency. If the target is moving, such as red blood cells, waves 
are reflected back to the transducer at an alternative frequency which is dependent on the 
direction of blood flow. When blood flow is moving towards the echocardiographic 
transducer, the frequency of reflected ultrasonic waves is increased and when blood flow 
moves away from the transducer, the frequency of reflected ultrasonic waves is attenuated 
(Arvan, 1984). The change in frequency between the emitted and returning waves is known as 
the Doppler shift and is calculated by the echocardiographic machine. These changes in 
frequency can be used to calculate the maximum velocity of blood flow that is directly 
parallel to the axis of the ultrasonic beam (equation 2.13) (Baker et al., 1977).  
 
Equation 2.13. 
Velocity of blood flow = 
θcos2 f
fC∆
 
Where ∆ƒ = change in frequency, C = velocity of sound in tissue (1540 ms-1), ƒ = frequency 
of waves emitted by the transducer and θ = angle of the transducer in relation to blood flow 
(assumed to be 0˚). 
(Braunwald et al., 2001) 
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The pulse repetition frequency represents the sampling rate of the reflected ultrasonic waves 
(Baker et al., 1977). To prevent aliasing, the pulse repetition frequency must be at least twice 
the expected Doppler frequency shift (Nyquist, 2002). A large frequency shift can occur when 
measuring blood flow due to its high velocity (10-100cm/s) (Erbel et al., 1996). Therefore, 
the pulse repetition frequency is set as high as is possible for the depth of the sample volume 
(if both the depth of the sample volume and the pulse repetition frequency are high, there will 
not be enough time for ultrasonic waves to be reflected from the sample before the next burst 
is emitted). The sensitivity of the transducer is increased to detect blood flow signals of low 
amplitude and a high pass filter is applied to the data to remove signals of low velocity, 
originating from other moving tissues (Garcia et al., 1998). 
Systole 
Doppler 
cursor placed 
on the mitral 
leaflets in the 
left ventricle 
 
Diastole 
4 chamber 
view 
 
Deceleration 
time 
Left 
ventricle 
 
Right 
ventricle 
 
Flow 
profile 
 
Peak A wave velocity 
Peak E wave velocity 
 
Figure 2.15. Doppler blood flow echocardiogram 
Figure 2.15. Spectral mode flow profile from subject 1, showing left ventricle filling 
patterns. E wave = early diastole. A wave = late diastole. Transducer placed in the 
apical window showing the 4-chamber plane 
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In the present investigation, Doppler echocardiographs were recorded from the apical position 
showing the 4 chamber view (figure 2.13c, page 63). The Doppler cursor was placed at the 
tips of the mitral leaflets. This records the flow of blood from the left atrium, across the mitral 
valve and into the left ventricle. Doppler measurements were recorded for several cardiac 
cycles and displayed in spectral mode as a flow profile (figure 2.15). Spectral mode depicts 
increases in reflected wave frequency (blood flow towards the transducer) as positive 
deflections on the flow profile and decreases in wave frequency (blood flow away from the 
transducer) as negative deflections. The height of these deflections is relative to the blood 
flow velocity. 
 
On a Doppler trace, blood flow across the mitral valve during early diastole is represented by 
the E wave (figure 2.15). Peak blood flow velocity during early diastole is represented by the 
peak of the E wave. As the left ventricle fills with blood, the pressure gradient between the 
left ventricle & left atrium decreases, causing the flow of blood into the left ventricle to fall. 
This is measured by the deceleration time (figure 2.15). Blood flow into the left ventricle is 
then increased by atrial contraction during late diastole causing the A wave (figure 2.15). 
Peak blood flow velocity during late diastole is represented by the peak of the A wave. 
 
Doppler blood flow echocardiographic measurements were recorded in normocapnia and 
hypocapnia and the E/A (E wave/A wave) ratio and deceleration time were calculated. In 
normal healthy subjects, atrial contraction accounts for only 30% of total diastolic filling. 
During this period, blood flow velocity is low. Thus the A wave is always smaller than the E 
wave (Hamlin et al., 2004). The difference between these waves is represented by the E/A 
ratio and in normal subjects this is always greater than 1 (Hamlin et al., 2004) (table 2.5). 
 70
Deceleration time is always short due to the fast inflow of blood into the left ventricle during 
early diastole (~200 ± 40ms) (Nishimura & Tajik, 1997). Myocardial ischemia causes the 
relaxation phase of the cardiac cycle to be impaired resulting in Grade I (mild) diastolic 
dysfunction (Nishimura & Tajik, 1997). Therefore, if hypocapnia was to cause myocardial 
ischemia in the present study, blood flow into the left ventricle during early diastole would be 
reduced.  This would cause a decrease in E wave amplitude and a compensatory increase in A 
wave amplitude, resulting in a decreased E/A ratio (<1) and prolonged deceleration time 
(>0.22 seconds) (Garcia et al., 1998). 
 
2.10.4. Tissue Doppler echocardiography 
Tissue Doppler echocardiography measures the velocity of left ventricular wall motion during 
diastole and systole. Tissue Doppler echocardiography uses the same principles as Doppler 
blood flow echocardiography. The myocardium moves at low velocity (<10 cm/s) and reflects 
ultrasonic waves of high amplitude (Erbel et al., 1996). To view Doppler frequency shifts 
from the tissues, the high pass filter used in standard Doppler echocardiography is removed 
and the sensitivity of the ultrasonic transducer is reduced so that low amplitude signals (from 
blood flow) are not recorded (Mcdicken et al., 1992). Because the expected Doppler 
frequency shifts are small, the pulse repetition frequency can be reduced allowing a sample 
volume of increased depth. As with standard Doppler measurements, a sample volume is 
positioned over the myocardial area of interest on the 4 chamber plane and a Doppler cursor is 
placed on the myocardial wall of interest (figure 2.16, 2.17). Tissue Doppler wall velocity 
profiles are displayed in spectral mode (figure 2.16, 2.17). The height of the waves on these 
profiles represents the velocity of the target wall at that point in the cardiac cycle. 
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For tissue Doppler recordings made in the present study, the echocardiographic transducer 
was placed in the apical position showing the 4 chamber view (figure 2.13c, page 63). The 
Doppler cursor was placed on the septum (figure 2.16) and lateral wall (figure 2.17) segments 
of the left ventricle. Tissue Doppler imaging depicts myocardial wall velocities as Em waves 
(early diastole), Am waves (late diastole) and Sm waves (systole) which allows wall 
velocities to be distinguished at different stages of the cardiac cycle (figures 2.16, 2.17). The 
peaks of these waves represent the peak velocity of the myocardial wall being imaged.  
Diastole Systole 
4 chamber 
view 
 
Left 
ventricle 
 
Tissue 
Doppler 
cursor dissects 
the septal wall  
Septal wall 
Sm wave 
Velocity 
profile 
 
Figure 2.16. Spectral mode velocity profile from subject 1, showing velocity of the 
septum. Em wave = early diastole. Am wave = late diastole. Sm wave = systole. 
Transducer placed in the apical window showing the 4-chamber plane 
Figure 2.16. Tissue Doppler echocardiogram of the septum. 
Peak Em wave velocity Peak Am wave velocity 
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Normal mean values for myocardial wall velocities are presented in table 2.5. During 
myocardial ischemia, wall velocities are significantly reduced by 31-57% in diastole (Em 
wave) and 39% in systole (Sm wave) and the decrease in wall velocity is correlated with the 
size of the ischemic region (Garcia-Fernandez et al., 1999; Kostkiewicz et al., 2003). In the 
present study, a decrease in diastolic wall velocity below 8cm/s during hypocapnia would be 
suggestive of the presence of myocardial ischemia (Garcia-Fernandez et al., 1999; Garcia et 
al., 1998; Kostkiewicz et al., 2003). 
Diastole Systole 
Tissue Doppler 
cursor dissects the 
lateral wall of the 
left ventricle 
 
Figure 2.17. Spectral mode velocity profile from subject 1, showing velocity of the 
lateral wall. Em wave = early diastole. Am wave = late diastole. Sm wave = systole. 
Transducer placed in the apical window showing the 4-chamber plane 
4 chamber 
view 
 
Left 
ventricle 
 
Lateral 
wall 
Sm wave 
Velocity 
profile 
 
Peak Am wave velocity 
 
Peak Em wave velocity 
 
Figure 2.17. Tissue Doppler echocardiogram of the lateral wall. 
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Chapter 3 
 
Does ECG electrode placement modification cause clinically significant changes in the 
standard 12 lead ECG of healthy subjects at rest? 
 
3.1. Summary 
In experiments studying the effects of hypocapnia, induced by mechanical hyperventilation, 
on the ECG, Rutherford et al., (2005) placed the limb electrodes on the torso, as is routinely 
done during exercise stress testing or when the limbs are inaccessible. It is unclear to what 
degree such electrode modification alters the amplitudes of the ECG waves, or whether it 
produces clinically important, false positive ECG changes in healthy subjects (e.g. ST 
segment changes of greater than 0.1mV, T wave changes greater than 0.5mV in the frontal 
plane or 1mV in transverse plane, QRS axis shifts or alterations to the QTc interval). 
 
This experiment demonstrated in healthy and semi-recumbent subjects (n = 18), that electrode 
modification caused small R and T wave amplitude changes in the frontal plane and QRS axis 
changes that are statistically, but not clinically significant. For example, in lead I, electrode 
modification caused a decrease in the amplitude of the R wave of 21% (0.13mV, P < 0.001) 
and T wave of 19% (0.06mV, P < 0.001). In the transverse plane, modification does not 
produce statistically or clinically significant changes in ECG wave amplitudes or in ST 
segment morphology or QTc interval duration. When separated by gender, T wave amplitude 
and ST segment height in the transverse plane remain unaffected by electrode modification. 
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This study shows that electrode modification does significantly alter the amplitude of the R 
and T wave. However, these ECG changes are not clinically significant in healthy subjects 
and thus have no effect on the clinical specificity of the 12 lead ECG. 
 
3.2. Introduction 
The position of the ECG electrodes was defined by Einthoven (1912) (limb electrodes) and 
Barnes et al., (1938) (precordial electrodes). Motion of the limbs can disrupt the ECG 
sufficiently to make the limb electrode placement impractical during exercise testing. Mason 
and Likar (1966) developed an alternative electrode placement to avoid this muscular 
interference during exercise. They repositioned the arm electrodes onto the “infraclavicular 
fossa medial to the border of the deltoid muscle” and the left leg electrode onto “anterior 
axillary line, halfway between the costal margin and the crest of the illium” (Mason & Likar, 
1966) (Modified1, table 3.1). It was claimed that ECGs recorded using this electrode 
modification vary only slightly from the standard electrode placement, but data presented 
showed an increase in R and T wave amplitude of up to 40% in leads I-III (table 3.2). 
Subsequent studies have disputed the accuracy of the M-L modified electrode placement 
claiming it could result in false diagnosis of disease in normal healthy patients because the 
modified placement shifts wave amplitudes and electrical (QRS) axes beyond normal limits 
(Kleiner et al., 1978; Rautaharju et al., 1980; Gamble et al., 1984; Papouchado et al., 1987; 
Edenbrandt et al., 1989; Sevilla et al., 1989).  
 
The modified electrode placement was of interest in this thesis investigation because 
Rutherford et al., (2005) used a modified electrode placement when studying the effects of 
hypocapnia on the ECG. A review of the literature revealed much disagreement as to the 
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Author Electrode 
placement
Diagram Author Electrode 
placement
Diagram Author Electrode 
placement
Diagram
M-L (Modified Diamond Lund 
(Modified1) (Modified2) (Modified3)
Arm electrodes 
are placed on the 
infraclavicular 
fossa medial to the 
border of the 
deltoid muscle. 
The left leg 
electrode is placed 
on the anterior 
axillary line, 
halfway between 
the costal margin 
and the crest of the 
illium
Arm electrodes 
are placed below 
the outer third of 
the right/left 
cavicle. The left leg 
electrode is placed 
4cm below the 
umbilicus and the 
right leg electrode 
is positioned in the 
mid clavicular line 
at the level of the 
umbilicus
Arm electrodes 
are placed on the 
lateral side of the 
arms at the level of 
the axillary fold. 
The left leg 
electrode is 
positioned on the 
left iliac crest in the 
anterior axillary 
line
Sevilla Krucoff Takuma
(Modified4) (Modified5) (Modified6)
Arm electrodes 
are placed on the 
right & left mid-
clavicular lines, just 
below the clavicle. 
The leg electrodes 
are placed on the 
left & right anterior 
axillary lines, just 
above the 
subcostal margins
Arm electrodes 
are placed on the 
lateral extent of the 
clavicle. The leg 
electrodes are 
placed on the left 
& right iliac crests 
in the midaxillary 
line 
Arm electrodes 
are placed on the 
left & right anterior 
acromial regions. 
The leg electrodes 
are placed on the 
left & right anterior 
superior iliac 
spines                      
Sevilla et 
al., (1989)
Krucoff et 
al.,  (1994)
Takuma et 
al., (1995)
Diamond et 
al.,  (1979)
Edenbrandt 
et 
al., (1989)
Mason & 
Likar (1966)
Table 3.1. Alternative electrode placements of the standard 12 lead ECG. Standard electrode placement indicated by 
blue crosses on the limbs. 
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Table 3.2. Frontal plane leads. Table shows the absence of quantifiable data included in 
previous studies investigating the effects of modified electrode placements on the ECG.  
 
 
 
Table 3.2. Modified1 = M-L placement, modified2 = Diamond placement, modified3 = 
Lund placement, modified4 = Sevilla placement, modified5 = Krucoff placement, 
modified6 = Takuma placement. Values represent mean changes from standard ECG in 
mV. Data is ranked with the study showing the largest ECG changes (in mV) first.  
* = <50% change, ** = >50% change, *** = >100% change from the standard ECG. 
 
 
correct use of the modified electrode placement during exercise and at rest. A study of the 
specific changes caused by electrode modification was therefore conducted with particular 
interest placed on how modification affects R, T, and ST segment amplitudes and QRS axes 
and whether these changes affect the clinical specificity of the 12 lead ECG. 
Rank Author Electrode placement/ 
number of subjects
Mean R wave change 
(mV) with 
modification
Mean T wave change 
(mV) with 
modification
Mean ST segment change 
height/slope (mV or 
mV/ms)
I: – 0.03 * No data No data
II: + 0.11 *
III: + 0.06 *
aVR: + 0.04 *
aVL: – 0.07 *
aVF: + 0.10 *
I: only % given* I: only % given* No data
II: only % given* II: only % given*
III: only % given* III: only % given*
I: – 0.12 * I: – 0.02 * No data
II: + 0.06 * II: no data
III: + 0.21 ** III: no data
aVR:  no data aVR: no data
aVL: – 0.11 * aVL: no data
aVF: + 0.08 * aVF: + 0.05 *
I: – 0.12 * I: no data I: no data
II: + 0.31 * II: + 0.09 * II: + 0.15 mV/ms *
III: + 0.24 ** III: + 0.07 *** III: + 0.16 mV/ms ***
aVR: no data aVR: no data aVR: no data
aVL: – 0.21 * aVL: – 0.04 * aVL: – 0.08 mV/ms *
aVF: + 0.33 ** aVF: + 0.09 ** aVF: + 0.16 mV/ms ***
I: – 0.03 * No data No data
II: + 0.05 **
III: + 0.07 ***
aVR: no data
aVL: – 0.03 **
aVF: + 0.07 ***
6 Kleiner, et al.,  (1978) Modified1   (n = 75) No data No data No data
7 Diamond, et al., (1979) Modified2   (n = 11) No data No data No data
8 Sevilla et al., (1989) Modified4   (n = 44) No data No data No data
9 Pahlm et al.,  (1992) Modified3/5   (n = 26) No data No data No data
10 Krucoff et al.,  (1994) Modified5   (n = 30) No data No data Mean differences in all 
leads <0.02mV *
11 Takuma et al.,  (1995) Modified6   (n = 10) No mean values No mean values No mean values
12 Jowett et al.,  (2005) Modified6   (n = 50) No data No data No data
4
5
Table 3.2.
1
2
3 Modified1 (n = 104)
Mason & Likar (1966)
Frontal plane leads
Rautaharju, et al.,  (1980) Modified1 (n = 68)
Papouchado et al.,  (1987)
Modified1 (n = 19)
Modified1 (n = 29)
Edenbrandt et al.,   (1989) Modified3 (n = 10)
Gamble et al.,  (1984)
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Table 3.3. Transverse plane leads. Table shows the absence quantifiable data included in 
previous studies investigating the effects of modified electrode placements on the ECG. 
 
 
 
Table 3.3. Modified1 = M-L placement, modified2 = Diamond placement, modified3 = 
Lund placement, modified4 = Sevilla placement, modified5 = Krucoff placement, 
modified6 = Takuma placement. Values represent mean changes from standard ECG in 
mV. Data is ranked with the study showing the largest ECG changes (in mV) first.  
* = <50% change, ** = >50% change, *** = >100% change from the standard ECG.  
 
Many electrode placements have been proposed claiming to eliminate discrepancies between 
standard and modified ECGs (table 3.1). Such modification should not cause considerable 
alterations to the ECG waveform in the transverse plane leads, because the modified electrode 
placement does not involve movement of the precordial exploring electrodes (V1-6). The only 
Rank Author Electrode placement/ 
number of subjects
Mean R wave change 
(mV) with 
modification
Mean T wave change 
(mV) with 
modification
Mean ST segment change 
height/slope (mV or 
mV/ms)
V1: 0.00 * No data No data
V2: – 0.02 *
V3: – 0.04 *
V4: – 0.02 *
V5: 0.00 *
V1: no data V1: no data No data
V2: no data V2: no data
V3: only % given* V3: only % given*
V4: only % given* V4: only % given*
V5: only % given* V5: only % given*
V6: only % given* V6: only % given*
V1: – 0.01 * V1: – 0.01 * No data
V2: – 0.02 * V2: no data
V3: no data V3: no data
V4: no data V4: no data
V5: no data V5: no data
V6: no data V6: no data
4 Kleiner, et al.,  (1978) Modified1   (n = 75) No data No data No data
5 Diamond, et al., (1979) Modified2   (n = 11) No data No data No data
No data No data No data
7 Papouchado et al.,  (1987) Modified1   (n = 29) No data No data No data
8 Sevilla et al., (1989) Modified4   (n = 44) No data No data No data
9 Pahlm et al.,  (1992) Modified3/5   (n = 26) No data No data No data
10 Krucoff et al.,  (1994) Modified5   (n = 30) No data No data Mean differences in all 
leads <0.02mV *
11 Takuma et al.,  (1995) Modified6   (n = 10) No mean values No mean values No mean values
12 Jowett et al.,  (2005) Modified6   (n = 50) No data No data No data
2
3
6
1
Table 3.3.
Modified1 (n = 19)
Modified1  (n = 104)Gamble et al.,  (1984)
Transverse plane leads
Modified3 (n = 10)Edenbrandt et al.,   (1989)
Mason & Likar (1966)
Rautaharju, et al., (1980) Modified1
 (n = 68)
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aspect of the transverse plane leads that should alter is the reference central terminal, 
movement of which is likely to have less effect on the final waveform amplitudes (table 3.3). 
Modification does, however, produce differences in wave amplitude in the frontal plane leads 
of the ECG (table 3.2). Most changes are no greater than +/- 50% of the standard values 
although it has been suggested that even these changes could result in false positive exercise 
stress tests in healthy subjects (Gamble et al., 1984; Jowett et al., 2005; Kleiner et al., 1978; 
Pahlm et al., 1992; Papouchado et al., 1987; Sevilla et al., 1989; Wiens & Chaitman, 1997).  
 
The modified electrode placement has been shown to cause changes in ST segment height of  
between 0.02mV (Krucoff et al., 1994) to 0.13 mV (Takuma et al., 1995). Others claim that 
the modified electrode placement causes clinically important ST segment changes, despite a 
lack of supporting data (table 3.2 and 3.3) (Rautaharju et al., 1980; Gamble et al., 1984; 
Jowett et al., 2005; Wiens & Chaitman, 1997). The extent to which the modified electrode 
placement affects the ST segment in the 12 lead ECG is of interest because it contains 
important diagnostic information for myocardial ischemia and infarction. 
 
The modified electrode placement is thought to cause a rightward shift in the QRS axis. Data 
shows that the M-L placement (modified1) alters the QRS axis from between -3° to 45° (table 
3.4) (Gamble et al., 1984; Kleiner et al., 1978; Papouchado et al., 1987; Rautaharju et al., 
1980).  
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Table 3.4 QRS axis. Table shows the modified electrode placement used in previous 
studies causes a rightward shift on the frontal plane of the ECG, ranging from 4° to 48°. 
 
 
 
Table 3.4. Modified1 = M-L placement, modified2 = Diamond placement, modified3 = 
Lund placement, modified4 = Sevilla placement, modified5 = Krucoff placement, 
modified6 = Takuma placement. Modified lead placements are defined in table 3.1. 
Values represent mean changes from standard ECG in degrees. Data is ranked with the 
study showing the largest ECG changes (in mV) first. 
 
It appears that there is no agreement on precisely which modified configuration should be 
used, what ECG amplitude changes are induced and whether such changes are clinically 
relevant. Thus, Kligfield et al., (2007) simply concludes that; 
 
“ECGs recorded with torso placement of the extremity electrodes cannot be considered 
equivalent to standard ECGs for all purposes and should not be used interchangeably 
with standard ECGs for serial comparison”. 
 
Rather than just measuring again whether modification produces statistically significant 
changes in healthy subjects, here the aim was to establish whether modification moves the 
Rank Author Electrode placement/ 
number of subjects
Mean QRS axis 
change with 
modification
Mean T axis change 
with modification
1 Sevilla et al., (1989) Modified4   (n = 44)  + 48° No data
2 Kleiner, et al.,  (1978) Modified1   (n = 75)  + 45° No data
3 Papouchado et al.,  (1987) Modified1   (n = 29)  + 30° No data
4 Jowett et al.,  (2005) Modified6   (n = 50)  + 27°  + 25° 
5 Rautaharju, et al., (1980) Modified1 (n = 68)  + 16° No data
6 Takuma et al.,  (1995) Modified6   (n = 10)  + 8° No data
7 Edenbrandt et al.,   (1989) Modified3 (n = 10)  + 4° No data
8 Gamble et al.,  (1984) Modified1  (n = 104)  – 3° No data
9 Pahlm et al.,  (1992) Modified3/5   (n = 26) No mean data No data
10 Mason & Likar (1966) Modified1 (n = 19) No data No data
11 Diamond, et al., (1979) Modified2   (n = 11) No data No data
12 Krucoff et al.,  (1994) Modified5   (n = 30) No data No data
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waveforms beyond the clinical limits of normality, as recently defined by the American Heart 
Association, the American College of Cardiology Foundation and the Heart Rhythm Society 
(Rautaharju et al., 2009; Surawicz et al., 2009; Wagner et al., 2009) and Wagner (2008) (table 
2.3, page 60).  
 
Wave amplitudes, ST segment height, QRS axes and QTc interval duration were compared in 
both standard and modified electrode placements. By quantifying observed changes in the 
context of current clinical guidelines, it was hoped the clinical specificity of the modified 
ECG for detecting myocardial ischemia could be established. In additional analysis, T wave 
amplitudes and ST segment heights were separated by gender and compared to gender 
specific ECG clinical thresholds, as recommended by Wagner et al., (2009). A secondary aim 
of this study was to determine whether Rutherford et al., (2005) were correct in using a 
modified electrode placement when studying the effects of mechanical hyperventilation on the 
ECG. Therefore, the effect of electrode modification during mechanical hyperventilation in 
normocapnia was also examined. 
 
Since the purpose of modification is to keep the limb electrodes off the extremities, they 
should ideally be placed just on the torso, but as near to the limbs as possible. Of all the 
possible modifications, that of Takuma et al., (1995) (Modified6, table 3.1) was chosen 
because it is nearest to this ideal and should therefore have the least effect on the ECG 
waveform (Gamble et al., 1984; Wilson et al., 1934). Arm electrodes were placed on the 
“anterior acromial region” and leg electrodes on the “anterior superior iliac spine” (Takuma et 
al., 1995). This electrode placement is considered useful in a number of clinical settings 
because in addition to reducing the artefact of motion on the patient’s ECG, it also to allows 
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recordings to be made without the removal of patient’s shoes, trousers or stockings, eliciting 
faster application (important in an emergency).  
 
3.3. Methods 
Eighteen normal healthy subjects aged 24 ± 3 years old (20-30 years old) (13 male) gave 
informed consent to participate in the study and all experiments were approved by the Walsall 
Local Research Ethics Committee. Data were collected on four separate occasions and 
subjects lay resting and semi-recumbent on a bed. Ten Blue sensor ECG electrodes (Ambu) 
were placed in standard positions (figure 2.4, page 43) and four more in the modified 
positions (Modified6, table 3.1). Two minute recordings were made in the standard electrode 
positions followed by the modified positions using the ECG apparatus previously described 
(chapter 2.9.2, page 50). Data from the ECG electrodes were recorded simultaneously using 
Spike2 data acquisition software and subsequently analysed offline.  
 
An average waveform (of ~120 beats) was calculated in each lead for both standard and 
modified electrode placements. Amplitudes of the R and T waves were calculated from these 
waveforms. ST segment height, QRS axes and QTc interval duration were measured as 
previously described (chapter 2.9.3, page 55). T wave, ST segment and QTc interval data 
were measured because they are most commonly used as indicators of myocardial ischemia 
and therefore were of interest to this thesis investigation. QRS axis data was included in this 
study because it has been commonly used in a number of previous studies to demonstrate the 
extent of electrode modification on the ECG (Gamble et al., 1984; Sevilla et al., 1989; Jowett 
et al., 2005; Takuma et al., 1995; Edenbrandt et al., 1989; Kleiner et al., 1978; Papouchado et 
al., 1987; Rautaharju et al., 1980).  
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Wave amplitudes were defined as the wave heights (from zero) minus the isoelectric line 
(figure 2.3, page 41). An average of these wave amplitudes, electrical axes and interval 
durations was calculated for each subject over their 4 visits. T wave amplitudes and ST 
segment heights in the transverse plane were compared to non gender specific clinical 
thresholds for normality. In addition, data were also separated by gender and compared to 
gender specific thresholds. T wave and ST segment heights were analysed in this way because 
gender differences in the ventricular repolarisation phase of the cardiac cycle are known to 
exist (Bidoggia et al., 2000; Macfarlane, 2001; Surawicz & Parikh, 2002). Recent clinical 
guidelines suggest that they should therefore be considered separately in leads exhibiting the 
largest T wave and ST segments (i.e., transverse plane leads) (Rautaharju et al., 2009; Wagner 
et al., 2009). 
 
The effects of electrode modification on the ECG during mechanical hyperventilation (in 
normocapnia) were also considered in nine subjects. Mechanical hyperventilation was 
performed as previously described (chapter 2.3, page 26). This was investigated to establish 
whether changes that occur at rest also occur at increased breathing rates during mechanical 
hyperventilation. It was not the aim of this study to examine whether the modified electrode 
placement affects the ECG waveform during hypocapnia.  
 
All data presented are expressed as means ± standard error. A 2-tail paired t-test was 
performed in each lead to compare wave amplitudes and interval durations in the standard and 
modified electrode placements. The Bonferroni correction for multiple (12) comparisons was 
applied, on the assumption that all 12 measurements were independent and uncorrelated.   
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3.4. Results  
As expected in transverse plane leads, figure 3.1 shows that modification of the ECG 
electrode placement causes no significant changes in the amplitudes of the R wave and T 
waves. Figure 3.2 shows this is also the case during mechanical hyperventilation in 
normocapnia. 
 
In the frontal plane leads, figure 3.3 shows that modification does produce statistically 
significant changes in some R wave (leads I, II, III, aVL and aVF) and T wave amplitudes 
(leads I, II, III, aVL and aVF) at rest. In lead I, electrode modification caused a significant 
decrease in the amplitudes of the R wave by 0.13 ± 0.01mV (decrease of 21%, P < 0.001) and 
T wave by 0.06mV ± 0.01mV (decrease of 19%, P < 0.001) (figure 3.3).  
 
The largest changes in R and T wave amplitudes were in lead III, with increases of 0.27 ± 
0.03mV (>33%, P < 0.001) in the R wave and 0.12 ± 0.01mV (>74%, P < 0.001) in the T 
wave (figure 3.3). Electrode modification did not cause any T wave amplitudes to exceed 
their corresponding clinical thresholds for normality (table 2.3, page 60).  
 
R and T wave changes in the frontal plane due to electrode modification were no different 
during mechanical hyperventilation in normocapnia. Figure 3.4 shows that during mechanical 
hyperventilation, electrode modification causes similar increases in R wave amplitude of up to 
0.26 ± 0.03mV (in lead III; increase of 36%, P < 0.01) and T wave amplitude of up to 
0.12mV ± 0.01mV (in lead III; increase of 146%, P < 0.001) as those seen at rest (figure 3.3). 
In lead I, electrode modification during mechanical hyperventilation caused a significant 
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decreases in the amplitude of the R wave by 0.09 ± 0.01mV (decrease of 19%, P < 0.05) and 
T wave by 0.04mV ± 0.01mV (decrease of 17%, P < 0.01) (figure 3.4).  
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Figure 3.1. Mean + SE of R and T wave amplitudes in the transverse plane 
in standard and modified lead placements. Thresholds for clinical abnormality 
( ........... ) of T waves (table 2.3) are also shown. All modified placement 
amplitudes, NS vs. standard placement.
V1 V2 V3 V4 V5 V6
T 
w
a
ve
 
a
m
pl
itu
de
 
(m
V)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
Clinical
theshold
exceeds
n = 18
Standard placement
Modified placement
Figure 3.1. As expected, modification does not change waveform amplitudes in 
the transverse plane leads
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Figure 3.2. Mean + SE of R and T wave amplitudes in the transverse plane 
in standard and modified lead placements during mechanical hyperventilation. 
Thresholds for clinical abnormality ( ........... ) of T waves (table 2.3) are also 
shown. All modified placement amplitudes, NS vs. standard placement.
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Figure 3.2. As expected, modification does not change waveform amplitudes in 
the transverse plane leads during mechanical hyperventilation in normocapnia
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Figure 3.3. Mean + SE of R and T wave amplitudes in the frontal plane in standard 
and modified lead placements.  Thresholds for clinical abnormality ( .......... ) of T 
waves (table 2.3) are also shown. * P < 0.05, ** P < 0.01,*** P < 0.001, NS vs. 
standard placement.
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Figure 3.3. As expected, modification does change waveform amplitudes in the frontal 
plane leads
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Figure 3.4. Mean + SE of R and T wave amplitudes in the frontal plane in standard 
and modified lead placements during mechanical hyperventilation.  Thresholds for 
clinical abnormality ( .......... ) ofT waves (table 2.3) are also shown. * P < 0.05, ** 
P < 0.01,*** P < 0.001, NS vs. standard placement.
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Figure 3.4. During mechanical hyperventilation in normocapnia, electrode modification 
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Figure 3.5 shows that modification does not produce any statistically or clinically significant 
changes in ST segment height in either frontal or transverse planes. The largest non-
significant increase (0.03 mV) in ST segment height was in lead V2 (P > 0.35) and this was 
well within the clinical limit (> 0.2mV in V2-3) for normality (Wagner et al., 2009). Figure 3.5 
shows that ST segment height in lead V3 was below the clinical threshold for ST depression 
when electrodes were placed in the standard positions (-0.07 ± 0.04mV). This depressed ST 
segment was not accompanied by ST(80) point depression or ST flattening. 
 
Figure 3.6 shows modification caused a rightward shift of 14 ± 1° in the QRS axis that is 
statistically (P < 0.001) but not clinically significant (i.e. <> -30 to +90°, Surawicz et al., 
2009). As expected, modification did not alter the QTc interval duration measured in lead I of 
the ECG (0.42 ± 0.01 seconds vs. 0.42 ± 0.00 seconds). 
 
Figure 3.7 shows that T wave amplitude (in the transverse plane leads) in the modified 
electrode placement does not exceed gender specific clinical thresholds for normality in males 
or females. Figure 3.8 shows that ST segment height (in the transverse plane leads) in the 
modified electrode placement does not exceed gender specific clinical thresholds for 
normality in men and women. Once again, ST segment height in lead V3 (-0.12 ± 0.04mV) (in 
male subjects) in the standard placement was below the clinical threshold for ST depression (-
0.05mV, Wagner et al., 2009) (figure 3.8a). The ST segment in the modified electrode 
placement was also depressed below clinical thresholds (-0.09 ± 0.03mV) (figure 3.8a). ST 
segment depression in both leads was not accompanied by ST(80) point depression or ST 
flattening. 
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Figure 3.5. ST segments are defined by deviation of the J point from the isoelectric line. 
The extent of these changes is estimated by deviation of the ST(80) point. J and ST(80) 
points are presented as means + standard error. Dotted line represents clinically significant 
deviation from isoelectric line (straight line). All modified placement ST heights, NS vs.
standard placement.
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Figure 3.5. Electrode modification did not cause significant ST segment changes in any of 
the 12 leads of the ECG
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Figure 3.6. Mean + SE of the electrical axes of the QRS complex in both the standard 
and modified lead placements. Thresholds for clinical abnormality ( ......... ) (table 2.3) 
shown. Modified placement, *** P < 0.001 vs. standard placement.
Figure 3.6. Modification causes a statistically but not clinically significant rightward 
shift in the QRS axis
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Figure 3.7. Mean + SE of T wave amplitudes in the transverse plane in standard 
and modified lead placements in males (a) and females (b). Gender specific clinical 
thresholds for abnormality ( ........... ) in the T wave (table 2.4) are also shown. All 
modified placement amplitudes, NS vs. standard placement.
Figure 3.7. There are no effects of electrode modification in the transverse 
plane leads when T wave amplitudes are seperated by gender
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Figure 3.8. Mean + standard error of ST segment height (J point & ST[80] point) in the 
transverse plane in males (a) and females (b). Dotted lines are gender sepecific and represent
clinically significant deviation from isoelectric line (straight line). All modified placement 
ST heights, NS vs. standard placement.
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Figure 3.8. There are no significant effects of electrode modification in the transverse plane
leads when ST heights are seperated by gender
n = 13
ST
 
se
gm
en
t h
ei
gh
t (m
V)
a) Males
b) Females
Lead V2 Lead V3
Lead V4 Lead V5 Lead V6
Lead V1 Lead V2 Lead V3
Lead V4 Lead V5 Lead V6 n = 5
 93
3.5. Discussion 
The modified electrode placement causes statistically significant decreases in both the R wave 
and T wave of lead I at rest. Statistically significant changes in ECG wave amplitude were 
only seen in the frontal plane, but electrode modification did not cause these wave amplitudes 
to exceed clinical thresholds for healthy and semi-recumbent subjects. These changes could 
also be seen during mechanical hyperventilation in normocapnia. Electrode modification did 
not cause any changes in the ST segment. Therefore, the modified electrode placement does 
not reduce the clinical specificity of the 12 lead ECG for detecting myocardial ischemia and 
may be of use in situations where monitoring the ST segment is of great importance. 
 
Data in the present study were averaged over multiple heart beats, on four separate occasions, 
in 18 subjects. This maximises the possibility of detecting whether modification causes any 
small waveform changes that are consistent in one direction. Beat-to-beat changes in ECG 
waveforms do occur in healthy subjects, for instance when the heart beat happens to coincide 
with maximum lung inflation (Rutherford et al., 2005). It is therefore important that a large 
number of heart beats are averaged to produce a balanced representation of the normal 
waveform. Having shown that modification produces no clinically significant changes, 
detection of any consistent change in an individual waveform in any new subject would be 
sufficiently unusual to require further investigation. 
 
3.5.1. Electrode modification in the transverse plane 
ECG electrode modification did not cause any statistically significant changes in any of the 
wave amplitudes measured in the transverse plane at rest or during mechanical 
hyperventilation (figure 3.1, 3.2, 3.5). As a result, modification also did not cause clinically 
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important changes in these leads. Separating data by gender did not reveal any hidden 
variation between standard and modified electrode placements in the transverse plane. This 
lack of changes was expected because electrode modification does not involve altering any of 
the precordial electrode positions. These findings are contrary to some previous studies that 
have reported changes in the transverse plane leads of up to 0.04mV in the R wave (due to 
alteration in the ‘position’ of the central terminal reference point) (Edenbrandt et al., 1989; 
Mason & Likar, 1966; Rautaharju et al., 1980; Krucoff et al., 1994). These changes however, 
were always within 50% of standard values (table 3.3).  
 
As expected, electrode modification did not cause any significant changes in the QTc interval 
duration. This confirms the suggestion by Kligfield et al., (2007) that electrode modification 
does not adversely affect rhythm diagnosis in the ECG.  
 
3.5.2. Electrode modification in the frontal plane 
In the frontal plane leads, one would expect modification to alter the ECG waveform because 
the limb electrodes are moved onto the torso. Statistically significant changes in R and T 
wave amplitudes were observed in all these leads except of in aVR (figure 3.3). Changes in 
leads I, II and aVF were <50% and this was in accordance with previous studies (Edenbrandt 
et al., 1989; Gamble et al., 1984; Mason & Likar, 1966; Papouchado et al., 1987; Rautaharju 
et al., 1980). The findings of previous studies that modification does significantly alter the 
QRS axis (by 14 + 1°) in the frontal plane was also confirmed (figure 3.6) (Edenbrandt et al., 
1989; Gamble et al., 1984; Papouchado et al., 1987; Rautaharju et al., 1980; Jowett et al., 
2005; Kleiner et al., 1978; Sevilla et al., 1989; Takuma et al., 1995). 
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The modified electrode placement causes statistically significant decreases of ~20% in both 
the R and T wave of lead I at rest. This effect was also evident during mechanical 
hyperventilation in normocapnia. The effects of electrode modification on the amplitudes of 
the R and T waves in lead I were of interest in this thesis investigation because Rutherford et 
al., (2005) used the modified electrode placement to study the effects of hypocapnia, induced 
by mechanical hyperventilation, on the ECG. The findings of the present study suggest that 
the modified electrode placement used by Rutherford et al., (2005) may have significantly 
altered the absolute R and T wave amplitudes in their study. Subsequent studies in this thesis 
investigation will therefore use the standard electrode placement in order the measure true 
wave amplitude changes during mechanical hyperventilation in normocapnia and hypocapnia.  
 
3.5.3. Electrode modification and the ST segment 
The ST segment is used as a key indicator of myocardial ischemia/infarction during exercise 
stress testing and emergency monitoring. This study shows that modification does not change 
the ST segment in any leads (figure 3.5, 3.8). ST depression beyond the clinical threshold for 
normality was observed in lead V3 when leads were placed in the standard electrode 
placement. This was not thought to be of interest because ST segment depression was not 
accompanied by ST(80) depression or ST flattening, recordings were made in the standard 
positions in clinically normal subjects at rest and ST segment depression did not occur in any 
other leads (for ST segment depression to be of clinical importance it must occur in two 
anatomically contiguous leads, Wagner et al., 2009). 
 
The largest non-statistically significant increase in ST height was only 0.03 mV (V2), which is 
similar to that found with the modification of Krucoff et al., (1994). Although Weins & 
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Chaitman (1997) and Jowett et al., (2005) claimed that the Takuma modification (used in this 
study) did cause ST elevation in both the inferior and lateral leads to such a degree that false 
diagnosis of myocardial injury could occur, no numerical data was provided. Other 
modifications may also produce clinically important ST segment changes (Rautaharju et al., 
1980; Gamble et al., 1984), although it appears their ST changes may be within the most up to 
date clinical boundaries (Wagner et al., 2009). This study therefore provides unequivocal 
evidence that electrode modification does not cause clinically significant changes in the ST 
segment, and thus does not introduce false positive ischemic ECG changes.  
 
3.5.4. Conclusions 
No previous study has quantified the precise differences in amplitude in every waveform and 
found an objective means of judging whether such differences matter. This study addresses 
this issue using an ECG apparatus that improves confidence in wave amplitude measurements 
and compares any differences with the latest AHA, ACCF and HRS guidelines on the clinical 
thresholds for abnormality in the ECG (table 2.3; Wagner, 2008; Wagner et al., 2009; 
Rautaharju et al., 2009; Surawicz et al., 2009). The study shows that wave amplitude changes 
caused by electrode modification are sufficiently small to remain within the clinical limits for 
normality. These small changes may be of importance in a research setting such as when 
studying the subtle effects of hypocapnia in normal subjects. However, because all ECG wave 
amplitude changes were within the clinical limits for normality, it can be concluded that 
modification does not affect the clinical specificity for myocardial ischemia of the 12 lead 
ECG.  
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This investigation does not attempt to test whether electrode modification alters the sensitivity 
of the standard ECG in patients with known ECG abnormalities. If modification produced 
similar changes in these patients, it could alter sensitivity. For instance, diagnosis of a new 
onset bundle branch block relies, in part, on assessment of the QRS axis. In an acute 
myocardial infarction situation with a borderline axis, the change caused by modification in 
the present study would be of critical importance for immediate patient management. 
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Chapter 4 
 
Does hypocapnia, induced by mechanical hyperventilation, cause a significant change in 
cardiac electrical activity or heart function in normal healthy subjects? 
 
4.1. Summary 
The effects of the most severe hypocapnia tolerable (20 ± 0mmHg), induced by mechanical 
hyperventilation, on cardiac electrical activity and heart function were examined in 18 normal 
healthy resting subjects. Cardiac electrical activity was assessed by a standard 12 lead ECG 
and heart function was measured using 3 modes of echocardiography (M-mode, Doppler 
blood flow and tissue Doppler echocardiography).  
 
Hypocapnia only caused a significant increase in T wave amplitude in the anteroseptal leads 
(V1-3) of the ECG (up to 0.9mV [15%]). This elevation did not cause any T wave amplitude to 
increase beyond the clinical limits for normality set out by the AHA, ACCF and HRS 
(Rautaharju et al., 2009; Wagner, 2008). Hypocapnia had no effect on R wave amplitude, ST 
segment height or QTc interval duration in any leads.  
 
Hypocapnia did not cause any significant changes in LVID, FS, E/A ratio, deceleration time 
or diastolic septal and lateral wall velocities measured by echocardiography.  
 
The findings of this study suggest that mechanically induced hypocapnia (20 ± 0mmHg) does 
not induce ischemic changes in the heart (measured by electrocardiography and 
echocardiography) in normal healthy subjects. These findings do not discount the possibility 
 99
of ischemic ECG changes occurring in patients suffering from coronary artery disease. 
However, they do suggest that the overall effect is not as severe as was previously thought. 
 
4.2. Introduction 
Hypocapnia causes coronary vasoconstriction and an increased affinity of haemoglobin for 
O2, both of which decrease O2 delivery to the myocardium (Laffey & Kavanagh, 2002; Neill 
& Hattenhauer, 1975; Rutherford et al., 2005). Animal studies have shown that hypocapnia 
(23mmHg), induced by mechanical hyperventilation, causes large reductions in myocardial 
blood flow to the septum (by 44%), right ventricle wall (by 50%) and left ventricle wall (by 
44%) in anaesthetized pigs (Karlsson et al., 1994) and reductions in coronary flow of 23-33% 
in anaesthetized dogs (Coetzee et al., 1984; Vance et al., 1973). In normal healthy humans, 
hypocapnia (19-20mmHg) induced by voluntary hyperventilation, has been shown to reduce 
coronary blood flow by 30% which is thought to be caused by coronary vasoconstriction 
(Rowe et al., 1962; Yokoyama et al., 2008).  
 
Hypocapnia causes an increased affinity of haemoglobin for oxygen (Roughton, 1964). This 
shift of the oxygen dissociation curve to the left is known as the Bohr shift (figure 1.1, page 
13). This is caused by the direct effect of decreased CO2 on haemoglobin and an increase in 
arterial blood pH caused by decreased PaCO2 (Roughton, 1964). In humans, this effect has 
been demonstrated by a higher than expected partial pressure of O2 in the coronary sinus 
(venous) blood during hypocapnia (19mmHg) (Neill & Hattenhauer, 1975).  
 
This investigation aims to test whether hypocapnia can cause myocardial ischemia, which in 
turn, can induce noticeable, clinically significant ECG changes in normal healthy subjects. If 
 100
this is the case, hypocapnia induced by mechanical hyperventilation may be of clinical value 
for use in the early diagnosis of coronary artery disease (i.e. hypocapnia could be used as a 
provocation test in patients with suspected coronary artery disease). The aim of a provocation 
test is to stimulate noticeable changes in a patient population which do not occur in normal 
healthy subjects. The advantage of a provocation test that produces additional small and 
consistent changes in a normal population is that it validates any negative results (i.e. the 
provocation worked but did not cause large changes because the disease was not present). It 
was therefore of interest to see whether hypocapnia can produce small but repeatable ischemic 
changes in normal subjects that become accentuated further in patient populations. 
 
4.2.1. Voluntary hyperventilation and the ECG 
In normal subjects, hypocapnia (14-24mmHg), induced by voluntary hyperventilation, has 
been shown to cause inconsistent changes in the T wave, ST segment and QTc interval in 8-
57% of subjects (table 1.2, page 19) (Barker et al., 1939; Biberman et al., 1971; Christensen, 
1946; Golden et al., 1975; Joy & Trump, 1981; Kemp & Ellestad, 1968; Lary & 
Goldschlager, 1974; McCance, 1932; Scherf & Schlachman, 1947; Thompson, 1943; 
Wasserberger et al., 1956). Because voluntary hyperventilation does not allow breathing 
frequency or tidal volume to be accurately controlled, it is difficult to induce a consistent level 
of hypocapnia that is severe enough to induce changes in O2 delivery to the heart. Few studies 
have quantified the level of hypocapnia induced and in those that do, it differs by as much as 
10mmHg (Biberman et al., 1971; Golden et al., 1975). Inconsistent findings may be caused 
by differing levels of hypocapnia induced by voluntary hyperventilation.  
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Inconsistent inflation volumes also affect ECG changes during hyperventilation. Rutherford et 
al., (2005) demonstrated that increasing inflation volume by 0.6 litres increases the distance 
between the heart and ECG electrodes causing the size of the T wave and R wave in lead I to 
decrease by 0.2-0.3mV. The effects of varying inflation volumes on ECG wave amplitudes 
can been seen in studies where similar R wave decreases are reported with T wave depression 
(Barker et al., 1939; Christensen, 1946; Scherf & Schlachman, 1947). 
 
Voluntary hyperventilation increases physical exertion and metabolic rate due to increased 
work of the respiratory muscles. This means more CO2 is produced than at rest, making 
hypocapnia more difficult to induce. This increased physical exertion also limits the duration 
one can comfortably hyperventilate for. Previously, subjects have voluntarily hyperventilated 
for between 10 seconds and 16 minutes (Barker et al., 1939; Biberman et al., 1971; 
Christensen, 1946; Golden et al., 1975; Joy & Trump, 1981; Kemp & Ellestad, 1968; Lary & 
Goldschlager, 1974; Scherf & Schlachman, 1947; Thompson, 1943; Wasserberger et al., 
1956). It is not clear how long (or to what degree) hypocapnia was maintained for during 
these periods. It is unlikely that hyperventilating for 10 seconds would be long enough to 
induce a significant level of hypocapnia, and therefore, the true effects of hypocapnia may not 
have been revealed. 
 
Voluntary hyperventilation may also cause changes in plasma electrolyte concentration. The 
extent of these changes is unclear and data from previous studies are confusing. It is thought 
that voluntary hyperventilation causes increases (of 0.3-0.5mEq/L from 3.6-4.6mEq/L) (Yu et 
al., 1959; Biberman et al., 1971; Krapf et al., 1995) or decreases in blood potassium (of 
0.2mEq/L from 4mEq/L) (Mostellar & Tuttle, 1964) and decreases in blood calcium (of 
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0.1mg/100ml from 10-10.5 ± 0.1mg/100ml) (Yu et al., 1959). However, the electrolyte 
changes in these studies appear to be within the normal range for both K+ (4-5mEq/L) and 
Ca2+ (9-11mg/100ml) (Wagner, 2008). It is possible that changes in plasma electrolytes are 
caused by sympathetic activation which also causes changes in heart rate (increase of 9-
58bpm) (Biberman et al., 1971; Christensen, 1946; Joy & Trump, 1981; Mcgregor et al., 
1962; Miyagi et al., 1989; Previtali et al., 1989; Richardson et al., 1972; Burnum et al., 
1954). Changes in plasma electrolytes would be of interest because hypokalemia causes ECG 
changes such as T wave inversion (-0.15mV), ST depression (-0.1mV) and QTc interval 
prolongation (>0.43 seconds) that are not of ischemic origin (Wagner, 2008). Hyperkalemia 
causes hyperacute T waves (>0.5-1.0mV) and hypocalcemia causes QTc interval 
prolongation. Rutherford et al., (2005) showed the hypocapnia induced by mechanical 
hyperventilation does not cause significant changes in plasma electrolytes. Here, venous 
blood samples were taken during mechanical hyperventilation in normocapnia and 
hypocapnia to confirm this. Heart rate and mean arterial pressure were also recorded 
continuously, to confirm that subjects were relaxed throughout mechanical hyperventilation 
and that hypocapnia causes only trivial (if any) changes in heart rate and blood pressure. 
 
Because of the difficultly in separating the effects of hypocapnia on the ECG from the effects 
of changing inflation volumes, inconsistent breathing frequency and physical exertion, 
voluntary hyperventilation is not considered a reliable method for studying the effects of 
hypocapnia on cardiac electrical activity (Rutherford et al., 2005).  
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4.2.2. Mechanical hyperventilation and the ECG 
Mechanical hyperventilation via face mask produces consistent and reproducible changes in 
PetCO2 that can be accurately controlled (Cooper et al., 2004). It allows hypocapnia to be 
induced at a constant tidal volume and set breathing frequency, eliminating the effects of 
varying inflation volumes on the wave amplitudes of the ECG. Mechanical hyperventilation 
requires no physical exertion, allowing sustained periods of hypocapnia to be induced without 
causing discomfort to the subject.  
 
A reduction in T wave amplitude, thought to be caused by decreased O2 availability in the 
myocardium, has been demonstrated previously in normal healthy subjects during hypocapnia 
induced by mechanical hyperventilation (Rutherford et al., 2005). In 13/15 subjects (87%), 
hypocapnia (20mmHg) was shown to cause a significant reduction in T wave amplitude of 0.1 
± 0.0mV in lead I, independently of R wave changes. They also showed that hypocapnia and 
mechanical hyperventilation have no effect on plasma K+ or Ca2+ concentrations. This was the 
first study to provide irrefutable evidence that hypocapnia causes a reduction in T wave 
amplitude, even in normal healthy subjects. This experiment was performed using a 3 lead 
ECG (ECG waveform recorded in lead I) with ECG electrodes positioned in the modified 
electrode placement. As yet, these findings have not been replicated nor reproduced using a 
12 lead ECG. Measuring the effects of hypocapnia on a 12 lead ECG would be of interest 
because it permits a more comprehensive assessment of the global affects of hypocapnia on 
cardiac activity.  
 
This investigation aimed to establish whether T wave changes seen during hypocapnia 
induced by mechanical hyperventilation in lead I of the ECG can be reproduced in a 12 lead 
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ECG. In addition to measures of R and T wave amplitude, supplementary indicators of 
myocardial ischemia such as ST segment height and QTc interval duration were also 
measured. All waveform amplitudes and interval durations were compared to AHA, ACCF 
and HRS clinical guidelines for myocardial ischemia (table 2.3, page 60) (Rautaharju et al., 
2009; Kenigsberg et al., 2007; Wagner, 2008; 2009). ST segment height and T wave 
amplitude recorded in the transverse plane were also separated by gender and compared to 
gender specific clinical thresholds, for reasons previously described (chapters 2.9.1, page 47). 
 
4.2.3. Hypocapnia and the echocardiogram 
Echocardiography was used in the present investigation as an independent measure of any 
potentially ischemic changes in heart function observed by electrocardiography during 
hypocapnia. Echocardiography is a useful tool for identification of myocardial ischemia in 
patients suffering from coronary artery disease (Fujii et al., 1988; Garcia-Fernandez et al., 
1999; Kostkiewicz et al., 2003; Nishimura & Tajik, 1997). 
 
Echocardiography has rarely been used to investigate the effects of hypocapnia on heart 
function. Fujii et al., (1988) used echocardiography and voluntary hyperventilation to assess 
wall motion abnormalities in 27 patients with variant angina. They measured wall motion 
with two-dimensional m-mode echocardiography recorded from the standard 
parasternal/subcostal short-axis view of the left ventricle at the level of the papillary muscles. 
They found measurable decreases in wall motion and systolic wall thickening (no data 
presented) and these were associated with ST segment deviation. 
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In the present investigation, two-dimensional directed m-mode echocardiography, Doppler 
blood flow analysis of global diastolic function and tissue Doppler measures of left 
ventricular wall velocity were used to identify signs of myocardial ischemia during 
hypocapnia.  
 
4.3. Methods 
Eighteen normal healthy subjects aged 24 ± 3 years old (20-30 years old) (13 male) with no 
known cardiovascular disease were tested on three separate occasions on different days. 
Subjects gave informed consent and all experiments were approved by the Walsall Local 
Research Ethics Committee. All experiments were performed in accordance with the 
Declaration of Helsinki as stated by the American Physiological Society (2002). During each 
visit, subjects lay semi-recumbent on a bed and listened to the radio through headphones.  
 
In all experiments, continuous blood pressure was recorded using a finger plethysmograph 
(Finapres 2300) and end-tidal CO2 was recorded from expiration through an in-line 
capnograph (Hewlett Packard 78354A). To confirm the effects of hypocapnia on plasma K+, 
Ca2+ and pH, venous blood samples were taken from the antecubital vein in 14 subjects 
during each condition and analysed using a Rapid Lab 865 analyzer.  
 
Mechanical hyperventilation was performed at baseline with normal PetCO2 (normocapnia) 
and reduced PetCO2 (hypocapnia) using a positive pressure mechanical ventilator (Engstrom 
Erica II) as previously described (chapter 2.3, page 26). Breathing frequency (16 br.pm) and 
tidal volume (~1.3litres) were kept constant throughout both conditions during mechanical 
hyperventilation. It is known that hyperventilation decreases the amplitude of the ECG 
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waveform due to increased inflation volume (Rutherford et al., 2005). It was therefore 
expected that ECG waveforms would decrease between spontaneous breathing and 
normocapnia. It was not the aim of the present investigation to examine this phenomenon 
further; therefore ECG waveforms were not analysed during spontaneous breathing prior to 
mechanical hyperventilation.  
 
12 lead ECGs were recorded in 18 subjects during normocapnia and hypocapnia in two 
separate trials, using the ECG apparatus previously described (chapter 2.9.2, page 50). All 
ECG electrodes were placed in the standard electrode placement defined in Kligfield et al., 
(2007) (figure 2.4, page 43). The order that normocapnia and hypocapnia were induced was 
altered between trials to remove any possible effect of order or duration of ventilation on the 
recorded ECG waveforms (figure 4.1).  
 
An average ECG waveform was calculated from each two minute recording in each lead and 
each condition (as previously described in chapter 2.9.3, page 55). Further analysis scripts 
were used to calculate the amplitudes of the R and T waves, ST segment height and QTc 
interval duration. Two-dimensional m-mode, Doppler blood flow and tissue Doppler 
echocardiographic measurements were recorded in both normocapnia and hypocapnia in 18 
subjects during a third trial. LVID in diastole and systole (in 2D M-mode), fractional 
shortening (in 2D M-mode), E/A ratio (in Doppler blood flow mode) and myocardial wall 
velocities (in tissue Doppler mode) were measured as indicators of myocardial ischemia 
during hypocapnia. 
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Mechanical hyperventilation – constant breathing frequency (16 br.pm) and tidal volume (~1.3 litres) 
(45 mins) 
Spontaneous 
breathing 
(5 mins) 
CO2 added to 
inspired air 
Normocapnia 
(40mmHg) for 10 mins 
CO2 removed 
from inspirate  
 
2 minute ECG 
recording 
2 minute ECG 
recording 
2 minute ECG 
recording 
Hypocapnia  
(20mmHg) for 10 mins 
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CO2 added to 
inspired air 
Mechanical hyperventilation – constant breathing frequency (16 br.pm) and tidal volume (~1.3 litres) 
(45 mins) 
Spontaneous 
breathing 
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CO2 added to 
inspired air 
Normocapnia 
(40mmHg) for 10 mins 
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CO2 added to 
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Trial 1: 
Trial 2: 
Figure 4.1. Order and duration that normocapnia and hypocapnia were induced during each trial in mechanical hyperventilation 
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Data from both recordings in normocapnia in each trial were averaged. ECG and 
echocardiographic data is presented with non-gender specific clinical thresholds for normality 
(Wagner, 2008; Rautaharju et al., 2009; Surawicz et al., 2009; Wagner et al., 2009; Salcedo, 
1978; Weyman, 1982; Hamlin et al., 2004; Garcia et al., 1998; Garcia-Fernandez et al., 1999; 
Garcia et al., 1998; Kostkiewicz et al., 2003). ST segment height and T wave amplitude 
(recorded in the transverse plane) were also separated by gender and compared to gender 
specific clinical thresholds as recommend by Wagner et al., (2009) and Rautaharju et al., 
(2009). 
 
All data are expressed as means ± standard error for 18 subjects. To identify the statistical 
significance between wave amplitudes and QTc interval duration recorded in normocapnia 
and hypocapnia, a 2-tail paired t-test was performed in each lead with application of the 
Bonferroni correction for multiple (12) comparisons. The Bonferroni correction assumes that 
all 12 measurements are independent and uncorrelated. The difference between measures of 
LVID in diastole and systole, fractional shortening, E/A ratio and myocardial wall velocities 
in each condition were calculated by a 2-tail paired t-test without correction. 
 
4.4. Results 
In all subjects, mechanical hyperventilation, without the addition of CO2 to inspired air, 
caused PetCO2 to decrease by 18 ± 0mmHg (figure 4.2). This caused an increase in venous 
blood pH by 0.2 ± 0.0 pH units to 7.6 (figure 4.3). Hypocapnia did not cause significant 
changes in venous blood K+ concentration (figure 4.4). Hypocapnia caused small decreases in 
venous Ca2+ concentration (by 0.03 ± 0.00mmol/l, P < 0.001) but these were within the 
normal clinical range for Ca2+ changes that affect the ECG (figure 4.4). Hypocapnia caused 
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decreases in mean arterial pressure (by 9 ± 3mmHg, P < 0.01) (figure 4.5) and increases in 
heart rate (by 4 ± 1 bpm, P < 0.01]). 
 
 
Figure 4.2. PetCO2 decreases by 18 mmHg during mechanical 
hyperventilation in hypocapnia in all subjects
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Figure 4.2. Mean + SE PetCO2 during mechanical hyperventilation in 
normocapnia and hypocapnia in 18 subjects. 
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Figure 4.2. PetCO2 decreases by 18 mmHg during mechanical 
hyperventilation in hypocapnia in all subjects
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Figure 4.2. Mean + SE PetCO2 during mechanical hyperventilation in 
normocapnia and hypocapnia in 18 subjects. 
Figure 4.4. Hypocapnia causes small changes in venous blood electrolyte 
concentrations in 14 normal subjects
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Figure 4.4. Mean + SE potassium and calcium ion concentrations in venous 
blood during mechanical hyperventilation in normocapnia and hypocapnia. 
Values in hypocapnia, *** P < 0.001 or NS vs. normocapnia
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Figure 4.3. Hypocapnia increase venous blood pH in all subjects during 
mechanical hyperventilation
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Figure 4.3. Mean + SE venous blood pH in venous blood during mechanical 
hyperventilation in normocapnia and hypocapnia.*** P < 0.001 vs. normocapnia
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Figure 4.5. Mean + SE heart rate and blood pressure changes during mechanical 
hyperventilation in normocapnia and hypocapnia in 18 subjects. ** P < 0.01 vs 
normocapnia. 
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Figure 4.5. Hypocapnia causes a significant increase in heart rate and 
significant decrease in mean arterial pressure in all subjects during mechanical 
hyperventilation
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4.4.1. Electrocardiography 
During hypocapnia, a reduction in T wave amplitude occurred in 11/18 subjects (61%) in lead 
I of the ECG. The largest decrease in any one subject was 0.05mV (decrease of 14%). 
However, the mean decrease in T wave amplitude was just 0.002 ± 0.025mV (decrease of 
1%) and this was not statistically significant (p > 0.80) (figure 4.6). As expected, there was no 
significant change in R wave amplitude in lead I (0.49 ± 0.05mV [normocapnia] vs. 0.49 ± 
0.05mV [hypocapnia] [p > 0.95]) (figure 4.7). 
 
Hypocapnia caused a statistically significant increase in T wave amplitude in the anteroseptal 
transverse plane leads; V1 (increase of 0.06 ± 0.01mV [> 31%], P < 0.01), V2 (increase of 
0.09 ± 0.02mV [> 15%], P < 0.001) and V3 (increase of 0.07 ± 0.02mV [> 11%], P < 0.05) 
(figure 4.6). These changes were not accompanied by any R wave changes (figure 4.7) and 
were within clinically acceptable limits for normal T wave amplitudes (<1.0mV). Increases in 
T wave amplitude were not accompanied by significant changes in the ST segment in any of 
the 12 leads of the ECG (figure 4.8). The largest ST segment deviation was seen in V4 
(increase of 0.02 ± 0.01mV, P > 0.20) but this was within clinically acceptable limits.  
 
When T wave and ST segment data in the transverse plane was separated by gender, increases 
in T wave amplitude persisted in lead V1 (0.06 ± 0.02mV [> 40%] in men and 0.06 ± 0.02mV 
[> 125%] in women, P <0.05) (figure 4.9). In addition, statistically significant increases in T 
wave amplitude persisted in leads V2 (0.10 ± 0.02mV [15%], P < 0.01) and V3 (0.08 ± 
0.02mV [11%], P < 0.05) in male subjects but disappeared in female subjects (figure 4.9). T 
wave amplitudes in both men and women were below their respective gender specific clinical 
thresholds.  
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Figure 4.6. Hypocapnia does not significantly decrease T wave amplitude in any of 
the 12 leads of the ECG but does cause significant T wave elevation in the antero-
septal leads V1-3
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Figure 4.6. Mean + SE T wave amplitudes during mechanical hyperventilation in 
normocapnia and hypocapnia. * P < 0.05, ** P < 0.01, *** P < 0.001 and NS vs. 
normocapnia. Dotted lines indicate upper thresholds for normal T wave amplitudes.
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Figure 4.7. Hypocapnia does not have any significant affect on R wave amplitude in 
any of the 12 leads of the ECG in 18 normal subjects
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Figure 4.7. Mean + SE R wave amplitudes during mechanical hyperventilation in 
normocapnia and hypocapnia. All wave amplitudes in hypocapnia, NS vs. normocapnia
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Figure 4.8. Mean + SE ST segment height, defined by deviation of the J point from the 
isoelectric line. The extent of these changes is estimated by deviation of the ST(80) 
point. All points in hypocapnia, NS vs. normocapnia. Dotted line represents clinically 
significant deviation from isoelectric line.
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Figure 4.8. Hypocapnia did not cause significant ST segment changes in any of the 12 
leads of the ECG during mechanical hyperventilation
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Figure 4.9. Mean + SE T wave amplitude in the transverse plane during 
normocapnia and hypocapnia in males (a) and females (b). Gender specific clinical 
thresholds for abnormality ( ........... ) in the T wave (table 2.4) are also shown. All 
amplitudes in hypocapnia, * P < 0.05, **P < 0.01 or NS vs. normcapnia.
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Figure 4.9. Hypocapnia causes T wave elevation in leads V1-3 in male subjects 
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ST segment height in the transverse plane of female subjects was unaffected by hypocapnia 
(figure 4.10b). In male subjects, hypocapnia caused statistically significant ST segment 
elevation in lead V3 (0.02 ± 0.01mV [22%], P < 0.05) but this was not accompanied by 
significant ST(80) point elevation and was below the clinical threshold for normality (figure 
4.10a). In lead V4 in male subjects, the ST segment was elevated beyond clinical limits for 
normality during hypocapnia but this was not statistically significant (0.04 ± 0.02mV [57%], 
P > 0.05) (figure 4.10a). 
 
In all subjects, hypocapnia did not cause statistically or clinically significant QTc interval 
prolongation in any of the 12 leads of the ECG (figure 4.11). 
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Figure 4.10. Mean + SE of ST segment height (J point & ST[80] point) in the transverse 
plane in males (a) and females (b). Dotted lines are gender sepecific and represent clinically 
significant deviation from isoelectric line (straight line). All ST heights in hypocapnia, 
* P < 0.05 or NS vs. normocapnia.
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Figure 4.10. Hypocapnia causes significant ST segment elevation in lead V3 in 13 normal 
male subjects but not in 5 female subjects when data is seperated by gender
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Figure 4.11. Hypocapnia does not cause significant QTc interval prolongation
in any of the 12 leads of the ECG of 18 normal subjects
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Figure 4.11. Mean + SE QTc interval duration during mechanical hyperventilation 
in normocapnia and hypocapnia. All durations in hypocapnia, NS vs. normocapnia. 
The dotted line indicates the upper threshold for normal QTc interval duration. 
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4.4.2. Echocardiography 
Figure 4.12 shows that hypocapnia has no effect on (a) LVID difference or (b) fractional 
shortening during mechanical hyperventilation, measured by m-mode echocardiography in 18 
subjects. LVID difference (-1.8 ± 0.0cm) and fractional shortening (34%) during hypocapnia 
were within clinically normal limits. This indicates that left ventricular contractility was not 
affected by hypocapnia as the left ventricle walls contracted to the same degree in both 
normocapnia and hypocapnia.  
 
Doppler blood flow analysis performed on the left ventricle at the level of the mitral valve 
revealed no evidence of diastolic dysfunction during hypocapnia. A non significant decrease 
in E/A ratio from 1.99 ± 0.13 in normocapnia to 1.78 ± 0.14 was recorded during hypocapnia 
(P > 0.10) (figure 4.13a) but this was accompanied by a normal deceleration time (0.20 ± 0.01 
seconds) (figure 4.13b). These values were within clinically normal limits (E/A ratio >1 and 
deceleration time <0.22). 
 
Tissue Doppler analysis of septal and lateral wall velocity revealed no evidence of myocardial 
ischemia. Figure 4.14 shows that during hypocapnia, diastolic wall velocities in both the 
septum and lateral wall remained unchanged. Septal wall velocity (12.6 ± 0.5cm/s) (figure 
4.14a) and lateral wall velocity (16.7 ± 0.6cm/s) (figure 4.14b) during diastole were not 
significantly different in hypocapnia from normocapnia (P > 0.60) and were comparable with 
clinically normal values.  
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Figure 4.12. Hypocapnia has no affect on LVID difference (a) or fractional 
shortening (b) measured by m-mode echocardiography
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Figure 4.12a. Mean + SE LVID difference is calculated as the difference between 
LVID in diastole and systole. Values in hypocapnia, NS vs. normocapnia
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Figure 4.12b. Mean + SE Fractional shortening during normocapnia and hypocapnia. 
Values in hypocapnia, NS vs. normocapnia. Dotted line indicates the lower clinical 
threshold for normal fractional shortening.
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Figure 4.13. Hypocapnia causes no significant decrease in E/A ratio (a) and
deceleration time (b) measured by Doppler blood flow echocardiography
n = 18
n = 15
Deceleration time (seconds)
0.00 0.05 0.10 0.15 0.20 0.25
Hypocapnia
Normocapnia
Figure 4.13b. Mean + SE Deceleration time measured from the Doppler trace 
during mechanical hyperventilation in normocapnia and hypocapnia. Values in 
hypocapnia, NS vs. normocapnia. Dotted line indicates the upper clinical threshold 
for normal durations.
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Figure 4.13a. Mean + SE E/A ratio measured from the Doppler trace during 
mechanical hyperventilation normocapnia and hypocapnia. Values in hypocapnia, 
NS vs. normocapnia. Dotted line indicates the lower threshold for normal ratios.
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Figure 4.16. Hypocapnia causes no changes in diastolic wall velocity in either the 
septum (a) or lateral wall (b) measured by tissue Doppler echocardiography
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Figure 4.16. Mean + SE Septal and lateral wall velocity in the left ventricle during 
diastole in normocapnia and hypocapnia measured from the peak of the E wave on the 
tissue Doppler trace. Values in hypocapnia, NS vs. normocapnia. Dotted line indicates 
the lower clinical threshold for normal velocities.
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4.5. Discussion 
The present study shows that the most severe hypocapnia (20 ± 0mmHg) tolerable by normal 
subjects does not induce clinically significant changes on the 12 lead ECG or 
echocardiogram. These findings suggest that even though a more stable and sustained period 
of hypocapnia was induced than in previous studies using voluntary hyperventilation (table 
1.2, page 19), it was still not sufficient to reduce O2 delivery to the myocardium to such a 
degree that noticeable changes in cardiac electrical activity or heart function could be 
recorded. 
 
4.5.1 Changes in heart rate & blood pressure 
Mechanical hyperventilation, without the addition of CO2 to inspired air, caused PetCO2 to 
decrease by 18 ± 0mmHg to 20mmHg which caused blood pH to increase to 7.6 ± 0.0 pH 
units. Hypocapnia caused a small but significant increase in heart rate (4 ± 1 bpm). These 
findings confirm previous studies that hypocapnia causes only trivial changes in heart rate 
during mechanical hyperventilation (Rutherford et al., 2005; Prys-Roberts et al., 1972; 
Cooper et al., 2004; Kazmaier et al., 1998). These small changes are thought to be caused by 
aortic chemoreceptor stimulation caused by a hypocapnia induced decrease in O2 availability 
in arterial blood (Rutherford et al., 2005). In the present study, the fact that few significant 
ECG or echocardiographic changes occurred during hypocapnia, would suggest that such 
heart rate changes do not have any significant effect on the ECG waveform. 
 
In contrast, previous studies with voluntary hyperventilation have reported increases of 9-58 
bpm (Biberman et al., 1971; Christensen, 1946; Joy & Trump, 1981; Mcgregor et al., 1962; 
Miyagi et al., 1989; Previtali et al., 1989; Richardson et al., 1972; Burnum et al., 1954) 
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during hypocapnia. It is most likely that these cardiovascular changes occurred due to the 
physical exertion associated with voluntary hyperventilation.  
 
Hypocapnia caused a statistically significant decrease in mean arterial blood pressure (9 ± 
3mmHg). Previous studies report non-significant decreases of up to 7mmHg (Cooper et al., 
2004; Prys-Roberts et al., 1972) and no change (Kazmaier et al., 1998; Rutherford et al., 
2005) in mean arterial pressure during hypocapnia induced by mechanical hyperventilation. It 
is unclear whether the drop in blood pressure seen during the present investigation represents 
a true physiological effect of hypocapnia or just a limitation of the Finapres device for 
accurately measuring changes in blood pressure. It has been shown that the Finapres can 
overestimate absolute blood pressure values by up to 7 ± 11mmHg (Wesseling et al., 1985; 
Imholz et al., 1988; van Egmond et al., 1985; 1990). An overestimation of this amount would 
cause the size any observed blood pressure change to be exaggerated. In addition, despite 
attempts to prevent this from occurring, it is possible that the subjects’ hands may have 
become cold during the experiment, resulting in a reduction in blood flow to the fingers. This 
would limit the accuracy of subsequent estimations of blood pressure by the Finapres. Due to 
the lack of supporting evidence for a reduction of blood pressure during mechanical 
hyperventilation, the lack of electrocardiographic and echocardiographic changes and the 
limitations of the Finapres device used, the changes in blood pressure seen in the present 
study were not thought to be of physiological importance for the findings of this study. 
 
4.5.2. T wave changes during hypocapnia 
Hypocapnia caused a small non-significant reduction in T wave amplitude in 61% of subjects 
in lead I of the ECG. These findings were much smaller than those of Rutherford et al., 
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(2005) who demonstrated a significant T wave reduction of 0.1mV in 87% of subjects during 
hypocapnia induced by mechanical hyperventilation. The discrepancies between the 
Rutherford et al., (2005) study and the present investigation appear to be caused by the 
different ECG apparatus used. In the study by Rutherford et al., (2005), a single lead ECG 
was recorded using an analogue Neurolog NL840 amplifier calibrated against a custom built 
200uV generator. In contrast, the ECG apparatus used in the present study was calibrated 
against a patient simulator calibrator box (Dynatech Nevada Inc., Model 212B, Nevada, USA) 
and a standard digital ECG machine (Philips Hewlett Packard Pagewriter 200) commonly 
used in clinical practice. T wave amplitudes at rest in the Rutherford et al., (2005) study were 
0.73mV, which is more than double the size of those in the present study (0.32mV). The 
resting T wave amplitudes in the Rutherford et al., (2005) study would be considered 
clinically abnormal (hyperacute) if they were compared to the clinical thresholds used in the 
present study (>0.5mV [Wagner, 2008]). Because the data recorded in the present 
investigation were analogous to clinical ECG machines, they were considered comparable to 
clinical thresholds set out by the AHA, ACCF, HRS (Rautaharju et al., 2009; Surawicz et al., 
2009; Wagner et al., 2009) and Wagner (2008). 
 
Hypocapnia, induced by mechanical hyperventilation, caused significant T wave changes in 
the anteroseptal (transverse plane) leads V1-3 (increase of up to 0.09mV, 31%). These changes 
were not accompanied by any significant changes in the ST segment or QTc interval. In 
addition, these increases in T wave amplitude did not cause hyperacute T waves with 
amplitudes beyond non-gender specific clinical thresholds for normality. When T wave and 
ST segment data in the transverse plane were separated by gender, increases in T wave 
amplitude in the anteroseptal leads persisted in the male group. In females, significant 
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increases in T wave amplitude persisted in lead V1 but disappeared in leads V2-3. Importantly, 
in neither group did T wave amplitudes increase beyond gender specific clinical thresholds for 
normality. 
 
It is unlikely that T wave changes in the anteroseptal leads were caused by changes in plasma 
electrolytes. It is thought that voluntary hyperventilation causes increases (of 0.3-0.5mEq/L 
from 3.6-4.6mEq/L) (Yu et al., 1959; Biberman et al., 1971; Krapf et al., 1995) or decreases 
in blood potassium (of 0.2mEq/L from 4mEq/L) (Mostellar & Tuttle, 1964) and decreases in 
blood calcium (of 0.1mg/100ml from 10-10.5 ± 0.1mg/100ml) (Yu et al., 1959). In the 
present investigation, no changes in ionized potassium or electrocardiographic indicators of 
hypokalemia or hypocalcemia were observed. Significant decreases in ionized calcium did 
occur during hypocapnia (-0.03 ± 0.00mmol/l, P < 0.001), however, absolute ionized calcium 
concentrations (1.17 ± 0.00mmol/l) were within the clinically normal range (1.03-1.23mmol/l, 
Larsson & Ohman, 1978) and therefore were unlikely to cause ECG changes.  
 
The use of mechanical hyperventilation to induce hypocapnia enabled inflation volume to be 
kept constant throughout the experiment. Therefore, increases in T wave amplitude in the 
anteroseptal leads could not have been caused by changes in inflation volume.  
 
It is possible that increases in T wave amplitude observed in the present study represents the 
very earliest signs of grade I (early) localised transmural ischemia, caused by a decrease in O2 
availability in the myocardium due to increased coronary vasoconstriction and a decrease in 
O2 dissociation in the anteroseptal region of the heart (Rowe et al., Karlsson et al., 1994; 
Laffey & Kavanagh, 2002; Neill & Hattenhauer, 1975; 1962). Alternatively, increases in T 
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wave amplitude may have occurred due to normal variation of the T wave, known to occur in 
normal resting subjects (Taggart et al., 1979). It is difficult to draw conclusions as to the 
origins of the T wave changes seen in the present study because; 
– T wave changes seen in the anteroseptal leads (V1-3) were within normal clinically 
acceptable limits for healthy subjects (<1mV) (Wagner, 2008) and were not 
accompanied by any other ECG changes.  
– T wave changes alone are not reliable indicators of ischemia because clinically 
significant T wave changes occur in normal healthy subjects with normal coronary 
arteriograms (Taggart et al., 1979) and sometimes fail to appear in patients suffering 
from myocardial ischemia (Wagner, 2008). 
– Hyperacute T waves represent transmural ischemia in a region of the heart due to 
decreased blood supply caused by total coronary occlusion (Wagner, 2008). It is 
unlikely that total occlusion would occur as a result of hypocapnia in subjects with 
normal healthy coronary arteries, particularly in the absence of other markers for early 
transmural ischemia such as QTc interval prolongation (Kenigsberg et al., 2007). 
 
4.5.3. Hypocapnia and echocardiography 
Non-invasive echocardiography was employed as an independent measure of heart function 
during hypocapnia. No detectable nor statistically significant change in LIVD difference, 
fractional shortening, or tissue Doppler myocardial wall velocities were seen during 
hypocapnia in any subject. This suggests that hypocapnia had no effect on left ventricular wall 
motion during mechanical hyperventilation. There was also no decrease in E/A ratio or 
deceleration time measured during hypocapnia using Doppler blood flow echocardiography. 
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This suggests that hypocapnia did not induce myocardial ischemia of sufficient severity to 
stimulate a detectable reduction in global left ventricular function.  
 
4.5.4. Conclusions 
Indirect measures of cardiac electrical activity and heart function were not able to detect a 
noticeable ischemic effect of hypocapnia in normal healthy subjects. It has been calculated 
that the coronary arteries need to be occluded by at least 30-60% before blood flow is 
significantly impaired (May et al., 1963; Braunwald et al., 2001). Whilst it appears that 
hypocapnia does not induce a critical stenosis (30-60% occlusion) sufficient enough to reduce 
blood flow and cause ischemic ECG changes in normal healthy subjects, it remains to be seen 
whether ECG changes can be induced in patients already suffering from restricted coronary 
blood flow due to coronary artery disease. 
 
The calculations by May et al., (1963) and Braunwald et al., (2001) do not consider the 
additional effects of hypocapnia on the affinity of haemaglobin for O2. It is of interest to 
investigate whether the ECG changes that were observed during hypocapnia in normal 
subjects can be accentuated by hyperventilation in 15% O2 where myocardial O2 availability 
should be further reduced.  
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Chapter 5 
 
Can mechanical hyperventilation in 15% inspired O2 induce ischemic ECG changes in 
normal subjects? 
 
5.1. Summary 
The aim of this investigation was to see whether hypocapnia induced by mechanical 
hyperventilation in 15% O2 can provoke consistent ischemic ECG changes in normal subjects. 
This level of inspired O2 was considered safe for use in a clinical setting because it is 
equivalent to the air inspired on commercial aircraft and is not thought to cause chest pain or 
discomfort at rest. 
 
Spontaneous breathing with 15% O2 significantly reduced O2 saturation to 93 ± 1% (P < 
0.001) but otherwise had no affect on heart rate, blood pressure or ventilation. Hypocapnia in 
15% O2 did not significantly augment ECG changes seen during hypocapnia in 21% O2 or 
induce clinically significant ischemic changes in the R and T wave, ST segment or QTc 
interval. 
 
These findings show that hypocapnia induced by mechanical hyperventilation in 15% inspired 
O2 does not augment or induce significant ischemic ECG changes in normal healthy subjects, 
despite presumably inducing a more severe reduction in O2 availability than during 
hypocapnic mechanical hyperventilation in 21% O2. The fact that mechanical hyperventilation 
in 15% inspired O2 did not accentuate the increase in T wave amplitude seen during 
hypocapnia in 21% O2 suggests that these T wave changes were not caused by a decrease in 
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oxygen delivery to the heart. This indicates that in normal subjects, hypocapnia of this 
severity (20mmHg) is not sufficient to induce the critical stenosis necessary to substantially 
reduce blood flow and O2 delivery to the heart. 
 
5.2. Introduction 
Hypoxemia refers to an abnormally low O2 content in arterial blood (Steadman, 1972). It can 
be induced by inhaling 7.5-12% O2 for 5-35 minutes and causes T wave depression/flattening 
of up to 0.3mV and ST changes in normal subjects (Broch, 1972b; Katz et al., 1934; Levy et 
al., 1938; May, 1939; Levy et al., 1939; Barach et al., 1941; Haarstad & Broch, 1958). In 
patients with coronary artery disease, hypoxemia stimulates T wave depression (up to 
0.65mV), T wave inversion (< -0.15mV), ST changes (> 0.1mV) and chest pain (Broch, 
1972b; Katz et al., 1934; Levy et al., 1938; Barach et al., 1941; 1939; 1941; Turner & 
Morton, 1952; Haarstad & Broch, 1958; Rothschild & Kissin, 1933). Because these effects 
are more pronounced in patients, the hypoxemia test was proposed as a provocative test for 
coronary artery disease (Rothschild & Kissin, 1933; Levy et al., 1938; 1939; 1941; Turner & 
Morton, 1952; Haarstad & Broch, 1958; Broch, 1972a; 1972b; Stewart & Carr, 1954).  
 
Levy et al., (1938; 1939) standardised the hypoxemia test with a specific protocol involving 
inspiration of a 10% oxygen in 90% nitrogen gas mixture for 20 minutes whilst the ECG 
(leads I-III and a precordial lead called IVF) was recorded before, during and after the test. A 
criterion of threshold ECG values was developed for assessing coronary efficiency with a 
‘positive’ response to the test indicating the existence of coronary artery disease. An abnormal 
response to hypoxia (a positive hypoxemia test) was defined by ST deviation in all four leads 
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(I-III, IVF) totalling >0.3mV, inverted T waves in lead I coupled with a ST change of >0.1mV 
and/or T wave depression in lead IVF with ST deviation of >0.1mV (Levy et al., 1939; 1941).  
 
In patients with known coronary artery disease, the sensitivity and specificity of the 
hypoxemia test (using the Levy diagnostic criteria) is between 30-79% and 86-100% 
respectively (Levy et al., 1941; Turner & Morton, 1952; Haarstad & Broch, 1958; Stewart & 
Carr, 1954). However, the existence of coronary artery disease was identified by previous 
patient history and previous ECG records. The hypoxemia test has not been compared to a 
recognised gold standard (e.g. coronary angiography) and thus these sensitivity and specificity 
must be considered with caution. 
 
The hypoxemia test has a number of limitations; 
1) The hypoxemia test causes patient distress. Rothschild & Kissin, (1933) showed that 69% 
of patients with coronary artery disease, chest pain developed during the hypoxemia test and 
on a number of these occasions (number of occasions not specified), the test had to be stopped 
early. Extraordinarily, the authors described the appearance of chest pain and discomfort as 
“an evil necessary for the successful performance of the test”. Studies by Levy et al., (1938; 
1939; 1941), Barach et al., (1941), Turner & Morton (1952) and Haarstad & Broch (1958) 
have all reported cases where patients developed angina chest pain during hypoxemia.  
2) Performance of the hypoxemia test can result in sudden death (2/4 patients in one study) 
(Stewart & Carr, 1954).  
3) Adverse reactions to the hypoxemia test include lightheadedness, sense of lack of air, 
moderate headaches, vasovagal attacks (syscope & nausea), drowsiness, fatigue, choking, 
heavy chest, tetany, fear and anxiety (Stewart & Carr, 1954). According to Levy et al., 
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(1941), the dangers of the hypoxemia test are minimal, provided that the correct precautions 
are put in place and the test is only performed in certain groups of patients. Levy et al., (1941) 
state that patients should not participate in the test if they have known congestive heart 
failure, have suffered a myocardial infarction in the past 4 months, have already undergone a 
provocation test that day, have had a positive stress test via an alternative method or have an 
abnormal resting ECG (Turner & Morton, 1952). These exclusion criteria limit the use of the 
hypoxemia test in patient groups where, on some occasions, the test would be most useful 
(Burchell et al., 1948). 
 
The hypoxemia test is no longer used in clinical practice because of the dangers and 
discomfort associated with performing the test. Up to 69% of patients have been shown to 
develop chest pain (Rothschild & Kissin, 1933) and even sudden death (2/4 patients) (Stewart 
& Carr, 1954) during the hypoxemia test. 
 
In the present investigation, a milder form of inspired hypoxia (15% O2) was used to induce 
less severe hypoxemia in conjunction with hypocapnia (20mmHg) induced by mechanical 
hyperventilation. The aim was to examine whether hypocapnia combined with 15% O2 in 
inspired air would be sufficient enough to further reduce O2 delivery to the myocardium and 
create a functional hypoxia within the heart which accentuates the small ECG changes seen 
during hypocapnia in 21% O2 (increased T wave amplitude in leads V1-3, chapter 4, page 98). 
It was not the aim of this investigation to simply repeat previous studies by reducing inspired 
O2 to as low as possible in order to induce ECG changes. Instead, a milder form of inspired 
hypoxia that can be comfortably tolerated for extended periods of time was chosen which is 
equivalent  to  the  O2  inspired  from air  at an altitude of  6,700 feet (figure 5.1, Ward  et  al., 
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Figure 5.1. Changes in minute ventilation (a) and heart rate (b) as inspired O2 is 
reduced 
a) 
b) 
Figure 5.1a shows that noticeable changes in minute ventilation do not occur until 
inspired O2 is reduced below 10% (equivalent to O2 inspired at an altitude of 17,500 
feet) 
Figure 5.1b shows that changes in heart rate of >10bpm do not occur until inspired 
O2 is reduced below 12% (equivalent to O2 inspired at an altitude of 14,000 feet). 
Figures 5.1a & b from Dripps RD & Comroe JH (1947). The Effect of the 
Inhalation of High and Low Oxygen Concentrations on Respiration, Pulse Rate, 
Ballistocardiogram and Arterial Oxygen Saturation (Oximeter) of Normal 
Individuals. American Journal of Physiology 149, 277-291. 
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2000; Dripps & Comroe, 1947). 15% inspired O2 is commonly tolerated by people taking 
routine commercial aircraft flights (Cottrell, 1988). The advantage of mechanically 
hyperventilating subjects in 15% O2 instead of simply reducing their inspired O2 is that 
hypocapnia stimulates a functional hypoxia within the heart (via coronary vasoconstriction 
and an increased affinity of haemoglobin for O2) without substantially reducing arterial O2 
saturation which can result in distress and discomfort for the subject (Rothschild & Kissin, 
1933; Stewart & Carr, 1954). 
 
15% inspired O2 does not stimulate carotid chemoreceptors sufficiently to cause large 
physiological changes in the body. Dripps & Comroe (1947) have shown that inspiration of 
14.5% O2 for 6-8 minutes causes trivial changes in instantaneous minute ventilation (VE) 
(increase of 0.5 l/min) and heart rate (increase of 4 bpm) but significant changes do occur 
when inspired O2 is reduced to 10% (increase in VE of 1.3 l/min and heart rate of 21 bpm) 
(figure 5.1). To confirm these effects, measures of breathing frequency, tidal volume, VE, 
instantaneous CO2 production (VCO2), heart rate and mean arterial blood pressure were taken 
during 10 minutes spontaneous inspiration of either 15% inspired O2 or normal room air 
(normoxia) (5 minutes in each condition). Preliminary trials breathing 15% inspired O2 
revealed that 5 minutes is long enough to cause a drop and subsequent plateau in O2 saturation 
at rest. This was therefore considered long enough to confirm whether 15% inspired O2 is 
sufficient to cause changes in heart rate, blood pressure or ventilation. 
 
5.3. Methods 
Nine normal healthy subjects 23 ± 2 years old (aged 20-26 years old) (eight male) with no 
known cardiovascular disease were tested on two separate occasions. Subjects gave informed 
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consent and all experiments were approved by the Walsall Local Research Ethics Committee. 
All experiments were performed in accordance with the Declaration of Helsinki as stated by 
the American Physiological Society (2002). During each visit, subjects lay semi-recumbent on 
a bed and listened to the radio through headphones.  
 
During each experimental trial, continuous blood pressure (from a finger plethysmograph, 
Finapres 2300), end-tidal CO2 (from an in-line capnograph, Hewlett Packard 78354A) and O2 
saturation (from the finger using a pulse oximeter, N-200 series oximeter, Nellcor) were 
recorded. 
 
5.3.1. Examining the effects of 15% inspired O2 on spontaneous breathing 
The effects of inspiration of 15% O2 on spontaneous minute ventilation and metabolic rate 
were assessed with the breathing apparatus previously described (chapter 2.6, page 32). A 3 
lead ECG (for determination of heart rate only) and mean arterial blood pressure were 
continuously recorded for a period of 10 minutes during which subjects inhaled room air for 5 
minutes (normoxia) and 15% O2 in N2 for 5 minutes (hypoxia). The order in which room air 
and 15% O2 were inspired was established at random. A certified gas mixture of 15% O2 in 
85% N2 was used for all experiments in hypoxia. ECG, PetCO2, O2 saturation and breathing 
data were recorded by Spike2 data acquisition software via a CED power 1401 PC interface. 
Breathing frequency, tidal volume, VE, VCO2 and VE/VCO2 ratio were derived from the 
breathing apparatus data as previously described (chapter 2.6.1, page 34). 
 
All data are expressed as means ± standard error. Statistical analysis was performed on the 
breathing data by sampling all data points once every 5s (the minimum realistic resolution of 
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instantaneous breathing measurements). Analysis was performed by repeated measures 
analysis with two within subject factors (normoxia vs. hypoxia [condition] and effects over 
time [time]). Where the repeated measures analysis was significant according to the Huynh-
Feldt method, simple contrasts analysis was performed to compare subsequent time points 
against the first initial time point (zero). Significant F values were found for O2 saturation 
(time, F = 9.2, P < 0.001, condition, F = 68.5, P < 0.01, condition*time, F = 21.7, P < 0.001). 
Secondary analysis was performed to search for any consistent pattern of significant contrasts 
in the condition*time interactions. There were no significant F values for frequency, minute 
ventilation, VCO2, Ve/VCO2, heart rate and blood pressure. There were significant F values 
for tidal volume (condition only, F = 9.5, P < 0.05), but since the effects of time and 
time*condition were not significant, these were not pursued any further. 
 
5.3.2. Examining the effects of hypocapnia in 15% inspired O2 
Hypocapnia in 15% inspired O2 (hypocapnic hypoxia) was induced by removing the 
additional CO2 from inspired air (causing PetCO2 to fall) and replacing it with a 15% O2 in N2 
gas mixture from a pressurised cylinder. Mechanical hyperventilation in normocapnia, 
hypocapnia and hypocapnic hypoxia were induced using a mechanical ventilator (Däger Evita 
II) as previously described (chapter 2.3, page 26). Subjects were mechanically hyperventilated 
in four trials; twice in normocapnia and hypocapnia (PetCO2 of 20mmHg) (figure 4.1, page 
107) and twice in normocapnia and hypocapnic hypoxia (figure 5.2). Breathing frequency and 
tidal volume were kept constant throughout all stages of mechanical hyperventilation.
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Mechanical hyperventilation – constant breathing frequency (16 br.pm) and tidal volume (~1.3 litres) 
(45 mins) 
Spontaneous 
breathing 
(5 mins) 
CO2 added to 
inspired air.  
21% inspired O2  
Normocapnia 
(40mmHg) for 10 mins 
CO2 removed 
from inspired air. 
15% inspired O2  
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recording 
2 minute ECG 
recording 
2 minute ECG 
recording 
Hypocapnia in 15% O2 
(20mmHg) for 10 mins 
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Trial 3: 
Trial 4: 
Figure 5.2. Order and duration that normocapnia and hypocapnic hypoxia were induced during each trial in mechanical 
hyperventilation (trials 1 & 2 are shown in figure 4.1) 
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All 12 leads of the ECG were recorded during mechanical hyperventilation with 10 Blue 
sensor ECG electrodes (P-00-S/50, Ambu) which were placed in the standard electrode 
placement defined by Kligfield et al., (2007) (figure 2.4, page 43). All ECG leads were 
recorded simultaneously, as previously described (chapter 2.9.2, page 50). ECG waveforms 
were averaged for each lead over two minute periods in each condition (as previously 
described in chapter 2.9.3, page 55). R and T wave amplitudes, ST segment height and QT 
interval duration were measured from these averaged waveforms. Mean wave amplitudes and 
durations were calculated for each condition, in all subjects, across all trials. Data from each 
condition are presented with non-gender specific clinical thresholds for normality (Wagner, 
2008; 2009; Rautaharju et al., 2009). ST segment height and T wave amplitude (recorded in 
the transverse plane) were also separated by gender and compared to gender specific clinical 
thresholds as recommend by Wagner et al., (2009) and Rautaharju et al., (2009). 
 
The statistical significance between R and T wave amplitudes, ST segment height, QTc 
interval duration, heart rate and mean arterial pressure during mechanical hyperventilation in 
normocapnia, hypocapnia and hypocapnic hypoxia was investigated. Statistical analysis was 
performed using repeated measures analysis with application of the Huynh-Feldt correction 
for nonsphericity. Separate analysis was performed in each lead as it was assumed that all 12 
leads are independent and uncorrelated. No significant F values were found for condition in 
any wave amplitudes or durations in all leads. When data were separated by gender, 
significant F values were found between T wave amplitudes in male subjects in lead V2 (F = 
5.0, P < 0.05). The sources of this significance were investigated using a 2-tail paired t-test. 
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The statistical significance between O2 saturations measured in normocapnia, hypocapnic 
hypoxia (during mechanical hyperventilation) and hypoxia (during spontaneous breathing) 
was also investigated. Statistical analysis was performed using repeated measures analysis 
with application of the Huynh-Feldt correction for nonsphericity. Significant F values were 
found for comparisons of O2 saturation in normocapnia, hypocapnic hypoxia and hypoxia (F 
= 97.4, P < 0.001). The source this of significance was investigated using a 2-tail paired t-test. 
 
5.4. Results 
5.4.1. Normoxia vs. hypoxia 
As expected, spontaneous inspiration of 15% O2 caused a significant reduction in O2 
saturation from 55 seconds onwards (figure 5.3). After 5 minutes, O2 saturation was reduced 
by 4 ± 0% to 93 ± 1%. This hypoxia did not cause significant changes in heart rate or mean 
arterial pressure (figure 5.4).  
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Figure 5.3. Spontaneous inspiration of 15% Oxygen (hypoxia) causes significant 
decreases in O2 saturation in 9 normal subjects
Figure 5.3. Mean + SE O2 saturation during 5 minutes of normoxia and 5 minutes of 
hypoxia in 9 normal subjects. * P < 0.05, ** P < 0.01, *** P < 0.001, normoxia vs. 
hypoxia over time.
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Figure 5.5 shows that there was no significant difference in breathing frequency, tidal volume 
or instantaneous VE during 15% inspired O2 compared to normoxia. As expected, 
instantaneous VCO2 (indicating metabolic rate) was unaffected by inspiration of 15% O2 
(figure 5.6). Therefore, instantaneous VE/VCO2 ratio remained unchanged throughout the 10 
minutes of spontaneous breathing of different gas mixtures indicating that the subjects were 
not hyper/hypo-ventilating at any point during the experiment (figure 5.6).  
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Figure 5.4. 5 minutes of spontaneous inspiration of 15% Oxygen (hypoxia) does not 
cause significant changes in heart rate or mean arterial pressure in 9 normal subjects.
Figure 5.4. Mean + SE Heart rate (a) and mean arterial pressure (b) during 5 minutes of 
normoxia and 5 minutes of hypoxia in 9 normal subjects. All data points in hypoxia, NS vs.
normoxia over time.
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Figure 5.5. Mean + SE Breathing frequency (a), tidal volume (b) and instantaneous minute 
ventilation (Inst. Ve) (c) during 5 minutes of normoxia and 5 minutes of hypoxia in 9 normal 
subjects. All data points in hypoxia, NS vs. normoxia.
Figure 5.5. As expected, spontaneous inspiration of 15% Oxygen (hypoxia) does not cause
a significant change in breathing frequency, tidal volume or minute ventilation in 9 normal 
subjects
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5.4.2. Heart rate, blood pressure and ECG changes during hypocapnic hypoxia      
Mechanical hyperventilation caused a decrease in PetCO2 of 19 ± 0mmHg during hypocapnia 
and hypocapnic hypoxia from baseline (normocapnia) in all nine subjects (figure 5.7). 
Hypocapnic hypoxia did not cause the significant change in O2 saturation seen in hypoxia in 
spontaneous breathing (99% in normocapnia [P < 0.001 vs. hypoxia] vs. 93% in hypoxia vs. 
99% during hypocapnic hypoxia [P < 0.001 vs. hypoxia]) (figure 5.8). Both hypocapnia and 
hypocapnic hypoxia had no significant effect on heart rate (57 ± 1 bpm in normocapnia vs. 59 
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Figure 5.6. As expected, spontaneous inspiration of 15% Oxygen (hypoxia) does not cause
significant changes in metabolic rate, expressed as instantaneous VCO2, and does not 
cause hyper/hypo-ventilation (Ve/VCO2 ratio does not change) in 9 normal subjects. 
Figure 5.6. Mean + SE Metabolic rate expressed as intantaneous CO2 production (Inst. 
VCO2) (a) and instantaneous Ve/VCO2 ratio (b) (showing hyper/hypo-ventilation) during 
5 minutes of normoxia and 5 minutes of hypoxia in 9 normal subjects. All data points in 
hypoxia, NS vs. normoxia.
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± 2 bpm in hypocapnia vs. 65 ± 3 bpm in hypocapnic hypoxia [P > 0.05]) or mean arterial 
pressure compared to normocapnia (93 ± 4mmHg in normocapnia vs. 86 ± 6mmHg in 
hypocapnia vs. 93 ± 4mmHg in hypocapnic hypoxia [P > 0.45]) (figure 5.9). 
Figure 5.8. The decrease in O2 saturation during hypoxia at rest does not occur
during hypocapnic hypoxia in mechanical hyperventilation
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Figure 5.8. Mean + SE O2 saturation of arterial blood during mechanical hyper-
ventilation in normocapnia and hypocapnic hypoxia and spontaneous breathing in
hypoxia. % saturation in hypoxia, ***P < 0.001 vs. normocapnia or hypocapnic 
hypoxia, normocapnia, NS vs. hypocapnic hypoxia. 
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Figure 5.7. Mechanical hyperventilation caused PetCO2 to decrease by 
19mmHg during hypocapnia and hypocapnic hypoxic conditions
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Figure 5.7. Mean + SE PetCO2 during mechanical hyperventilation in 
normocapnia, hypocapnia and hypocapnic hypoxia in 9 subjects. 
 145
  
Figure 5.9. Mean + SE heart rate and blood pressure changes during mechanical 
hyperventilation in normocapnia, hypocapnia and hypocapnic hypoxia in 9 subjects. 
Data points in all conditions, NS vs. normocapnia. 
H
ea
rt 
ra
te
 
(be
a
ts
 
pe
r 
m
in
u
te
)
0
20
40
60
80
Normocapnia Hypocapnia Hypocapnic Hypoxia
M
ea
n
 
ar
te
ria
l p
re
ss
u
re
 
(m
m
Hg
)
0
20
40
60
80
100
120
Figure 5.9. The addition of hypoxia to hypocapnia does not cause significant 
changes in heart rate or blood pressure in 9 subjects. 
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Hypocapnic hypoxia did not augment any of the small ECG changes seen during hypocapnia 
in 21% O2. Figure 5.10 shows that in nine subjects, T wave amplitude increased during 
hypocapnia in the anteroseptal leads (V1-3) but this was not statistically significant (increase of 
0.05 ± 0.02mV [>38%]) in V1, 0.09 ± 0.03mV [>13%] in V2 and 0.08 ± 0.03mV [>11%] in 
V3 [P > 0.65]) (figure 5.10). Hypocapnic hypoxia did not cause significant increases in T 
wave amplitude in any leads, nor did it significantly augment T wave changes originally seen 
in the anteroseptal leads (V1-3) during hypocapnia in 21% O2 (chapter 4, page 107) (figure 
5.10). As expected, no R wave changes occurred in any leads (figure 5.11). All T wave 
amplitudes measured during hypocapnic hypoxia were within clinical thresholds (>0.5-
1.0mV) for normality.  
 
Figure 5.12 shows that no statistically or clinically significant changes in ST segment height 
occurred during hypocapnia or hypocapnic hypoxia in any of the 12 leads of the ECG. When 
T wave and ST segment data were separated by gender in the transverse plane, statistically 
significant increases in T wave amplitude appeared in lead V2 in males during hypocapnia 
(0.13 ± 0.02mV [18%] vs. normocapnia [P < 0.05]) and hypocapnic hypoxia (0.09 ± 0.03mV 
[13%] vs. normocapnia [P < 0.05]) (figure 5.13a). No clinically significant changes occurred 
in either the male or female subjects (figure 5.13). No other gender differences occurred in T 
wave amplitude or ST segment height during mechanical hyperventilation (figure 5.13 and 
5.14).  
 
Hypocapnic hypoxia did not cause prolongation of the QTc interval in any of the 12 leads of 
the ECG (figure 5.15). 
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Figure 5.10. The addition of hypoxia to hypocapnia does not significantly alter T 
wave amplitude in any of the 12 leads of the ECG.
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Figure 5.10. Mean + SE T wave amplitudes during mechanical hyperventilation in 
normocapnia, hypocapnia and hypocapnic hypoxia. Data points in all conditions, NS 
vs. normocapnia. Dotted lines indicate upper boundries for normal T wave amplitudes
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Figure 5.11. The addition of hypoxia to hypocapnia does not have any significant 
affect on R wave amplitude in any of the 12 leads of the ECG in 9 normal subjects
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Figure 5.11. Mean + SE R wave amplitudes during mechanical hyperventilation in 
normocapnia, hypocapnia and hypocapnic hypoxia. Data points in all conditions, NS 
vs. normocapnia. Dotted lines indicate upper boundries for normal T wave amplitudes
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Figure 5.12. Mean + SE ST segment height are defined by deviation of the J point from 
the isoelectric line. The extent of these changes is estimated by deviation of the ST(80) 
point. All points in all conditions, NS vs. normocapnia. Dotted line represents clinically 
significant deviation from isoelectric line.
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Figure 5.12. The addition of hypoxia to hypocapnia did not cause significant ST segment 
changes in any of the 12 leads of the ECG.
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Figure 5.13. Mean + SE T wave amplitude in the transverse plane during normo-
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plane in males (a) and 1 female (b). Dotted lines are gender sepecific and represent clinically 
significant deviation from isoelectric line (straight line). All ST heights in all conditions, 
NS vs. each other.
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Figure 5.14. The effects of hypocapnia & hypocapnic hypoxia on the ST segment height 
in the transverse plane are not altered when data is controlled for gender. 
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Figure 5.15. The addition of hypoxia to hypocapnia does not cause significant 
QTc interval prolongation in any of the 12 leads of the ECG of 9 normal subjects
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Figure 5.15. Mean + SE QTc interval duration during mechanical hyperventilation in 
normocapnia, hypocapnia and hypocapnic hypoxia. All durations in all conditions, NS 
vs. normocapnia. The dotted line indicates the upper boundry for non-ischemic QTc 
interval duration. 
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5.5. Discussion 
Reducing inspired O2 to 15% during hypocapnia, induced by mechanical hyperventilation, 
does not augment the small ECG changes seen during hypocapnia in 21% O2 in normal 
healthy subjects.  
 
5.5.1. Absence of physiological changes during hypoxia  
As expected, inspiration of 15% O2 caused O2 saturation to decrease (by up to 4.2 ± 0.4%) in 
all subjects. If inspired O2 had been reduced to 12-7.5%, a larger decrease in O2 saturation (of 
12-33%) would be expected (Broch, 1972a; Broch, 1972b; Levy et al., 1938; Barach et al., 
1941). The aim of the present investigation was not to continually reduce inspired O2 until 
chest pain and discomfort appear. Therefore, 15% inspired O2 was used because it is 
equivalent to an altitude of 6,700 ft and is known to be well tolerated by people taking routine 
commercial aircraft flights (Cottrell, 1988; Ward et al., 2000).  
 
This study attempted to confirm that spontaneous inspiration of 15% O2 only causes trivial 
changes in heart rate or mean arterial pressure (figure 5.4). Dripps & Comroe (1947) showed 
that breathing a 14.5% O2 mixture for 6-8mins causes a small but significant increase in heart 
rate of 4 bpm in resting subjects. This increase in heart rate was thought to be caused by 
carotid chemorecepter stimulation caused by reduced O2 availability in arterial blood. In the 
present investigation, no consistent changes in heart rate or blood pressure were seen during 
spontaneous inspiration of 15% O2.  
 
Analysis of ventilation during normoxia and hypoxia revealed that breathing frequency, tidal 
volume and instantaneous VE were not significantly affected by hypoxia (figure 5.5). These 
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findings confirm those of Dripps & Comroe (1947) who reported that ventilation is not 
affected by inspiration of 14.5% O2. The absence of changes in VE and VCO2 mean that the 
VE/VCO2 ratio was unaffected by hypoxia (figure 5.6). It can therefore be concluded that 
subjects did not hypo/hyper-ventilate during the spontaneous inspiration of 15% O2.  
 
5.5.2. Physiological changes during hypocapnic hypoxia 
During mechanical hyperventilation in nine subjects, hypocapnia and hypocapnic hypoxia 
caused no significant change in heart rate (1 ± 1 bpm in hypocapnia and 8 ± 3 bpm in 
hypocapnic hypoxia). Previous studies suggest that an increase in heart rate might have been 
expected during hypocapnic hypoxia, even though the inspired O2 was only reduced to 15% 
(Dripps & Comroe, 1947). However, the lack of decrease in O2 saturation suggests that the 
stimulus for an increase in heart rate (decrease in O2 availability in arterial blood [Dripps & 
Comroe, 1947; Rutherford et al., 2005]) may have been removed. 
 
Mechanical hyperventilation in hypocapnia and 15% O2 did not accentuate the increases in T 
wave amplitude seen previously in the anteroseptal leads (V1-3) (chapter 4.4.1, page 112), nor 
did it cause significant T wave changes in any other leads. Again, hypocapnia did not cause 
statistically or clinically significant changes in ST height. The fact that inspiration of 15% O2 
did not accentuate the increases in T wave amplitude seen during hypocapnia in 21% O2, 
suggests that these original T wave changes were not caused by a functional hypoxia within 
the myocardium.  
 
When data from male subjects and 1 female subject were separated, statistically significant 
differences in the T wave amplitude of lead V2 in males were revealed during hypocapnia and 
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hypocapnic hypoxia. In addition, clinically (but not statistically) significant ST segment 
elevation was seen in V4 during hypocapnia. Hypocapnic hypoxia did not significantly 
augment T wave amplitude or ST segment height from that seen during hypocapnia in 21% 
O2. This suggests that hypocapnia in 15% inspired O2 does not significantly alter ECG 
changes seen during hypocapnia alone.   
 
The significant decrease in O2 saturation seen during spontaneous breathing in 15% O2 was 
not seen in the presence of hypocapnia during mechanical hyperventilation. The reduction in 
the partial pressure of CO2 and the increase in blood pH during hypocapnia causes the affinity 
of haemoglobin for O2 to augment (Roughton, 1964). In addition, according to the alveolar 
gas equation (Fenn et al., 1946), as the partial pressure of alveolar CO2 (PACO2) decreases, 
the partial pressure of alveolar O2 (PAO2) increases. Therefore, during hypocapnia, the 
maintenance of normal O2 saturations could be explained by increased PAO2, increased 
uptake of O2 at the lungs and decreased dissociation of O2 into the working tissues. 
 
This represents a potential limitation to this study which might explain the lack of observed 
ECG changes. It appears that during mechanical hyperventilation, the augmented breathing 
frequency and tidal volume increased the amount of O2 being exchanged in the lung, therefore 
compensating for the lower proportion of O2 in the air. The absence of any changes in O2 
saturation suggests that O2 delivery to the myocardium during hypocapnic hypoxia was no 
different to O2 delivery during hypocapnia in normal room air. To achieve the desired 
reduction in O2 saturation, it would therefore be necessary to reduce inspired O2 further, to a 
level which would not normally be considered safe in normal resting conditions.  
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 5.5.3. Conclusions 
The findings of this study suggest that inspiration of 15% O2 during mechanical 
hyperventilation in hypocapnia was not sufficient to reduce O2 availability further and cause a 
functional hypoxia within the myocardium of normal subjects. 
  
The lack of ECG changes occurred because a functional hypoxia within the myocardium 
could not be induced in healthy subjects. It appears that inspiring 15% O2 during mechanical 
hyperventilation does not have any additional effect on PaO2, coronary blood flow or O2 
availability in the myocardium.  
 
It is known that compensatory vasodilatation occurs in the coronary arteries during significant 
hypoxia which causes blood flow to increase (Kaufmann et al., 2001; Arbab-Zadeh et al., 
2009). However, this is unlikely to have counteracted the vasoconstrictive effects of 
hypocapnia in the present investigation because the 15% O2 inspired was not severe enough to 
cause increases in heart rate which are associated with coronary vasodilatation during 
hypoxia. 
 
The effects of hypocapnia on the ECG in normal healthy subjects are not as noticeable as was 
previously thought. It is however, still of interest to see whether hypocapnia can provoke 
ischemic ECG changes in patients already suffering from reduced blood flow to the heart due 
to coronary artery disease. 
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Chapter 6 
 
Does hypocapnia induced by mechanical hyperventilation cause clinically significant 
changes in the electrocardiogram of patients suffering from coronary artery disease? 
 
6.1. Summary 
The effect of hypocapnia on the ECG of patients suffering from coronary artery disease has 
not yet been satisfactorily assessed. In this pilot study, 16 patients have so far been identified 
as eligible to participate; however, only four have successfully completed the full 
experimental protocol. Of those four, two patients were taking long acting, isosorbide 
mononitrate medication (coronary vasodilator medication) which may have interfered with 
the effects of hypocapnia and were therefore considered in the medicated group A. The 
remaining two patients were not taking any medication known to interfere with the effects of 
hypocapnia and were grouped into the non-medicated group B. All patients were suffering 
from coronary artery disease with stable angina.  
 
Hypocapnia did not cause any clinically significant ECG changes in any leads in the 
medicated group A.  It was thought that the coronary vasodilator medication that these 
patients were taking may have interfered with the vasoconstrictive effects of hypocapnia and 
thus prevented a critical coronary occlusion.  
 
In the non-medicated group B, hypocapnia caused an increase in T wave amplitude (of up to 
0.05 ± 0.01mV [18%] in 3 leads) in patient 1B. In lead III, the increase in T wave amplitude 
resulted in the appearance of a hyperacute T wave. Hypocapnia also caused up sloping ST 
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segment depression in four anatomically contiguous leads (of up to 0.13 ± 0.02mV) in patient 
2B. J point depression in these leads exceeded clinical thresholds for normality although it is 
possible that these ST segment changes were due to normal variations in the ECG.  
 
These preliminary findings cannot confirm whether or not hypocapnia causes significant ECG 
changes in patients suffering from coronary artery disease. Conclusions about the effects of 
hypocapnia in these patients cannot be made until additional subjects are investigated. 
Therefore, further study is required to determine whether consistent changes can be induced 
by hypocapnia in patients who are not taking coronary vasodilator medication. 
 
6.2. Introduction 
As previously described (chapter 1.2.1, page 12), hypocapnia causes coronary 
vasoconstriction and decreased oxygen dissociation from haemoglobin which reduces O2 
delivery to the myocardium. In normal healthy subjects, this reduced O2 delivery does not 
cause consistent, ischemic ECG changes of clinical importance (chapter 4, page 98). The aim 
of this investigation was to test whether hypocapnia causes clinically significant ECG changes 
in patients suffering from coronary artery disease with stable angina. If ECG changes are 
detected they could have important diagnostic implications. In patients who present with chest 
pain, it is necessary to perform a provocation test to reveal the existence of coronary artery 
disease (Braunwald et al., 2001). Hypocapnia could potentially provoke myocardial ischemia 
by reducing coronary blood flow and decreasing O2 dissociation from haemoglobin therefore 
causing an imbalance between O2 demand and delivery. 
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6.2.1. Hypocapnia and the diagnosis of variant angina  
Hypocapnia, induced by voluntary hyperventilation, causes significant ECG changes in 
patients suffering from a variant form of angina known as Prinzmetal’s (Yasue et al., 1978; 
Girotti et al., 1982; Freeman & Nixon, 1985; Kruyswijk et al., 1986; Ardissino et al., 1987; 
Takaoka et al., 1988; Fujii et al., 1988; Weber et al., 1988; Chelmowski & Keelan, 1988; 
Miyagi et al., 1989). This form of angina occurs at rest or during normal activity and is 
characterized by the fact that it is not brought on by exercise, it is generally longer in duration 
and more severe than normal angina and it can be identified on an ECG by way of ST 
elevations with reciprocal depressions in leads corresponding to one specific coronary artery 
(Prinzmetal et al., 1959). Prinzmetal’s angina is brought on by a coronary artery spasm. 
Studies have shown that voluntary hyperventilation (for 2-8 minutes) can induce this coronary 
artery spasm resulting in both clinically significant ischemic ST segment changes (depression 
>1.5mV, elevation >2.0mV) and chest pain in 83-100% of patients tested (Girotti et al., 1982; 
Previtali et al., 1989; Freeman & Nixon, 1985; Kruyswijk et al., 1986; Ardissino et al., 1987; 
Takaoka et al., 1988; Fujii et al., 1988; Weber et al., 1988; Chelmowski & Keelan, 1988; 
Miyagi et al., 1989). 
 
The mechanism that causes a coronary artery spasm in these patients is unclear. Possible 
causes have been proposed such as increased extracellular Ca2+
 
(Yasue et al., 1978; 
Kruyswijk et al., 1986; Ardissino et al., 1987; Chelmowski & Keelan, 1988; Fujii et al., 
1988), hypersensitization of the coronary vascular bed to a normal physiological trigger of 
coronary artery spasm (Freeman & Nixon, 1985; Ardissino et al., 1987; Chelmowski & 
Keelan, 1988) or a delayed response to respiratory alkalosis (Girotti et al., 1982; Weber et al., 
1988). 
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Because voluntary hyperventilation causes consistent ECG changes in patients suffering from 
variant angina, it is considered an acceptable provocation test to be used in the diagnosis of 
this disease (Previtali et al., 1989; Magarian & Mazur, 1991). It compares well with 
established diagnostic techniques such as ergonovine testing although its sensitivity is 
dependent on the severity of the disease. In patients who suffer from frequent spontaneous 
angina attacks, the hyperventilation test has a sensitivity of 96%, but in patients where attacks 
are less frequent, this may fall to as low as 55% (Previtali et al., 1989). The effectiveness of 
this test is also affected by the degree of hypocapnic alkalosis that is induced by voluntary 
hyperventilation. Positive ECG changes should be accompanied by an arterial blood pH of 
>7.55 for variant angina to be positively identified (Magarian & Mazur, 1991). Voluntary 
hyperventilation is also useful in assessing the type of drug therapy to prescribe to patients 
with variant angina. Girotti et al., (1982) showed that in patients with positive 
hyperventilation tests, the effectiveness of a variety of drug treatments could be assessed by 
performing a subsequent hyperventilation test following administration of individual drugs 
such as phentolamine, isosorbide dinitrate, propanolol, nifedipine and verapamil. Effective 
drugs were identified as those that produced a negative response to hyperventilation following 
drug administration. 
 
6.2.2. Hypocapnia and the diagnosis of coronary artery disease with stable angina 
The effects of hypocapnia on patients suffering from stable angina have been studied but 
findings are inconsistent because of the limitations associated with inducing hypocapnia with 
voluntary hyperventilation (chapter 1.2.3, page 18). Studies have demonstrated ischemic T 
wave changes (T wave inversion > -0.15mV) in up to 70% of patients suffering from coronary 
artery disease (Jacobs et al., 1974; Joy & Trump, 1981; Kemp & Ellestad, 1968; Ardissino et 
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al., 1987; Lary & Goldschlager, 1974). ‘False positive’ results are widely reported by those 
using voluntary hyperventilation to detect coronary artery disease (Wasserberger et al., 1956; 
Mchenry et al., 1970; Lary & Goldschlager, 1974; Jacobs et al., 1974; Evans & Lum, 1977; 
Joy & Trump, 1981).  
 
Hypocapnia, induced by mechanical hyperventilation, eliminates the limitations associated 
with voluntary hyperventilation as previously described (chapter 1.2.2, page 17). Therefore, in 
the present investigation, mechanical hyperventilation was used with the digital ECG 
recording system described in chapter 2.9.2 (page 50) to examine the effects of hypocapnia on 
patients suffering from coronary artery disease with stable angina. The ECG was recorded and 
compared to recent AHA, ACCF and HRS clinical thresholds for myocardial ischemia 
(Kenigsberg et al., 2007; Wagner, 2008; 2009; Rautaharju et al., 2009).  
 
6.3. Methods 
Sixteen patients suffering from coronary artery disease were identified as eligible to 
participate, however, only four (aged 61 ± 8 years old [42-74 years old]) (4 male) consented 
to participate in the full experimental protocol. All four patients had normal resting ECGs but 
had a positive exercise stress test. All four patients had undergone a coronary angiogram to 
determine the extent of their disease (see figures 6.1 and 6.2 for details) and were awaiting 
either coronary angioplasty or a coronary artery bypass graft after participation in the 
experiment was complete. Patients gave informed consent and experiments were approved by 
the Walsall Local Research Ethics Committee. All experiments were performed in accordance 
with the Declaration of Helsinki as stated by the American Physiological Society (2002). All 
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patients were given a medical examination prior to participation in the study by the consultant 
cardiologist. Full patient details and past medical history can be seen in appendix.  
 
Initially, patients taking long acting isosorbide mononitrate medication (coronary vasodilator 
medication) were included in the study. However, after no obvious ECG changes were seen in 
two patients it was decided by the consultant cardiologist that patients taking this type of 
medication should be excluded as it may interfere with the effects of hypocapnia. Data from 
two of these patients has been included in this report and is considered in the ‘medicated’ 
group A. To allow those on long acting nitrate medication to participate in the study, ethical 
approval was obtained to ask all those receiving nitrate treatment to refrain from taking their 
medication for a period of 36 hours prior to the experimentation procedure. Two patients not 
taking any medication thought to interfere with this investigation were grouped into the ‘non-
medicated’ group B. 
 
Coronary artery disease affected different arteries in each patient and thus each was 
considered separately. The region and vessel affected by the coronary artery disease dictates 
the ECG lead in which ischemic changes occur. Details of the patient’s disease and the ECG 
leads in which changes during provocation of angina were expected are presented in table 6.1 
(medicated group A), table 6.2 (non-medicated group B) and figures 6.1-6.2 (which show the 
location of vessel occlusion in each subject). 
 
For each trial, continuous blood pressure was recorded using a finger plethysmograph 
(Finapres 2300) and end-tidal CO2 was recorded with an in-line capnograph (Hewlett Packard 
78354A). O2 saturation was monitored continuously using a pulse oximeter (N-200 series 
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oximeter, Nellcor) as a safety precaution. A continuous 7 lead ECG (6 limb leads, 1 
precordial lead) was recorded using a portable patient monitor (Philips IntelliVue, MP30) to 
allow instantaneous ST segment monitoring throughout the experiment. 
 
 
Table 6.1. Group A (medicated) - Patient’s related medication, disease type, disease 
location and affected ECG leads.  
 
 
Table 6.1. LAD = left anterior descending coronary artery. LCX = left circumflex 
artery. RCA = right coronary artery.  
 
Patient/ 
Disease type 
Coronary 
vasodilator
medication 
Affected 
vessel 
Affected region 
of the heart 
Affected ECG 
leads 
1A.  
Single vessel 
disease 
 
Long acting 
nitrates 
 
LAD 
(see figure 
6.1a) 
Extensive anterior 
Anteroseptal 
I, aVL, V1-6 
2A.  
Triple vessel 
disease 
Long acting 
nitrates 
 
LAD 
LCX 
RCA 
(see figure 
6.1b) 
Extensive anterior 
Anteroseptal 
Lateral 
Inferolateral 
I, II, III, aVL, aVF, 
V1-6 
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Partial occlusion 
of the LAD 
Figure 6.1. Group A (medicated) – location of coronary artery disease identified on the 
coronary angiogram 
 
a) Patient 1A (single vessel disease) 
b) Patient 2A (triple vessel disease)  
Partial occlusion 
of the LAD 
Partial occlusion 
of the RCA 
Partial occlusion 
of the LCX 
 165
Table 6.2. Group B (non-medicated) - Patient’s related medication, disease type, disease 
location and affected ECG leads.  
 
Table 6.2. LAD = left anterior descending coronary artery. LCX = left circumflex 
artery. RCA = right coronary artery. Left main = main left coronary artery 
 
 
Patient/ 
Disease type 
Coronary 
vasodilator
medication 
Affected 
vessel 
Affected region 
of the heart 
Affected ECG 
leads 
1B.  
Double 
vessel 
disease 
 
None LCX 
RCA 
(see figure 
6.2a) 
 
Lateral  
Inferolateral 
II, III, aVF, V1-2 
2B.  
Double 
vessel 
disease 
None Left main 
LAD 
(see figure 
6.2b) 
 
Extensive anterior 
Anteroseptal 
I, II, III, aVL, aVF, 
V1-6 
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Blocked LAD 
Partial occlusion 
of the left main 
artery  
 
Partial occlusion 
of the RCA 
 
Blocked LCX 
Figure 6.2. Group B (non-medicated) – location of coronary artery disease identified 
on the coronary angiogram 
 
a) Patient 1B (double vessel disease) 
b) Patient 2B (double vessel disease) 
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Mechanical hyperventilation was used to induce normocapnia and hypocapnia, in two trials as 
previously described in chapter 2.3 (page 26). The order and duration of normocapnia and 
hypocapnia can be seen in figure 4.1 (page 107). A 12 lead ECG was recorded for two 
minutes at the end of each condition (figure 4.1). T wave amplitude and ST segment height 
were measured in each lead and compared to AHA, ACCF and HRS gender and age specific 
clinical thresholds for myocardial ischemia (tables 2.3 [page 60] and 2.4 [page 61]) 
(Rautaharju et al., 2009; Surawicz et al., 2009; Wagner et al., 2009; Wagner, 2008).  
 
A positive result in the ‘diagnostic test’ was defined by a T wave elevation/inversion and/or 
ST segment elevation/depression in two more, anatomically contiguous ECG leads associated 
with the known affected region of the myocardium (identified by coronary angiography). All 
data are expressed as means ± standard error for each patient across both trials. ECG leads 
affected by coronary artery disease (identified by the coronary angiogram) are indicated on 
each graph by the grey boxes. A 2-tail paired t-test was performed to compare heart rate and 
blood pressure in normocapnia and hypocapnia. Statistical analysis was not performed on 
individual patient’s ECG data because each was examined with respect to their specific 
disease state. 
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6.4. Results  
Figure 6.3. In all 4 patients PetCO2 decreased by 17 mmHg during hypocapnia 
and heart rate and mean arterial pressure remain unchanged
Normocapnia Hypocapnia
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Figure 6.3. Mean + SE PetCO2, heart rate and mean arterial pressure (MAP) 
changes during mechanical hyperventilation in normocapnia and hypocapnia 
in 4 patients. All values in hypocapnia, NS vs. normocapnia.
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Figure 6.3 shows that in all patients, mechanical hyperventilation in hypocapnia caused a 
mean decrease in PetCO2 of 17 ± 0 mmHg but had no affect on heart rate or blood pressure. 
 
6.4.1. ECG changes in the medicated group A 
Patient 1A (medicated group) 
In patient 1A, hypocapnia caused an increase in T wave amplitude in leads V1-3 (increase of 
0.03 ± 0.01mV [20%] in V1, increase of 0.07 ± 0.01mV [15%] in V2, increase of 0.03 ± 
0.04mV [7%] in V3) but wave amplitudes did not exceed clinically significant thresholds 
(figure 6.4). No ST segment elevation or depression was seen in any of the 12 leads of the 
ECG (figure 6.5). 
 
Patient 2A (medicated group) 
Hypocapnia did not cause clinically significant T wave changes in any of the 12 leads of the 
ECG (figure 6.6). In addition, hypocapnia did not cause any clinically significant ST segment 
deviation in any of these leads. The largest ST segment change was depression of 0.07 ± 
0.02mV in lead V4 (figure 6.7) but this remained within clinical limits for normality. 
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Figure 6.4. In patient 1A (medicated group), hypocapnia did not cause clinically 
significant T wave elevation in any of the frontal or transverse plane leads of the ECG 
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Figure 6.4. Mean + SE of 2 trials. T wave amplitudes during normocapnia and 
hypocapnia in patient 1A. Wave amplitudes above the dotted line are considered of 
clinical importance. Relevant leads are highlighted by grey boxes.
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Figure 6.5. Mean + SE of 2 trials. ST segments are defined by deviation of the J point from 
the isoelectric line. The extent of these changes is estimated by deviation of the ST(80) 
point. Data points above/below the dotted line represent clinically significant deviation from 
isoelectric (straight line). Relevant leads are indicated by the grey boxes
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Figure 6.5 In patient 1A (medicated group), hypocapnia did not cause significant ST 
segment changes in any of the 12 leads of the ECG 
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Figure 6.6. In patient 2A (medicated group), hypocapnia did not cause clinically 
significant T wave elevation in any of the frontal or transverse plane leads of the ECG 
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Figure 6.6. Mean + SE of 2 trials. T wave amplitudes during normocapnia and 
hypocapnia in patient 2A. Wave amplitudes above the dotted line are considered of 
clinical importance. Relevant leads are highlighted by grey boxes.
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Figure 6.7. Mean + SE of 2 trials. ST segments are defined by deviation of the J point from 
the isoelectric line. The extent of these changes is estimated by deviation of the ST(80) 
point. Data points above/below the dotted line represent clinically significant deviation from 
isoelectric (straight line). Relevant leads are indicated by the grey boxes
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Figure 6.7. In patient 2A (medicated group), hypocapnia did not cause significant ST 
segment changes in any of the 12 leads of the ECG
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6.4.1. ECG changes in the non-medicated group B 
Patient 1B (non-medicated group) 
Hypocapnia caused an increase in T wave amplitude in leads II (increase of 0.04 ± 0.02mV 
[11%]), III (increase of 0.05 ± 0.01mV [18%]) and aVF (increase of 0.05 ± 0.01mV [15%]) 
(figure 6.8). The absolute T wave amplitude in lead III did exceed clinical thresholds for 
ischemia suggesting that it had become hyperacute during hypocapnia. Figure 6.9 shows that 
T wave elevation was not accompanied by ST segment changes in any of the expected leads.  
 
Patient 2B (non-medicated group) 
Figure 6.10 shows that hypocapnia caused no changes in T wave amplitude in any clinically 
relevant leads. Hypocapnia did not cause any clinically significant ST segment elevation in 
the affected ECG leads (figure 6.11). However, a small ST depression did occur during 
hypocapnia in leads V2 (-0.06 ± 0.01mV), V3 (-0.11 ± 0.01mV), V4 (-0.13 ± 0.02mV) and V5 
(-0.11 ± 0.01mV) which was beyond the clinical thresholds of -0.05 to -0.10mV (figure 6.11). 
ST segment depression in these leads was not accompanied by ST flattening or depression of 
the ST(80) point. 
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Figure 6.8. Mean + SE of 2 trials. T wave amplitudes during normocapnia and 
hypocapnia in patient 1B. Wave amplitudes above the dotted line are considered of 
clinical importance. Relevant leads are highlighted by grey boxes.
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Figure 6.8. In patient 1B (non-medicated group), hypocapnia causes clinically 
significant T wave elevation in lead III on the frontal plane of the ECG
Frontal plane
I II III aVR aVL aVF
T 
w
a
ve
 
a
m
pl
itu
de
 
(m
V)
-0.3
-0.2
-0.1
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
Affected leads
 176
 
-0.1
0.0
0.1
0.2
Figure 6.9. Mean + SE of 2 trials. ST segments are defined by deviation of the J point from 
the isoelectric line. The extent of these changes is estimated by deviation of the ST(80) 
point. Data points above/below the dotted line represent clinically significant deviation from 
isoelectric (straight line). Relevant leads are indicated by the grey boxes
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Figure 6.9. In patient 1B (non-medicated), hypocapnia did not cause significant ST 
segment changes in any of the 12 leads of the ECG
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Figure 6.10. In patient 2B (non-medicated), hypocapnia did not cause clinically 
significant T wave elevation in any of the frontal or transverse plane leads
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Figure 6.10. Mean + SE of 2 trials. T wave amplitudes during normocapnia and 
hypocapnia in patient 2B. Wave amplitudes above the dotted line are considered of 
clinical importance. Relevant leads are highlighted by grey boxes.
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Figure 6.11. Mean + SE of 2 trials. ST segments are defined by deviation of the J point from 
the isoelectric line. The extent of these changes is estimated by deviation of the ST(80) 
point. Data points above/below the dotted line represent clinically significant deviation from 
isoelectric (straight line). Relevant leads are indicated by the grey boxes
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Figure 6.11. In patient 2B (non-medicated group), hypocapnia causes ST segment 
changes in leads V2-5 of potential clinical importance
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6.5. Discussion 
In the present investigation, patients in the medicated group A did not display any consistent 
or clinically significant ECG changes during hypocapnia induced by mechanical 
hyperventilation. The absence of changes could be attributed to either a lack of effect of 
hypocapnia on cardiac electrical activity or isosorbide mononitrate medication interfering 
with this effect. In the non-medicated group B, hypocapnia caused small changes in T wave 
amplitude and ST segment height. Absolute T wave amplitudes in lead III during hypocapnia 
in one patient were beyond clinical limits for normality. In another patient, up sloping ST 
segment depression was seen in four anatomically contiguous leads. This was beyond clinical 
thresholds for normality although the actual change from normocapnia was small and 
depression of the J point was not accompanied by depression of the ST(80) point. These 
changes do not confirm the presence of myocardial ischemia during hypocapnia in patients 
suffering from coronary artery disease. However, investigations in further patients are needed 
before any definitive conclusions can be made. 
 
6.5.1. Absence of ECG changes in group A (medicated) 
In both patients in the medicated group A, hypocapnia did not cause any clinically significant 
ECG changes. In these patients, it is possible that the lack of changes were due to the nitrate 
medication they were taking. Isosorbide mononitrate medication stimulates the production of 
nitric oxide in the coronary arteries which relaxes the vascular smooth muscle causing 
vasodilation (Braunwald et al., 2001). It is possible that the vasodilatory effects of isosorbide 
mononitrate may have counteracted the vasocostrictive effects of hypocapnia, thus preventing 
the critical coronary stenosis necessary to reduce O2 delivery to the myocardium.  
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Alternatively, the lack of ECG changes seen in this medicated group A may simply represent 
the lack of effect that hypocapnia has on the ECG in patients suffering from coronary artery 
disease. Whilst previous studies suggest that hypocapnia reduces blood flow and O2 delivery 
to the myocardium (Rowe et al., 1962; Karlsson et al., 1994; Laffey & Kavanagh, 2002; Neill 
& Hattenhauer, 1975; Yokoyama et al., 2008), none have comprehensively proven that this is 
sufficient to cause consistent ECG changes in patients suffering from coronary artery disease. 
To the contrary, Kazmaier et al., (1998) suggested that in patients suffering from coronary 
artery disease, hypocapnia (31mmHg) has no effect on coronary blood flow although in this 
case the stimulus may not have been severe enough to cause an effect. It is possible that in 
some patients, diseased arteries do not respond the stimuli of low PaCO2 that causes coronary 
vasoconstriction in the same way as normal healthy arteries. Without knowledge of the 
mechanism which causes coronary vasoconstriction, it is difficult to speculate as whether or 
not this is the case. 
 
Following the study of these patients in the medicated group A, it was decided by the 
consultant cardiologist that any other patients taking long acting nitrate medication either 
refrain from taking their medication during testing periods or should be excluded from the 
study.  
 
6.5.2. T wave changes in group B (non-medicated) 
In those patients not taking nitrate medication, hypocapnia did cause small ECG changes that 
could be of clinical interest. During hypocapnia, increases in T wave amplitude of up to 0.05 
± 0.01mV occurred in leads II, III and aVF in patient 1B. This resulted in the appearance of a 
hyperacute T wave in lead III. This patient suffered from double vessel coronary artery 
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disease of the left circumflex artery and right coronary artery. This hyperacute T wave in lead 
III would therefore be consistent with the occurrence myocardial ischemia due to insufficient 
O2 delivery from the right coronary artery. If this were the case, hyperacute T waves would 
also be expected in leads II and aVF. However, consistent changes of this type were not seen.  
 
Previous studies have also failed to produce consistent T wave changes during hypocapnia 
induced by voluntary hyperventilation. In 114 patients, Kemp & Ellestad (1968) reported 11 
cases (10%) where voluntary hyperventilation caused ischemic T wave changes. Others have 
demonstrated T wave changes in patients suffering from coronary artery disease (diagnosed 
by coronary angiography) during voluntary hyperventilation in up to 70% of patients (Jacobs 
et al., 1974; Joy & Trump, 1981; Ardissino et al., 1987). Lary & Goldschlager (1974) found 
that 7/192 patients (3%) with coronary artery disease, diagnosed by coronary angiography, 
exhibit ischemic T wave changes during voluntary hyperventilation. In the present 
investigation, it is impossible to draw conclusions from T wave changes seen in one non-
medicated patient, particularly as hyperacute T waves were not seen in all the relevant ECG 
leads. 
 
6.5.3. ST segment changes in group B (non-medicated) 
Clinically significant ST segment elevation was not seen in any patients during hypocapnia. 
Significant depression of the ST segment (at the J point) was seen during hypocapnia in the 
non-medicated patient 2B in leads V2-5 (figure 6.11). The importance of these changes is 
unclear because J point depression was not accompanied by depression of the ST(80) point 
(ST flattening) and the largest absolute decrease in ST height between normocapnia and 
hypocapnia was only 0.05 ± 0.01mV. 
 182
ST segment depression in leads V2-5 indicates the existence of subendocardial ischemia in the 
anteroseptal and extensive anterior regions of the heart. Subendocardial ischemia is usually 
caused by increased oxygen demand due to increased myocardial O2 demand (Wagner, 2008). 
In the present study, the patient’s heart rate and blood pressure (and therefore myocardial O2 
demand) remained normal throughout the experiment. The observed ECG changes were not 
consistent with a reduction in blood supply caused by the partially occluded left main 
coronary artery or the blocked LAD (as indicated by the coronary angiogram). It therefore 
seems unlikely that the observed changes are of clinical importance, particularly as ST 
segment flattening did not occur and up sloping ST segment depression often occurs due to 
normal variation of the ECG (Wagner, 2008). 
  
6.5.4. Conclusions 
The effects of hypocapnia in patients suffering from coronary artery disease remain 
inconclusive due to the small number of subjects recruited in this pilot study. In those patients 
who were investigated, it is not clear whether prescribed medication may have interfered with 
the effects of hypocapnia on the ECG.  
 
Ideally, it is best to recruit patients with established coronary artery disease (diagnosed by 
coronary angiography) that have not undergone any surgery and are not taking any 
medication. Where this was not possible, an attempt was made to identify medications most 
likely to interfere with the results of this investigation and recruit patients who are not taking 
them. It cannot be denied that other medications may have interfered with the results of this 
study via unknown interactions with hypocapnia and its effects on coronary vasoconstriction. 
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Consistent ECG changes induced by hypocapnia in patients suffering from coronary artery 
disease are yet to be demonstrated using mechanical hyperventilation. This pilot study shows 
that it is possible to investigate this if patients can be identified and conflicting medication can 
be properly managed. A full investigation of the effects of hypocapnia on the ECG in patients 
suffering from single, double or triple vessel coronary artery disease is necessary to establish 
whether this technique of inducing hypocapnia by mechanical hyperventilation has any 
clinical value in the early diagnosis of coronary artery disease.  
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Chapter 7 
 
General Discussion 
 
7.1. Summary of findings 
This thesis investigation set out to identify whether hypocapnia causes significant changes in 
the 12 lead ECG of normal subjects and whether these changes are exaggerated in patients 
suffering from coronary artery disease. This was done using an established method of 
mechanical hyperventilation (Cooper et al., 2004) in which hypocapnia can be induced 
without altering breathing frequency and tidal volume. An updated and improved version of 
the ECG apparatus used by Rutherford et al., (2005) was utilised so that 12 ECG leads could 
be recorded simultaneously and the effects of hypocapnia on cardiac electrical activity could 
be examined.  
 
This investigation confirms that mechanical hyperventilation is an effective method for 
inducing severe, sustained hypocapnia which is well tolerated by both normal healthy subjects 
and patients suffering from coronary artery disease. In all studies, PetCO2 was consistently 
reduced to 20 ± 0mmHg and kept at this level for >10 minutes in all subjects. Mechanical 
hyperventilation itself was well tolerated by all subjects, particularly in those accustomed to a 
hospital setting. 
 
The main finding of this thesis investigation is that hypocapnia, induced by mechanical 
hyperventilation, does not cause consistent ECG changes indicative of myocardial ischemia in 
normal healthy subjects. The findings of a pilot study examining the effects of hypocapnia on 
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patients suffering from coronary artery disease were inconclusive; however, preliminary 
results suggest that there is little effect on the ECG. Studies using echocardiography to assess 
the heart function also failed to show any effects of hypocapnia in normal healthy subjects. It 
therefore seems unlikely that ECG changes (in normal subjects) during hypocapnia are due to 
a reduction in O2 availability in the myocardium as has been previously suggested (Rutherford 
et al., 2005). These findings question the degree to which hypocapnia causes a reduction in O2 
delivery to the myocardium via coronary vasoconstriction and an increased affinity of 
haemoglobin for O2 as proposed by Neill & Hattenhauer (1975).  
 
The reasons for the discrepancy between the findings of this thesis investigation and those of 
Rutherford et al., (2005) are unclear. Both studies use the same method of inducing 
hypocapnia with mechanical hyperventilation in a similar number of normal healthy subjects 
(18 in the present investigation vs. 15 studied by Rutherford et al., 2005). The main difference 
between the two studies was the ECG apparatus used. Both were custom made for each 
experiment to enable accurate analysis of the ECG waveform. In the present investigation, the 
ECG apparatus used recorded a 12 lead ECG simultaneously and was calibrated against a 
patient simulator calibration box (Dynatech Nevada Inc., Model 212B, Nevada, USA) and a 
standard digital ECG machine (Philips Hewlett Packard Pagewriter 200). In the study by 
Rutherford et al., (2005), a single lead ECG was recorded using an analogue Neurolog NL840 
amplifier calibrated against a custom built 200uV generator. T wave amplitudes at rest 
recorded by Rutherford et al., (2005) were 0.73mV, more than double the size of those in the 
present study (0.32mV). Resting T wave amplitudes recorded using the ECG apparatus of 
Rutherford et al., (2005) would be considered clinically abnormal (hyperacute) if they were 
compared to the clinical thresholds used in the present study (>0.5mV [Wagner, 2008]). 
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A secondary aim of this thesis investigation was to quantify the degree to which electrode 
modification alters wave amplitudes in the 12 lead ECG. Electrode modification was found to 
significantly decrease R and T wave amplitudes in Lead I of the ECG by 20% at rest and 
during mechanical hyperventilation. Rutherford et al., (2005) used the modified electrode 
placement in experiments studying the effects of hypocapnia on the ECG. Even with a 20% 
reduction in T wave amplitude (which would have occurred had they used the standard 
electrode placement), the resulting T wave amplitude (0.58mV) would still have exceeded 
clinical thresholds for hyperacute T waves (>0.5mV [Wagner, 2008]). This further 
emphasises the notion that the ECG apparatus used by Rutherford et al., (2005) study did not 
produce an accurate representation of the ECG waveform. Because the ECG apparatus used in 
the present investigation was calibrated against two separate machines commonly used in 
clinical practice (Dynatech patient simulator calibrator box and Philips Hewlett Packard 
Pagewriter 200), ECGs recorded were considered accurate and comparable to clinical 
guidelines. 
 
It is unclear where the threshold of 0.1mV for a clinically important reduction in T wave 
amplitude was acquired by Rutherford et al., (2005). Up to date guidelines (Rautaharju et al., 
2009; Surawicz et al., 2009; Wagner et al., 2009) and textbooks (Wagner, 2008) suggest that 
changes in the amplitude of the T wave are only of clinical importance if a change in the 
polarity of the T wave occurs (a positive T wave becomes inverted or vice versa) or the 
absolute amplitude is above 0.5mV (in the frontal plane) or 1.0mV (in the transverse plane). 
Since the findings of Rutherford et al., (2005) were not repeatable in the present investigation 
and no evidence can be found to support the claims that their findings were of clinical 
importance, it appears likely that their observed changes in T wave amplitude during 
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hypocapnia were attributable to random variations rather than a decrease in O2 availability in 
the myocardium. 
 
7.2. Clinical Implications 
This thesis investigation shows that hypocapnia does not cause consistent ischemic ECG or 
echocardiographic changes in normal health subjects and is unlikely to in patients suffering 
from coronary artery disease. It is possible that a more severe hypocapnia might be more 
effective at producing ischemic ECG changes in both patients and normal subjects. However, 
the side effects that accompany the reduction of PetCO2 below 20 mmHg (such as tetany and 
paraesthesia, Macefield & Burke, 1991) mean that it would not be appropriate to perform this 
in a clinical setting or in normal healthy volunteers. 
 
The implications of these findings suggest that the technique of mechanical hyperventilation 
has less clinical value in the diagnosis of coronary artery disease than was previously thought. 
Had the induction of hypocapnia using mechanical hyperventilation caused more exaggerated 
ECG changes in patients suffering from coronary artery disease than those observed in normal 
healthy subjects then the technique may have been of some value as a provocation test for 
stable angina (Rutherford et al., 2005). However, this thesis investigation, including a pilot 
study in patients suffering from coronary artery disease, suggests that this was not the case 
and that mechanical hyperventilation is of little clinical value. It should be noted that the pilot 
study in patients was conducted in a small population of four patients, two of whom were 
taking medication which may have interfered with the effects of hypocapnia on coronary 
vasoconstriction. Therefore, it may be premature to make conclusions about the clinical 
implications of this technique in patients suffering from coronary artery disease. 
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7.3. Limitations 
Likelihood of myocardial ischemia 
Initially, it is worth considering the likelihood that hypocapnia can induce myocardial 
ischemia in normal healthy subjects. Existing evidence suggests that hypocapnia causes a 
reduction in coronary blood flow (Rowe et al., 1962; Neill & Hattenhauer, 1975; Yokoyama 
et al., 2008) and an increased affinity of haemoglobin for O2 (Neill & Hattenhauer, 1975). It 
has been suggested that this causes a reduction in O2 delivery to the myocardium which is 
reflected, even in normal healthy subjects, by ischemic changes in the T wave during 
mechanical hyperventilation in hypocapnia (Rutherford et al., 2005). Previous literature states 
that a coronary artery must be occluded by at least 30-60% for blood flow to become 
significantly reduced (May et al., 1963; Braunwald et al., 2001). However, even an occlusion 
of 60% will not necessarily result in myocardial ischemia. In the presence of coronary artery 
disease, current NICE guidelines suggest that an angina attack (myocardial ischemia) is only 
likely if the coronary artery is occluded by >70% (Cooper et al., 2010). It seems unlikely that 
hypocapnia would cause an occlusion of >70% and resulting myocardial ischemia in a subject 
with healthy coronary arteries, even with the additional effects of reduced O2 dissociation due 
decreased PaCO2.  
 
In light of the present investigation, which highlights the inaccuracies of the findings by 
Rutherford et al., (2005), the notion that hypocapnia causes myocardial ischemia in normal 
healthy subjects seems even less likely. The Rutherford et al., (2005) study is the only 
existing evidence that hypocapnia causes significant reductions in T wave amplitude. The 
present investigation suggests that these changes were not of ischemic origin and also 
questions the accuracy of the equipment used in the previous study to measure the ECG. 
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Changes in female sensitivity to CO2 
In women, the sensitivity of the respiratory system to changes in CO2 alters depending on the 
stage of the menstrual cycle (Dutton et al., 1989). The ventilatory responsiveness to changes 
in PACO2 was found to significantly increase by 2% between the follicular phase and luteal 
phase and significantly decrease by 5% between the luteal phase and menstrual phase. 
Therefore, CO2 sensitivity is significantly higher during the luteal phase of the menstrual 
cycle compared with the menstrual and follicular phases. This increase in CO2 sensitivity is 
thought to be related to an increase in progesterone, which is elevated during the luteal phase 
(Dutton et al., 1989). In the present investigation, this effect was not taken into account and 
therefore represents a potential limitation to the experiments conducted. It is not clear to 
whether changes in CO2 sensitivity throughout the menstrual cycle affect the coronary 
vasoconstriction seen during hypocapnia.  
 
If these experiments were repeated, it would advisable to control this variable by only 
studying female subjects during one phase of the menstrual cycle. It seems most appropriate 
to conduct experiments during the luteal phase of the menstrual cycle, at which point subjects 
would be most sensitive to changes in CO2. 
 
Modes of echocardiography  
Another limitation of this thesis investigation was in the echocardiographic measurements 
used to assess heart function. Three modes of echocardiography were utilised; two-
dimensional M-mode, Doppler blood flow and tissue Doppler analysis. The standard Doppler 
echocardiography used here assessed global left ventricular function by measuring the 
velocity of blood flow through the mitral valve and into the left ventricle during diastole. 
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Myocardial ischemia can cause diastolic dysfunction which would be reflected by a decrease 
in the velocity of blood flow into the left ventricle (Nishimura & Tajik, 1997). This measure 
of heart function is limited because it is insensitive to small changes in diastolic function (as 
might have occurred during hypocapnia). Therefore, only a large change in heart function 
would have been detected using this technique in the present investigation. 
 
In addition to Doppler echocardiography, measures of regional wall motion were made using 
directed two-dimensional M-mode echocardiography and tissue Doppler analysis of the 
lateral wall and septum. Whilst these methods can accurately detect small changes in wall 
motion in the region of the myocardium being imaged, this method of grouping entire walls 
into one is not very specific and will result in large areas of the left ventricle being ignored. 
 
If this experiment were to be repeated, it would be advantageous to take a different approach. 
Instead of using 3 different modes of echocardiography, it would be more beneficial to focus 
on small changes in heart function using detailed tissue Doppler analysis as described by 
Cerqueira et al., (2002). Using this method, the left ventricle is divided into 17 segments 
across three levels (Base, mid-cavity and apex) split into anterior, septal, inferior, and lateral 
segments on each level. Each segment is imaged individually resulting in a more detailed 
analysis of left ventricular function.  
 
Additional modes of echocardiography which could be used to assess left ventricular function 
include qualitative echocardiography and two-dimensional strain imaging. Qualitative 
echocardiography relies on the observer to classify myocardial wall segments according to 
their motion at rest and during myocardial stress. Segments are labelled as non-kinetic, 
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moderately kinetic or hyper kinetic. A difference between motion classifications would 
indicate a potential change in heart function. Two-dimensional strain imaging is advantageous 
because it is not dependant on the angle of the echocardiography transducer as in Doppler 
measurements. It relies on estimation of the vectorial velocities of every pixel within an 
echocardiographic image. These are used to calculate an angle-independant velocity of each 
wall segment over a specified time period (Citro et al., 2008) 
 
Hypocapnic ‘hypoxia’ 
The third study of this thesis investigation attempted to accentuate the effects of hypocapnia 
in 21% inspired O2 by hyperventilating subjects in 15% inspired O2. No differences were 
found between ECG waveforms recorded in both conditions. A possible limitation to this 
study was that by mechanically hyperventilating participants, the effectiveness of breathing 
15% inspired O2 may have been diminished. When subjects inhaled 15% O2 spontaneously, 
O2 saturation measured using pulse oximetry was found to decrease to 93 ± 1%. When 
subjects inhaled 15% O2 during mechanical hyperventilation, O2 saturation remained at 100 ± 
0%. It appears that during mechanical hyperventilation, the augmented breathing frequency 
and tidal volume increased the amount of O2 being exchanged in the lung, therefore 
compensating for the lower proportion of O2 in the air. O2 delivery to the myocardium during 
hypocapnic hypoxia was consequently no different to O2 delivery during hypocapnia in 
normal room air. 
 
In order to achieve the desired reduction in O2 saturation, it would be necessary to reduce 
inspired O2 further, to a level which would not normally be considered safe in normal resting 
conditions. Using the methodology of the present investigation, it would be difficult to predict 
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the level of inspired O2 needed to achieve this prior to experimentation. Therefore, if this 
experiment was to be repeated, a different method would be required. 
 
An alternative approach would be to sample respired gas in each subject and measure end-
tidal O2 (PetO2) instantaneously. This information could then be used in a simple feedback 
system to adjust inspired O2 in each individual in order to achieve a predefined level of PetO2. 
By titrating O2 in this way, it allows the subject’s PetO2 to be accurately controlled regardless 
of whether they are hyperventilating or breathing normally. This technique has been 
successfully utilised by Balanos et al., (2003), Talbot et al., (2008) and Dorrington et al., 
(2010) to study the effects of varying levels of PetO2 and PetCO2 on pulmonary vascular 
resistance. In these experiments, inspired O2 is automatically adjusted by a computer system 
to achieve a predefined PetO2. The same technique was used to alter PetCO2 and induce 
hypercapnia. In the present investigation, mechanical hyperventilation would still be of use if 
this technique were to be utilised because it is still the most efficient method of reducing 
PetCO2 in resting subjects. 
 
Small patient population 
An obvious limitation to final pilot study was the lack of patients studied. This made it 
difficult to draw conclusions as to the effects of hypocapnia on the ECG of patients with 
coronary artery disease. The primary reason for this small population of patients was the 
difficulty in gaining access to this specialist group of patients chosen for study. Whilst the 
prevalence of patients suffering from coronary artery disease is common, it is less common to 
find patients with established coronary artery disease who are not taking coronary vasodilator 
medications, haven’t undergone coronary bypass surgery and are not suffering from any co-
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morbidities (such as asthma, epilepsy, diabetes, renal failure or morbid obesity). Thus, from 
the beginning of the study the pool of eligible patients to recruit from was limited.  
 
In addition, the number of eligible patients who declined participate in the experiment was 
higher than anticipated and on five occasions, patients willing to participate were denied 
permission to by their GP. Although reasons for non-participation were not required, most 
subjects stated a wish not to jeopardise their health any further by participating in an 
experiment which was designed to provoke a stress on the heart. When coupled with the 
limited number of eligible patients for recruitment in first place, this lack of participation 
resulted in a disappointingly low number patients examined over the study period. 
 
If this pilot study was to be continued, it may be worth investigating the effect of hypocapnia 
on the ECG in patients who present with chest pain and have undergone an initial assessment 
of their risk of coronary artery disease. Studying patients with a relatively high risk of having 
coronary artery disease, before they undergo non-invasive cardiac imaging or coronary 
angiography, would increase the number of patients eligible for study and decrease the 
proportion of those eligible who are taking conflicting coronary vasodilator medication. This 
strategy of subject recruitment would also allow a direct comparison of whether there are any 
fundamental differences between the ECGs recorded during hypocapnia in patients eligible 
for diagnostic investigation who have coronary artery disease and those who do not.  
 
During future patient recruitment, only acknowledgement of a consenting patient’s 
participation would be requested from their GP. Since NHS policy does not require the GP to 
consent to a patient’s participation in an experimental study of this kind, it has been possible 
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to gain ethical approval to do this. The advantage of this alternation in recruitment procedure 
is that it takes the responsibility of the patient’s welfare (during the study) away from their 
GP, making it more likely that they will not intervene and prevent participation in the study. 
 
7.4. Future experiments 
As stated previously (in section 7.2), based on the findings of this thesis investigation, it 
seems unlikely that hypocapnia induced by mechanical hyperventilation will provoke 
myocardial ischemia in patients with coronary artery disease. To confirm this, it might be 
worth studying additional patients with varying severities of coronary artery disease under 
hypocapnic conditions to see if ECG changes occur. If this was to be done, the limitations 
highlighted in section 7.3 should be addressed. This would mean testing all female patients in 
the luteal phase of their menstrual cycle and using detailed (17 segment) tissue Doppler 
analysis to measure heart function. Should hypocapnia, induced by mechanical 
hyperventilation, still not result in measurable changes in cardiac electrical activity or heart 
function, then the preliminary assumption that this technique does not induce myocardial 
ischemia would be confirmed and therefore would not require further investigation. 
 
Alternatively, if significant ECG changes did occur and it was assumed that hypocapnia does 
cause myocardial ischemia in patients suffering from coronary artery disease, there are 
subsequent experiments which might be of interest. The investigation of electrocardiographic 
responses to hypocapnia in patients presenting with chain pain of unknown origin would be of 
use in determining whether this technique of mechanical hyperventilation has any use in the 
early diagnosis of coronary artery disease. This study could be incorporated into a larger 
randomised controlled trial comparing the technique of hypocapnia induced by mechanical 
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hyperventilation with a gold standard test for coronary disease (coronary angiography) to 
establish the sensitivity and specificity of this provocative test and whether it is cost effective 
to be used in a clinical setting.  
 
Another study of interest would be to investigate whether inducing hypocapnia with 
mechanical hyperventilation can be utilised with other cardiac imaging techniques. When 
used in conjunction with myocardial perfusion scintigraphy (MPS) using single proton 
emission computed tomography (SPECT), pharmacological stress agents such as adenosine, 
dipyridamole and dobutamine have a higher sensitivity for coronary artery disease than when 
they are used with echocardiography (91% vs. 79%, 90% vs. 72%, 84% vs. 81% respectively) 
(Heijenbrok-Kal et al., 2007). Future experiments would therefore investigate whether 
hypocapnia induced by mechanical hyperventilation is practical with MPS using SPECT or 
wall motion/perfusion magnetic resonance imaging, whether it improves the sensitivity and/or 
specificity for coronary artery disease and whether the techniques are cost effective when 
used in conjunction. 
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Appendix 
Patient details 
Patient 1A  
Age: 42 
Ethnicity: White British 
Allergies: Penicillin 
Past medical history:  
- Asthma (5 years ago) 
- Old gastric ulcer 
- Angina (not resting or night pain) 
Cardiovascular risk: 
- Not diabetic 
- BP normal 
- Cholesterol normal  
- Ex-smoker 
Family history of cardiovascular disease: 
- Mother had a MI aged 69 
- Father had two MIs aged 61 
Current medications: 
- Isosorbide mononitrate  
- Lansoprazole  
- Bisoprolol  
- Simvastatin  
- Aspirin  
- Recommended for surgery: Awaiting coronary angioplasty 
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Patient 2A  
Age: 72 
Ethnicity: White British 
Allergies: None 
Past medical history:  
- Transient ischemic attack (2 years previously) 
- Pleural plaques (no lung disease) 
- Angina (no night pain, occasional rest discomfort) 
Cardiovascular risk: 
- Not diabetic 
- Hypertension 
- Hypercholesterolaemia 
- Ex-smoker 
Family history of cardiovascular disease: 
- None 
Current medications: 
- Isosorbide mononitrate 20mg o.d.  
- Bisoprolol 1.25mg o.d.  
- Simvastatin 40mg o.d.  
- Aspirin 25mg o.d.  
- Ramipril 2.5mg o.d.  
- Recommended for surgery: Awaiting coronary bypass graft 
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Patient 1B  
Age: 54 
Ethnicity: South Asian 
Allergies: None 
Past medical history:  
- Duodenal ulcer 
- Previous right coronary artery stents  
- Angina (not resting or night pain) 
Cardiovascular risk: 
- Not diabetic 
- Normal BP 
- Hypercholesterolaemia 
- Current smoker 
Family history of cardiovascular disease: 
- None 
Current medications: 
- Atenolol 50mg o.d.  
- Simvastatin 40mg o.d.  
- Aspirin 75mg o.d.  
- Ramipril 2.5mg o.d.  
- Lansoprazole 15mg o.d.  
- Fenofibrate 67mg o.d.  
- Finasteride 5mg o.d.  
Recommended for surgery: Awaiting coronary bypass graft 
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Patient 2B 
Age: 74 
Ethnicity: White British 
Allergies: Shellfish 
Past medical history:  
- Angina (not resting or night pain) 
Cardiovascular risk: 
- Not diabetic 
- BP normal 
- Cholesterol normal  
- Ex-smoker 
Family history of cardiovascular disease: 
- None 
Current medications: 
- Simvastatin 40mg o.d.  
- Aspirin 75mg o.d.  
- Nicorandil 10mg o.d.  
- Ranitidine 300mg o.d.  
- GTN spray 
Recommended for surgery: Awaiting coronary bypass graft 
 
 
